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Evidence-based medicine is at the heart of current medical practice where clinical deci-
sions are driven by research data. However, most current therapy recommendations follow
generalized protocols and guidelines that are based on epidemiological (population) stud-
ies and thus not suited for the individual patient’s demands. Patient-tailored therapies are
considered, hence, an unmet clinical need. We believe that mathematical models of the
physiology can attend to such a clinical need, because they can be tuned to the individ-
ual patient. Such models provide a sound mathematical framework for personalized clinical
decisions. In particular, physiological models in medicine can serve the following two pur-
poses: 1) They can be an efficient tool to quantify cardiopulmonary dynamics, conduct
virtual clinical/physiological experiments, and investigate the effects of specific treatments.
2) Model-based estimation techniques can assess physiological parameters or variables, which
are otherwise impractical or dangerous to measure; they can effectively tune a generic model
to become patient-specific, able to mimic the behavior of a particular patient.
In this thesis, we propose a series of modifications to a previously developed cardiopul-
monary model (CP Model) in order to better replicate heart-lung interaction phenomena
that are typically observed under mechanical ventilation, hence allowing for a more accurate
analysis of ventilation-induced changes in cardiac function. The response of this modified
model is validated with experimental data collected during mechanical ventilation conditions.
Further, as an industrial application of mathematical models, we present a patient emula-
tor system that comprises the modified CPModel, a physical ventilator, and a piston-cylinder
arrangement that serves as an electrical-to-hydraulic transducer. The modified CP Model
then serves as the virtual patient that is being ventilated, where disease conditions can be
instilled. Such a system is designed to offer a well-controlled experimental environment
for ventilator manufacturers to efficaciously test and compare ventilation modalities and
therapies, thereby enhancing their verification and validation manufacturing processes.
Finally, we develop a model-based approach to estimate (noninvasively) the function of
the cardiovascular system, in terms of cardiac performance (i.e., cardiac output) and the
dynamics of the systemic arterial tree (i.e., time constant). With this technique, we envision
to provide continuous and real-time bedside monitoring of changes in cardiovascular function,
such as those induced by changes in ventilator settings.
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Recent advances in computing and sensor technologies have significantly enhanced the stan-
dard of care by enabling the measurement and continuous monitoring of physiological vari-
ables, like the electrocardiogram (ECG), the arterial blood pressure (ABP), and the satura-
tion of oxygen in the arterial blood (SpO2). Until recently, only a few medical specialists, like
cardiologists in the operating room, were using sophisticated monitoring devices. However,
the advent of technological solutions enabled the collection and interpretation of clinical
data in all departments within medicine. This, in turn, spurred the interest of the medi-
cal community to the paradigm of evidence-based medicine, where therapies are articulated
according to data-driven research work. Although more and more therapeutic trajectories
have been formulated based on scientific evidence, it became apparent that most therapy rec-
ommendations were largely based on average population features and generalized protocols
dictated by the subject’s medical history, chronic and acute disease states. Population-
based guidelines have indeed improved clinical standards; they have, though, suffered from
the lack of specificity regarding the individual patient’s characteristics and demands. How-
ever, it is well known, and even intuitive, that personalized therapies have a great potential
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to surpass therapy recommendations that follow general guidelines. While the latter are
developed based on epidemiological (population) studies, patient-tailored therapies take into
consideration the health status and pathophysiology of the specific patient.
For instance, general clinical protocols suggest institution of positive end-expiratory pres-
sure (PEEP) as a ventilation therapy to patients with chronic obstructive pulmonary disease
(COPD) who are under mechanical ventilation support. COPD is a common condition that
causes expiratory airflow limitation due to airway obstruction, thereby leading to lung infla-
tion and increased static alveolar pressure. Consequently, patients with COPD suffer from
increased and prolonged diaphragmatic muscle drive. This muscular activity is necessary to
initiate the inspiratory flow and also essential for the patient to fully exhale the volume of
air that contains the waste products of tissue metabolic activity. Accordingly, PEEP appli-
cation has become the recommended means to treat such patients. The externally applied
PEEP aims to balance the increased alveolar pressure, prompting better ventilation and a
decrease in the patient’s work of breathing. However, it is also well known that elevated
pressure in the lungs developed, for instance, due to high values of PEEP can adversely
affect cardiac output. Therefore, any potential ventilatory intervention on COPD patients
would need to be specifically tailored to the individual patient’s cardiac function.
Another example of the necessity of patient-tailored ventilation therapy pertains to wean-
ing from the mechanical ventilator. During periods of ventilation, PEEP and the level of
pressure support both contribute to elevate the intrathoracic and pericardial pressures. In
addition, it is well documented that ventricular wall stress is determined by the balance
between intra- and extra-ventricular (i.e., pericardial) pressures. As a result, an increase
in pericardial pressure yields a reduction in ventricular wall stress. This, in turn, allows
the heart to pump blood easier, thus improving cardiac function. Such a cardiac function
augmentation can significantly help congestive heart failure (CHF) patients who suffer from
reduced cardiac contractility. On the other hand, the weaning phase (i.e., liberation from the
mechanical ventilator), which is currently performed with a progressive reduction of pressure
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support and ultimately with spontaneous breathing trials, has the opposite effects on cardiac
activity. It reduces the intrathoracic pressure, thereby increasing the wall stress and adding
excessive load on the already impaired heart. If not treated appropriately, with the use of
inotropic drugs, reduction of pressure support during the weaning phase may eventually lead
to a complete heart failure.
The aforementioned cases demonstrate the benefits of a personalized treatment over gen-
eralized protocols when it comes to the effects of ventilation therapy on cardiac function.
Such conditions arise due to the mechanical interaction phenomena between heart and lungs.
Even though such cardiorespiratory interactions are pronounced in mechanically ventilated
patients, they are often overlooked in clinical settings when physicians select ventilator set-
tings and ventilation modalities. Furthermore, clinical decision-making usually relies on
personal experience, intuition, generalized protocols, and trial and error strategies. Clearly,
decisions made under such conditions lead to suboptimal ventilator settings affecting both
respiratory and cardiovascular systems. For example, the level of pressure support, which
is one of the ventilator settings under pressure support ventilation (PSV), directly affects
respiratory drive and determines the degree of unloading of the respiratory muscles. An
appropriate degree of respiratory muscle unloading is required to prevent muscle atrophy
and fatigue and thus it is a key determinant of successful weaning and liberation from the
ventilator. At the same time, the level of pressure support indirectly affects the intrathoracic
pressure through the mechanical properties of the lungs and chest wall. Choosing, then, a
value for the ventilator’s PSV setting without considering the characteristics of the respira-
tory system may not only lead to ventilator-induced lung injury, but also to the development
of excess pressure within the thoracic cavity. This, in turn, may compromise cardiac per-
formance. In particular, excess pressure in the thorax could potentially compress the venae
cavae, thus limiting the blood flow returning back to the heart (venous return). The loading
capacity of the heart would then be decreased, resulting in a reduction, according to the
Frank-Starling mechanism, of cardiac stroke volume.
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Undoubtedly, the existence of a methodical and rigorous approach to selecting the appro-
priate settings and therapies is a clear unmet clinical need. This is of particular significance
in intensive care units (ICUs) that are indispensable components of contemporary medical
centers. Solely in the United States, there exist more than 6,000 ICU rooms, admitting about
5 million patients per year [8], the majority of whom are diagnosed with either a cardiovas-
cular (e.g., CHF) or a respiratory (e.g., COPD) disorder [9]. Among them, about 30% (1.5
million patients), require the institution of mechanical ventilation as a form of life support
[10]; a number that is undoubtedly set to increase as a result of the high prevalence of COPD,
for instance. High occupancy of the ICUs [10] adds additional burden to the attending physi-
cians, further contributing to suboptimal choices in therapeutic decisions. For example, a
study [11] showed that standardized protocols provided optimal, patient-tailored, ventilator
settings during only 12% of the time. Additionally, not only does hospitalization in an ICU
room cost more than double of a hospital stay without critical care services (ranging up to
about $3,500 per day [12, 13]), but also it is more likely for an ICU patient to experience
major complications, like ventilator-induced lung injury and heart failure. In addition, pro-
longed institution of mechanical ventilation, either due to the patient’s own clinical condition
or to ventilation-associated complications, leads to higher costs for palliative care [14] and
higher mortality rates in post-ICU days [15]. It is therefore clear that selecting the optimal
ventilation therapy and/or cardiovascular intervention can dramatically reduce the length
of ICU stay, bringing about significant short- and long-term health benefits to the patients
and economic advantages to the clinical institutions.
Under this scheme, we believe that physiology-based mathematical models will have a
profound impact on clinical practice because they allow a mechanistic understanding of the
complex interaction phenomena that occur in the human cardiopulmonary system in both
health and disease. Multiple neural, humoral, and mechanical mechanisms interact to gener-
ate a life-sustaining response under different diseased conditions and external interventions
(e.g., institution of mechanical ventilation, fluid and drug administration). For instance,
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chemoreceptors control the partial pressures of oxygen and carbon dioxide in the arterial
blood by regulating the depth and frequency of the breathing efforts, i.e., minute ventila-
tion. At the same time though, the chemoreflex affects the sympathetic and vagal cardiac and
systemic innervations, thereby modulating cardiac activity and the vasculature’s mechanical
properties. External ventilatory support, on the other hand, although utilized as a means
to sustain adequate ventilation and gas exchange on patients who are unable to breath on
their own, affects the respiratory system’s dynamics. More importantly, it accentuates the
mechanical heart-lung interactions, which are often ignored or misinterpreted in critical care
settings. As such, a holistic view of the entire system’s function is critical for deciding and
selecting patient-tailored critical care services, such as mechanical ventilation support, fluid
resuscitation, and drug administration. Large-scale integrated models offer a deterministic
description of the cardiopulmonary’s system inherent dynamics and can potentially assist
physicians in assessing and understanding the effect of specific therapies and interventions
on the patient’s clinical condition.
Essentially, physiological models explain the time response of the cardiorespiratory sys-
tem’s components via differential equations. These equations are formulated according to
“first principles” and represent the physics of physiological mechanisms and their dynam-
ics. To this end, such equations include physiological state variables and their derivatives
along with parameters that represent the physical attributes of each organ (e.g., material
properties and geometry). For example, the circulatory system is typically described as a
series of fluid reservoirs (capacitors) interconnected via rigid tubes (resistors). The combi-
nation of all cardiopulmonary system’s components then forms an interconnected network of
physiological subsystems that continuously interact in a complex and nonlinear way via gas
exchange, tissue metabolism, mechanical linkages and several neural control mechanisms.
In that capacity, large-scale integrated models lend themselves to the possibility in creating
in-silico virtual patients that can replicate physiological responses observed under different
respiratory and cardiovascular interventions. By using such virtual patients, physicians can
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then adjust key model parameters and recreate the physiological dynamics indicative of a
patient class of interest, such as a COPD or a CHF patient. In turn, this customized class-
specific model will allow physicians to perform “what-if” scenarios to assess the effectiveness
of specific treatments with respect to the virtual patient health progression. Models can
also provide a framework to quantitatively compare the results from such test case scenar-
ios, enabling the selection of the optimal intervention (e.g., change in ventilator settings) in
accordance to a desired therapeutic trajectory and clinical goal.
Besides contributing to the improvement of clinical care standards, model-based virtual
patients can be transformed into high-fidelity emulators on which ventilators can be tested
and evaluated. Physiological models, in the form of patient emulators, can then enhance and
accelerate the design of new and advanced ventilators. This is particularly important for
medical device companies which are keen to develop fully automated ventilation modes, in an
effort to seize any opportunity presented in an expansive ventilator market that could exceed
$5 billion by 2020, according to a recent study [16]. Model-based patient emulators can create
a highly controllable experimental environment, enabling in such a way the quantitative
comparison of different ventilation modes that takes into consideration multiple factors, such
as virtual patient outcomes, patient-ventilator interactions, operator’s engagement time, and
hospitalization costs [11, 17]. As a consequence, such patient emulator systems can reduce or
even eliminate animal or human experimentation, thereby saving time and money—typically
spent on formulating the experimental protocol, on taking approval from the institutional
review board committee, and on patient recruitment—during the design and development
phases of mechanical ventilators.
It is thus evident that mathematical models can form a strong basis for understanding
physiological mechanisms and allow the development of physiology-based virtual patients and
patient emulators. Further, models can play a major role in the estimation of key cardio-
vascular parameters. Evaluation of the patient’s condition and therapeutic decision making
usually rely on only a few measurements that are readily available at the bedside, like the
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ABP signal. Complementary to these, model-based parameter estimation, or system identifi-
cation, techniques can enhance the clinical practice by providing physiological parameters or
variables that are otherwise impractical or dangerous to obtain. One example is the cardiac
output, an index of cardiac performance, which describes the amount of blood ejected by the
heart. Currently, one way to measure cardiac output involves a highly invasive procedure,
namely the thermodilution method, that requires the insertion of a triple-lumen catheter in
the pulmonary artery. Another noninvasive, but rather expensive, way to measure cardiac
output is via the Doppler ultrasound technique. The thermodilution technique is still con-
sidered the gold standard approach for measuring cardiac output, but its use has waned due
to the cardiovascular complications associated with it. Furthermore, both methods provide
only intermittent values and require expert personnel for the placement of the catheter or the
ultrasound probe. Clearly, a noninvasive model-based technique to estimate cardiac output,
or any other cardiovascular quantity, is highly desirable in the medical community. These
model-based techniques can provide a continual assessment of cardiac performance via the
estimation of cardiac output, which can be subsequently utilized to evaluate the circulatory
system’s health status.
In summary, Fig. 1.1 shows a high-level schematic representation of the motivation be-
hind the work in this thesis which aims to improve the current standard of care in clinical
settings. In particular, continual monitoring of the patient’s clinical condition via medical
instruments leads to a set of measured physiological variables, with one of them, for instance,
being the ABP signal. These, in turn, are fed into parameter estimation, or system iden-
tification, techniques that estimate parameters or variables that are otherwise impractical
or dangerous to measure (e.g., cardiac output). Practically, such techniques can fine tune a
generic physiological model to the particular patient under study, thus turning the generic
model into a patient specific one. The estimated parameters/variables can then comple-
ment the measured quantities for a more accurate assessment of the patient’s health status,
thereby offering a personalized clinical decision support (CDS) to the attending physicians
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and contributing to the articulation of optimal control strategies on medical devices, such




















Fig. 1.1. A high-level schematic representation of the motivation behind the work presented
in this thesis (green boxes). System ID, system identification; CDS, clinical decision support.
1.2 Thesis organization
This thesis outlines a plan to use physiological models as a key component for developing
tools to improve testing of mechanical ventilation therapies and to estimate important car-
8
1.2 Thesis organization
diovascular parameters and variables. It is thus structured based on the logical progression
toward the materialization of such a plan. In Chapter 2, we propose a series of modifications
(i.e., pericardial membrane, interventricular septum, modified pulmonary circulation) to a
previously developed cardiopulmonary model [18, 19] in order to better replicate the heart-
lung interaction phenomena typically observed in mechanical ventilation conditions. We also
describe simulation studies to validate the response of such a modified model and highlight
its limitations. Then, in Chapter 3, we present the patient emulator, a novel system that can
be used as a platform for in-silico testing of mechanical ventilation therapies. The system
is based on the proposed large-scale mathematical model of the human cardiopulmonary
system of Chapter 1, interfaced with a physical ventilator via a controlled piston-cylinder
configuration. The performance of the proposed patient emulator is demonstrated by sim-
ulating a realistic pressure support ventilation step protocol. Finally, in Chapter 4, we
introduce a model-based approach to estimate cardiac output from arterial blood pressure
measurements. Our approach is articulated after a comprehensive analysis of the systemic
circulation’s dynamic characteristics and a detailed evaluation of the limitations of current
estimation techniques. Validation of the proposed algorithm is carried out on synthetic data
simulated from either a lumped- or a distributed-parameter model of the arterial tree.
9
Chapter 2
Modeling the heart-lung interactions
during mechanical ventilation
2.1 Introduction
The human body is a complex dynamic system with sophisticated regulatory processes to
maintain the proper function of body organs. Physiological homeostasis, defined as the
body’s ability to keep vital physiological variables within normal ranges, is dependent on in-
teractions between the cardiopulmonary system and the neurohumoral control mechanisms
that regulate the system’s function via short- and long-term pathways. For instance, ade-
quate oxygen (O2) delivery to, and carbon dioxide (CO2) removal from, the body organs are
the result of neural feedback mechanisms acting on the cardiorespiratory system via inputs
from different sensors. Chemoreceptors and baroreceptors, for example, respectively monitor
the gas contents in blood and the level of blood pressure in the systemic arterial circula-
tion, while chemoreflex and baroreflex signals induce changes to efferent neural activities,
modulating cardiovascular and respiratory functions.
Neural pathways clearly have a major contribution to regulating the function of the car-
diopulmonary system. However, direct mechanical cardiorespiratory interactions also exist.
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These arise due to the location of the heart being inside the thoracic cavity. Despite its role
as a natural protective medium to the heart, the thorax also forms a mechanical linkage
between the heart and lungs that significantly affects cardiac activity. Lung inflation due to
respiratory activity causes cyclic variations in the intrathoracic (pleural) pressure, which, in
turn, affect all cardiovascular components within the thoracic cavity, such as thoracic veins,
heart, pulmonary circulation, and aorta. Not only do the respiratory-induced variations in
cardiac function appear under normal breathing conditions, giving rise to the well-known
phenomenon of “pulsus paradoxus” [20], but they are also prevalent in mechanically venti-
lated subjects—though reciprocal in nature (reversed pulsus paradoxus) [21].
Mechanical ventilation is a life support procedure. It is typically instituted when a patient
is unable to maintain adequate ventilation and gas exchange on their own. Positive pressure
ventilation, a ubiquitous form of mechanical ventilation, delivers air at the patient’s airway
opening and expands the lungs by increasing the transpulmonary pressure, the difference
between alveolar and pleural pressures. Such ventilatory events induce positive swings in
pleural pressure, which represents the external pressure for the thoracic veins. Consequently,
downstream pressure of the systemic venous return is increased, resulting in a decrease in
the flow of blood into the right atrium and right ventricle [22]. In addition, inflation of the
lung alveoli compresses the pulmonary peripheral vessels, hence raising the pulmonary cir-
culation’s impedance to blood flow [23]. Increase in right ventricular afterload in addition to
preload reduction during inhalation, respectively due to the increased pulmonary impedance
and decreased systemic venous return, limit the stroke volume ejected by the right ventricle.
Besides right ventricular activity, inspiratory events during positive pressure ventilation also
influence the function of the left ventricle. Compression of the pulmonary capillaries due
to alveolar inflation reduces the blood volume in the pulmonary circulation and increases
the flow of blood into the left atrium (pulmonary venous return) [24]. Thus, left ventricular
filling is raised during the inspiratory heart beats, thereby leading to a higher ventricular
output (stroke volume) according to the Frank-Starling mechanism.
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Despite such cyclic changes in left and right ventricular functions due to breathing, the
autonomic nervous system (ANS) is capable of adequately regulating the activity of the
heart [25]. However, erroneous ventilator settings (e.g., high pressure support level) or
sustained ventilation patterns, like in the case of positive end-expiratory pressure (PEEP),
can potentially compromise cardiac performance (PEEP is a constant pressure delivered
to the patient to prevent alveolar collapse). For instance, general clinical protocols [26]
suggest institution of PEEP to patients with acute respiratory distress syndrome (ARDS)
who are under mechanical ventilation support. ARDS is a common inflammatory condition
that causes increased permeability of the pulmonary vascular wall [27]. This allows fluid to
seep into the alveolar compartments, leading to a decreased lung compliance. Inevitably,
patients with ARDS suffer from poor gas exchange and could eventually develop arterial
hypoxemia if their condition is left untreated. Tachypnea is another typical manifestation
of ARDS. It is perceived to be a response of the ANS to counterbalance the impaired gas
exchange by increasing minute ventilation and permitting more oxygen-rich air to enter the
lungs. Accordingly, PEEP application has become the recommended method to treat such
patients [26] in an effort to expand the fluid-filled alveoli and reduce the edema. With
alveolar recruitment, gas exchange is expected to improve, thereby prompting better blood
oxygenation [28]. However, it is also well known that elevated pressure in the lungs, developed
due to high PEEP, can adversely affect cardiac output through a reduction in systemic
venous return. Therefore, any ventilatory intervention on ARDS patients would need to
be appropriately selected by taking into consideration potential detrimental effects on the
cardiovascular system.
It is apparent that determining the most effective therapy, like a treatment for an ARDS
patient, requires a systematic understanding of the inter-connections between the different
components of the human cardiopulmonary system. Mathematical models of the cardiopul-
monary physiology lend themselves to such an understanding. They establish a mechanistic
description of the complex cardiorespiratory interactions and demonstrate their cause-effect
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relationships. As a result, model-based computer simulations can provide an efficient quanti-
tative tool to analyze cardiopulmonary dynamics. Using such simulations, medical personnel
can conduct virtual physiological experiments, investigate different clinical scenarios, and as-
sess the outcomes of specific treatments based on a virtual patient health progression.
Over the past few years, several investigators [29, 30], besides our group [18, 19], have
proposed mathematical models of the combined cardiorespiratory physiology. However,
most of the earlier work was not tailored to simulate mechanical ventilation scenarios. This
would, in fact, require a model that includes both neural and mechanical cardiorespiratory
inter-connections, since both mechanisms are necessary to reproduce the cardiopulmonary
dynamics that occur under mechanical ventilation conditions (e.g., patient’s response to
changes in ventilator settings). Specifically, the model proposed by Cheng et al. [29], al-
though quite comprehensive, is primarily focused on the ANS response during sleep, like
simulation of Cheyne-Stokes respiration and sleep apnea. The model from Lu et al. [30],
on the other hand, has more rigor in describing the dynamics associated with the mechan-
ical heart-lung interactions. However, this model is less detailed in the description of the
short-term neural mechanisms involved in the cardiovascular and respiratory control sys-
tems. The integrated cardiopulmonary model (CP Model) that was recently introduced by
our group [18, 19] features cardiorespiratory control mechanisms, cardiovascular circulation,
respiratory mechanics, alveolar and tissue gas exchange, as well as gas transport. It is, to
our opinion, a truly comprehensive model and hence suitable to simulate cardiopulmonary
dynamics in mechanically ventilated subjects. However, despite its rigorous representation
of the neural pathways, the CP Model presented certain limitations, especially with regard
to the mechanisms that contribute to the mechanical heart-lung interactions, as highlighted
by Albanese et al. [18].
In fact, experimental studies [31] have indicated that the cyclic changes in cardiac ac-
tivity induced by respiratory events are predominantly attributed to four elements: the
thoracic cavity, the pericardial membrane (pericardium), the interventricular septum, and
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the pulmonary peripheral vessels whose resistance to blood flow changes as a function of
alveolar volume. Of these elements, the CP Model proposed by Albanese et al. [18] incor-
porated only the thoracic cavity. As such, the purpose of this work is to better model the
mechanical cardiorespiratory interactions by 1) adding the interventricular septum and the
pericardium to the cardiac model of the integrated CP Model and 2) introducing a modified
pulmonary circulation model that includes a varying pulmonary peripheral resistance as a
function of alveolar volume. Additionally, with the current study, we aim to validate the
“modified CP Model”, which includes the pericardium, the septum, and the varying pul-
monary peripheral resistance, by comparing the model-predicted cardiorespiratory variables
with experimental human data taken from literature. Such experimental datasets represent
ventilatory interventions and strategies typically considered by medical personnel.
2.2 The original cardiopulmonary model
The cardiopulmonary model (CP Model) was first proposed by Albanese et al. [18] and was
based on experimental evidence of the cardiopulmonary dynamics observed in healthy, spon-
taneously breathing, individuals. The parameters of the model were assigned in reference
to a generic 70-kg subject so that the model’s dynamic response illustrates features typical
to such average population data. The model was also validated with experimental data
under hypoxia and hypercapnia [19]. Subsequently, as part of our work for the development
of the patient emulator system of Chapter 3, we introduced certain modifications in order
to improve the model’s clinical interpretability and its response in mechanically ventilated
conditions1. In particular, we proposed an extension to the ventilatory control module by
including a simple model of the Hering-Breuer (HB) reflex. The HB mechanism affects
respiratory muscle activity in order to prevent lung over-inflation and it is of paramount
1As we will analyze in further detail in Chapter 3, the patient emulator system presents an industrial
application of the modified CP Model. The model then serves as the virtual patient that is being ventilated
by a real physical ventilator, where disease conditions can be instilled. Such a system was designed to offer
a well-controlled experimental environment for comparison of mechanical ventilation therapies.
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importance in spontaneously breathing subjects under mechanical ventilation support. Such
a reflex was modeled via a tidal volume threshold-based logic that adapts according to the
partial pressures of O2 and CO2 in the arterial blood. This logic determines the duration
of each inspiratory breathing cycle and forces the model’s respiratory muscle pressure gen-
erator to switch into the expiratory phase as soon as the tidal volume threshold has been
reached. Besides the ventilatory control module, we also introduced a series of changes in the
systemic circulation and respiratory mechanics models. Specifically, the four-compartment
lung mechanics model was replaced by a first-order single-compartment model [32] due to
its widespread use in the respiratory community. Further, the five-compartment systemic
arterial circulation was reduced to a dynamically equivalent two-compartment model, as in
the model proposed by Ursino [33], where the muscular, coronary, and cerebral components
were lumped into the extrasplanchnic element. This choice was dictated by the fact that
the analysis was not focused on studying the response of the different systemic vascular
compartments, but rather on analyzing the overall cardiovascular response to physiological
events induced by mechanical ventilation. Fig. 2.1 shows the high-level block diagram of the
CP Model after the aforementioned adaptations. It serves as the basis for the work presented
herein and will be referred to as the “original CP Model” in the following sections.
2.3 Model modifications
As mentioned in Section 2.1, a series of modifications are introduced to the cardiovascular
component of the original CP Model in the attempt to improve its capability to reproduce
heart-lung interaction mechanisms that are typically observed during mechanical ventilation.
These modifications are the inclusions of the pericardium, the interventricular septum, and
the modified pulmonary peripheral circulation and are all three depicted in the block diagram
of Fig. 2.2. The modified pulmonary circulation model includes the following connection































































Fig. 2.1. High-level block diagram of the cardiopulmonary model. CNS, central nervous sys-
tem; P aO2 and P aCO2 , oxygen (O2) and carbon dioxide (CO2) arterial blood partial pressures,
respectively; CaO2 and CaCO2 , O2 and CO2 gas concentrations in the arterial blood, respec-
tively; CvO2 and CvCO2 , O2 and CO2 gas concentrations in the venous blood, respectively;
Psa, systemic arterial blood pressure; Ppl, pleural (intrathoracic) pressure; Pmus, respiratory
muscle pressure; VT , tidal volume.
1) alveolar pressure (PA) acting as the extravascular pressure of the pulmonary capillaries,
and 2) alveolar volume (VA) affecting the flow of blood into the capillaries via a VA-dependent




Fig. 2.2. Schematic block diagram of the cardiovascular system of the modified CP Model.
Psa and Ppa, systemic and pulmonary arterial blood pressures; Pra and Pla, right and left
atrial pressures; Prv and Plv, right and left ventricular pressures; Ppal, pulmonary arteriolar
pressure; Ppc, pulmonary capillary pressure; Ppv, pulmonary venous pressure; Pperi, pericar-
dial pressure; Ppl, pleural (intrathoracic) pressure; PA, alveolar pressure; Vra and Vla, right
and left atrial volumes; Vrv and Vlv, right and left ventricular volumes; Vspt, septal volume;
Vperi, pericardial volume; VA, alveolar volume; Qrv,o and Qlv,o, right and left ventricular out-
put blood flows; Qpa, pulmonary arterial blood flow; Qpal, pulmonary arteriolar blood flow;
Qpc, pulmonary capillary blood flow; Qps, pulmonary shunt blood flow; MV, mitral valve;
AV, aortic valve; TV, tricuspid valve; PV, pulmonary valve; H, imaginary plane defining




The pericardium is a membrane that envelops the heart and serves as the connective medium,
inside the thoracic cavity, between the heart and the chest wall. Its behavior resembles that
of a passive fluid chamber with nonlinear elastic properties. To describe the pericardial
pressure-volume characteristics, we have used the exponential function proposed by Chung
et al. [34]. Such a function relates the transmular pressure across the pericardium (Ppcd)—
the difference between the pressure inside the pericardial membrane (Pperi) and the pleural
pressure outside of the pericardium (Ppl)—with the total blood volume enclosed by it (Vtot),
Ppcd(Vtot) = P0,pcd ·
(
ekE,pcd·(Vtot−Vu,pcd) − 1) . (2.1)
P0,pcd is a scaling factor, kE,pcd is an elastance coefficient, and Vu,pcd is the volume enclosed
by the pericardium when the transmular pressure Ppcd is zero (unstressed volume). The
values of these parameters have been taken from [30] and are reported in Table 2.1. Notice
that the total volume Vtot is composed of the volumes of all four heart chambers, the volume
of fluid within the pericardial space (Vperi = 40 ml [35]), in addition to the volumes of the
myocardial tissue and coronary circulation, which are, however, neglected in the modified
CP Model.
2.3.2 Interventricular septum
The original CP Model featured four mechanically independent heart chambers. In the
modified cardiopulmonary model, we modify the original cardiac model to include only the
interventricular septum, while we maintain the assumption of a rigid interatrial wall. That is,
we assume that atrial interference has a minimal contribution to the overall cardiovascular
hemodynamics despite the fact that such an interference could influence cardiac function
[38], particularly in patients with heart defects.
To model the interventricular septum, we follow the approach suggested by Chung et
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kE,(·) (ml-1) 0.011 [33] 0.014 [33] 0.005 [30] 0.175[36]
P0,(·) (mmHg) 1.5 [33] 1.5 [33] 0.5 [30] 1.11 [36]
Vu,(·) (ml) 35.904 [18] 14.758 [18] 200 [30] 0 [36]
Emax,(·)0 (mmHg/ml) 1.412 [37] 2.392 [37] — 32.4
Note that the subscript (·) is used as a placeholder to indicate the respective compartment,
that is rvf and lvf for the right (RV) and left ventricular (LV) free walls respectively, pcd
for the pericardium, and spt for the septum. The subscript 0 indicates the basal value of
the parameter Emax, which is subject to changes by the autonomic nervous system. kE,
elastance coefficient; P0, scaling factor; Vu, unstressed volume; Emax, wall elastance at the
maximum contraction point (end-systole).
al. [34] who extensively validated their proposed model with echocardiographic images. Ac-
cording to that work, the expansion of the original heart model to include the septum is
accomplished by splitting the total ventricular space via an imaginary plane H into three
compartments (Fig. 2.2). This separation creates three functional volumes: the right and
left ventricular free wall volumes (Vrvf and Vlvf , respectively) and the septal volume (Vspt).
Vrvf (or Vlvf ) represents the blood volume that is bounded between the right (left) ventric-
ular free wall and the plane H in Fig. 2.2. Similarly, Vspt characterizes the volume of blood
between the septal wall and H. Further, due to the natural position of the interventricular
wall protruding into the right ventricle, a septal curvature towards the right ventricular free
wall (Fig. 2.2) designates a positive Vspt. As a consequence, right and left ventricular volumes
are respectively defined as Vrv = Vrvf − Vspt and Vlv = Vlvf + Vspt.
Heart contraction is simulated by the activation of the three walls, i.e., the right and
left ventricular free walls and the interventricular septum. Modeling the ventricular walls
and septum as active contractile elements originates from the physiologic behavior of the
myocardium to contract as the electrical stimulus progresses via the right and left bundle
branches (septal myocardium) into the Purkinje fiber system (ventricular myocardium) [39].
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Moreover, such an electrical activation is known to induce the septum’s paradoxical move-
ment against its transmular pressure gradient [40], since left ventricular pressure (Plv) is
always larger than right ventricular pressure (Prv) under normal physiological conditions.
The contractile activity of the three walls is modeled by means of a variable-elastance
model such that the pressure-volume relationship varies between end-systolic and end-diastolic
states. The transition between these two states is governed by a half-sine activation function
φ(t) whose period is equal to the heart period [18]. The pressure-volume relationships of the
two ventricular free walls remain unchanged as compared to the ones in [18]. For instance,
the maximal isometric transmular pressure across the left ventricular free wall (Pmax,lvf ) is
defined as a function of Vlvf according to the equation
Pmax,lvf (t) = φ(t) · Pmax,lvf (Vlvf )|ES + (1− φ(t)) · Pmax,lvf (Vlvf )|ED. (2.2)
Pmax,lvf (Vlvf )|ES = Emax,lvf · (Vlvf − Vu,lvf ) and Pmax,lvf (Vlvf )|ED = P0,lvf · (ekE,lvf ·Vlvf − 1)
respectively are the end-systolic (ES) and end-diastolic (ED) components that determine
the elastic behavior of the free wall during a cardiac cycle. Emax,lvf is the wall elastance at the
maximum contraction point (end-systole), Vu,lvf is the unstressed volume of the ventricular
wall, and P0,lvf , kE,lvf are the parameters that characterize the end-diastolic exponential
function. Subsequently, the maximal pressure of the left ventricle (prior to any viscous
losses due to blood flow over the aortic valve) can be computed by taking into account that
Pperi acts as the external (reference) pressure of the ventricular free wall. Hence, Pmax,lv =
Pmax,lvf + Pperi. For the sake of brevity, the equations that are necessary to simulate the
complete ventricular function, including ventricular filling, valve operation, and ventricular
ejection, are omitted from this section. A detailed description of these elements can be found
in [33].
As for the elastic properties of the right ventricular free wall and septum, an analogous
approach is considered. The right ventricular free wall adheres to the same formulation
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of the biphasic pressure-volume relationship as in (2.2). On the other hand, the behavior
of the septal wall is modeled in the inverse way. Specifically, Chung et al. [34] suggests a
variable-elastance model that predicts the instantaneous septal volume Vspt as a function of
the pressure gradient across the septum, Pspt = Plv − Prv:
























+ Vu,spt, Pspt < 0
(2.5)
for end-systole (ES) and end-diastole (ED), respectively. The parameters Emax,spt, Vu,spt,
kE,spt, and P0,spt have the same meaning as those of the left ventricular free wall in (2.2).
The values of the parameters that characterize the elastic properties of all three cardiac walls
are reported in Table 2.1, along with the corresponding reference source.
It is important to note that the difference between Emax,(·)0 in Table 2.1 and Emax,(·)
used in (2.2–2.5) is attributed to the effect of the autonomic nervous system. The ANS
efferent sympathetic pathway regulates the magnitude of cardiac contraction by controlling
the elastance values of the two ventricular free walls and of the septum. Emax,(·)0 then
indicates the basal elastance value that is subject to modulation by the ANS, whereas Emax,(·)
is the resultant value after the action of the ANS. The equations describing the regulatory
mechanisms for the ventricular free wall elastances are kept the same as the ones in the
original CP Model [18], which were taken from Ursino and Magosso [37]. We then need
to introduce the model for the septal elastance effector response to the ANS sympathetic
activity. This model follows the same approach suggested by Ursino and Magosso [37] for
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the ventricular free wall elastances; that is, it includes a logarithmic function to describe
the effector’s static response, a pure delay, and a low-pass first-order filter for simulating its
dynamic behavior. Specifically, the maximal elastance of the septum (Emax,spt) changes with






fsh · (t−DEmax,spt)− fes,min + 1
)
, if fsh ≥ fes,min







· (−∆Emax,spt + σEmax,spt), and (2.7)
Emax,spt(t) = ∆Emax,spt(t) + Emax,spt0. (2.8)
σEmax,spt is the output of the logarithmic static function in (2.6), GEmax,spt is a gain factor,
DEmax,spt is the latency in the static response, τEmax,spt is the time constant of the first-order
filter, and fes,min is a threshold for sympathetic stimulation. Following the method by Ursino
and Magosso [37], GEmax,spt and Emax,spt0 are respectively set to 16.1% and 81% of the orig-
inal septal elastance value reported in [36]. The parameter values, besides Emax,spt0 (see
Table 2.1), of this reflex regulatory mechanism are reported in Table 2.2.
Table 2.2. Parameters of the septal elastance reflex effector model (Eqs. 2.6 and 2.7)
DEmax,spt = 2 s [37] τEmax,spt = 8 s [37]
GEmax,spt = 6.44 mmHg·ml-1·(spikes/s)-1 fes,min = 2.66 spikes/s [37]
See text for explanation of symbols.
2.3.3 Pulmonary peripheral vessels
The location of the pulmonary circulation within the lung interstitium, the space between the
alveoli and the visceral pleura, dictates that the external pressure of most of the pulmonary
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vessels, like the pulmonary arteries and veins, is equal (on average) to pleural pressure. How-
ever, the capillaries that participate in gas exchange are in direct contact with the alveoli.
This, in fact, allows the diffusion of gases, like O2 and CO2, to take place. Consequently,
it is reasonable to conclude that the extravascular pressure of these capillaries more closely
resembles an average alveolar pressure rather than the pleural pressure [31]. This consid-
eration is also supported by the “waterfall phenomenon” that has been observed between
pulmonary capillary and venous vasculatures [41]. Additionally, the close proximity of the
capillaries to the alveolar space contributes to the compression of the intra-capillary lumen
as alveolar volume increases [42]. Such a phenomenon is the primary factor in the increase
of pulmonary impedance and thus of right ventricular afterload, typically observed during
inspiration in positive pressure ventilation [23]. Reducing the vascular lumen inevitably
leads to a reduction of the blood flow toward the pulmonary capillaries, an event that can

















Fig. 2.3. Electrical diagram of the pulmonary circulation model of the modified CP Model.
P , pressure; Q, blood flow; R, resistance; L, inertance; C, compliance. Subscripts: pa,
pulmonary arteries; pal, pulmonary arterioles; pc, pulmonary capillaries; pv, pulmonary
veins; la, left atrium; ps, pulmonary shunt; pl, pleural space; A, alveolar space. The variable
resistances Ppal, Rpc, and Pps are indicated by diagonal arrows.
Accordingly, Fig. 2.3 shows the modified pulmonary circulation model that is developed
based on the work by Lu et al. [30]. The model consists of four pressure nodes—pulmonary
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arteries (Ppa), pulmonary arterioles (Ppal), pulmonary capillaries (Ppc), and pulmonary veins
(Ppv)—, a pulmonary shunt compartment, and three variable resistances—pulmonary arte-
riolar (or pre-capillary) resistance (Rpal), pulmonary shunt resistance (Rps), and pulmonary
post-capillary resistance (Rpc). In comparison with the original CP Model, the following
modifications have been introduced. 1) The single pulmonary peripheral compartment in
the original model [18] has been replaced by two nodes: the pulmonary arterioles and the
pulmonary capillaries. With this approach, we attain an explicit separation of the extra-
alveolar peripheral vessels from the capillary level that is in close proximity to the alveoli.
Pleural pressure (Ppl) can then be set as the external pressure of the pulmonary arterioles,
while the pressure at the pulmonary capillaries is referenced to alveolar pressure (PA). These
two distinct pressure nodes also allow for a more accurate representation of the pulmonary
shunt. Anatomically, the shunt is located between pulmonary arteries and pulmonary veins
and comprises the pulmonary peripheral vessels that do not participate in gas exchange.
Hence, it is more reasonable, from an anatomical point of view, to model the shunt as a
compartment, parallel to the pulmonary capillaries, that originates from the arteriolar pres-
sure node and thus it is not subjected to the same transmular pressure as the capillaries
(see Fig. 2.3). 2) The effects of the compression of the pulmonary capillaries due to lung
expansion have been modeled via a variable resistance (Rpal) that is function of alveolar
volume (VA). According to Lu et al. [30],






where Rpal,0 is a constant value that represents the arteriolar resistance when alveolar volume
has reached its maximum value, VA,max. Alveolar inflation hence yields a quadratic increase
in Rpal, thereby inducing a reduction of the blood flow toward the pulmonary capillaries.
Clearly, (2.9) is a function solely of VA. However, retaining such a relationship with no
additional modifications invalidates our modeling scheme, which includes a pulmonary shunt
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component (see Figs. 2.2 and 2.3) to simulate the amount of blood that does not contribute
to gas exchange. Modeling the effects of anatomical shunting is accomplished by adjusting
the resistance values of shunted and non-shunted pulmonary peripheral compartments, i.e.,
Rps, and Rpal and Rpc respectively, such that the distribution of blood between the two
segments matches the selected shunt fraction (sh). For example, in normal physiological
conditions sh is equal to 1.7%. This indicates that 1.7% of blood flow coming out of the
pulmonary arteries does not participate in gas exchange (shunted blood flow). As a result,
not only does the arteriolar resistance need to depend on VA but on sh as well. Hence, (2.9)
is modified as follows:
Rpal(VA, sh) =
Rpp,tot






where Rpp,tot is the total resistance of the pulmonary peripheral circulation at steady-state
conditions and at a nominal functional residual capacity (FRCnom),
Rpp,tot =
Rps · (Rpc + Ppal(VA = FRCnom))
Rps +Rpc + Ppal(VA = FRCnom)
. (2.11)
The value of FRCnom is selected equal to 2.25 liters as the model-predicted functional residual
capacity for a nominal set of respiratory system parameters, i.e., an airway resistance of
1.7459 cmH2O·s/l, and lung and chest wall compliances of 0.2 l/cmH2O and 0.2445 l/cmH2O,
respectively. The complete set of equations that describe the pulmonary circulation model
is presented in the Appendix.
Table 2.3 presents the parameters of the pulmonary circulation model of Fig. 2.3 along
with the reference sources where the parameter values were taken from. Notice that the
compliance and unstressed volume values of the pulmonary arterioles and pulmonary capil-
laries (Cpal and Vu,pal, and Cpc and Vu,pc, respectively) have been computed such that their
parallel arrangement (in zero-flow conditions) provides values equivalent to those published
in [18] and [37]. In particular, the unstressed volume of the pulmonary peripheral circu-
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lation in the original CP Model [18] is 108.24 ml, while Ursino and Magosso [37] report a
value of 5.8 ml/mmHg for the compliance of the peripheral compartments. To complete
the calculation, we follow the convention used by Lu et al. [30] where Cpc = 2 · Cpal and
Vu,pc = 3/2 · Vu,pal.









Cpa = 0.76 [18] Vu,pa = 0 [18] Rpa = 0.023 [18] Lpa = 1.8 · 10−4 [18]
Cpal = 1.93 Vu,pal = 43.30
Rpp,tot = 0.0894 [37]
Cpc = 3.87 Vu,pc = 64.94
Cpv = 25.37 [18] Vu,pv = 105.6 [18] Rpv = 0.0056 [18]
See text and Fig. 2.3 legend for explanation of symbols.
2.4 Comparison between modified and original models
In this section, we compare the response of the modified CP Model with the original model
under normal breathing conditions. The dynamic equations of the modified CP Model, in-
cluding those that describe the pericardium, the interventricular septum, and the modified
pulmonary circulation, were programmed in Simulink® (MathWorks, Natick, MA). Simulink®
is a computational environment specialized for high-accuracy numerical integration of or-
dinary differential equations. In our implementation, simulation of the cardiopulmonary
system’s dynamic response was attained by solving the model’s differential equations via
the fourth-order Runge-Kutta method with a fixed-size integration step of 0.0005 seconds
(2 kHz rate).
Comparison of the response of the modified CP Model with the original model serves two
primary purposes. 1) First, we intend to illustrate that the original and modified models are
dynamically equivalent, both in normal resting conditions (normoxia) and under external
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perturbations, namely hypercapnia and hypoxia. These scenarios were selected in line with
previous work by our group [18, 19], where model-predicted respiratory and cardiovascular
variables were compared against experimental data collected from healthy human subjects.
Demonstrating the equivalence of the responses from the two models effectively provides a
verification that any validation performed by Cheng et al. [19] would also hold for the modi-
fied CP Model. 2) Second, we want to illustrate the differences between the two models with
regard to the mechanical effects of respiration (normal breathing) on cardiovascular function.
This serves as a first demonstration of the improvements presented by the three newly intro-
duced model components toward a better representation of the heart-lung interactions. A
more rigorous analysis is presented in Section 2.5, where we validate the modified CP model
with experimental data, and in Section 2.6, where we evaluate the individual contribution
of the three new model components to the overall model response in mechanical ventilation
scenarios.
2.4.1 Normoxia
Table 2.4 includes the static values (at end-expiration) of main hemodynamic variables pre-
dicted by the modified CP Model in normoxic conditions. That is, we simulate the response
of a healthy individual who is breathing spontaneously from room air (F IO2 = 21.038% and
F ICO2 = 0.0421%). The predictions of the original CP Model under the same normoxic
conditions are also reported in Table 2.4, along with the normal ranges observed in the
general population. All model-predicted variables attain static values within their expected
physiological ranges. We notice no significant difference in the variability between the two
models and we can therefore conclude that the overall hemodynamic responses of the two
models are practically equivalent.
In detail, both end-systolic and end-diastolic left ventricular volumes (Vlv) of the modified
CP Model show a notable increase compared to those predicted by the original model. On
the other hand, right ventricular volumes (Vrv) are reduced relatively to their original values.
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Table 2.4. Static values of main hemodynamic variables in normoxic conditions
Variable Original model Modified model Normal range
Systemic arterial pressure, Psa (mmHg)
Mean 89.39 89.39 70–105 [18]
Systolic 121.83 121.85 100–140 [18]
Diastolic 76.66 76.77 60–90 [18]
Left ventricular pressure, Plv (mmHg)
Systolic 121.83 121.85 90–140 [18]
End-diastolic 4.68 4.65 4–12 [18]
Left ventricular volume, Vlv (ml)
End-systolic 52.64 55.98 37–57 [43]
End-diastolic 133.24 136.07 121–163 [43]
Left atrial pressure, Pla (mmHg)
Mean 4.55 4.35 4–12 [44]
Pulmonary arterial pressure, Ppa (mmHg)
Mean 15.10 14.35 9–18 [44]
Systolic 24.25 26.86 15–28 [18]
Diastolic 9.47 7.11 5–16 [18]
Right ventricular pressure, Prv (mmHg)
Systolic 24.25 26.86 15–28 [18]
End-diastolic 1.25 1.91 0–8 [18]
Right ventricular volume, Vrv (ml)
End-systolic 52.21 49.31 36–64 [45]
End-diastolic 129.94 127.05 121–167 [45]
Right atrial pressure, Pra (mmHg)
Mean 1.30 1.71 2–6 [18]
The model-predicted values are taken from the end-expiratory heart beat after a
2,000-second simulation.
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Such volumetric changes are attributed to the inclusion of the interventricular septum whose
natural position toward the right ventricular free wall (see Section 2.3) inevitably prompts
a decrease in right ventricular volume and a concomitant increase in the volume of the left
ventricle. As for the ventricular pressures, we anticipate that an increase (or decrease) in
the end-diastolic volume induces a decrease (increase) in the corresponding end-diastolic
pressure. For instance, a reduction in the end-diastolic left ventricular pressure (4.68 mmHg
in the original model versus 4.65 mmHg in the modified model) is observed following the
increase in the end-diastolic Vlv (133.24 ml versus 136.07 ml, respectively). It is worth
noticing though that the magnitudes of change in end-diastolic left and right ventricular
pressures (Plv and Prv, respectively) between original and modified models are significantly
different; namely, Prv increases by 0.66 mmHg whereas Plv is reduced by just 0.03 mmHg.
This phenomenon is associated with the compound effects of septum and pericardium on
each ventricle. On one hand, the septum-induced changes in ventricular volumes, and thus
pressures, are opposite in direction between left and right ventricles, i.e., decrease in Plv
and increase in Prv (secondary to the septum-induced increase in Vlv and decrease in Vrv).
On the other hand, the pericardium’s compressive forces tend to increase the pressures of
both ventricles, especially at the higher end-diastolic volumes. Hence, the magnitude of
change in end-diastolic Plv and Prv is practically determined by the net balance between
septal and pericardial forces, which can act either toward the same or the opposite direction.
Ventricular volumes influence mean atrial pressures as well. For instance, the increased
left ventricular volume (modified model) requires a larger blood flow out of the left atrium,
thereby inducing a reduction in left atrial pressure (Pla). On the other hand, right atrial
pressure (Pra) is elevated due to lower Vrv values. Finally, we notice that systemic and
pulmonary arterial pressures (Psa and Ppa, respectively) of the modified model exhibit a
disparate behavior with respect to the values of the original model. Mean, systolic, and
diastolic Psa exhibit a negligible change owing to the effects of the cardiovascular control
mechanisms (e.g., baroreceptors). Systemic pulse pressure, the difference between systolic
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and diastolic pressures, is slightly reduced (45.17 mmHg in the original CP Model versus
45.08 mmHg in the modified model) due to the small decrease in the left ventricular stroke
volume (80.59 ml versus 80.09 ml, respectively). However, Ppa is particularly affected by
the proposed model additions. Specifically, mean Ppa is reduced, whereas pulse pressure
is increased (9.15 mmHg originally versus 12.51 mmHg in the modified model). These
observations lead us to conclude that although we tried to maintain the same hemodynamic
behavior of the modified pulmonary circulation with respect to its original implementation
(see Section 2.3), the pulmonary system impedance in the modified CP Model was slightly
altered, thereby leading to the aforementioned changes in Ppa. The same conclusion can also
be drawn by Fig. 2.4, where we compare the left (left plot) and right (right plot) ventricular
pressure-volume loops from the two models. Even though the shape of the modified model’s
left ventricular pressure-volume loop remain the same as that of the original model (i.e.,
same systemic impedance), the pressure-volume loop of the right ventricle in the modified
model shows a significant change due to the change in pulmonary impedance.
2.4.2 Hypercapnia & Hypoxia
Hypercapnic conditions are simulated by controlling the fraction of inspired CO2 (F ICO2)
while keeping the fraction of inspired O2 (F IO2) at a normal room air level (21.038%). On the
other hand, hypoxia is attained by controlling F IO2 while maintaining F ICO2 at its normal
level (0.0421%). In the current study, we replicate the scenarios used by Cheng et al. [46]:
1) In the hypercapnic experiments, F ICO2 is adjusted from its baseline value in room air
to the desired hypercapnia level and subsequently reverted to baseline after a 25-minute
period. 2) For the hypoxia case, we first lower F IO2 from 21.038% to the desired level and
then, after 10 minutes, we change it back to room air level. For example, Figs. 2.5 and 2.6
display the dynamic respiratory responses of the original and modified CP Models during
a 7% CO2 hypercapnic stimulus and a 7% O2 hypoxic stimulus, respectively. Both figures
include the time profiles of tidal volume (VT ), respiratory rate (RR), minute ventilation
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Fig. 2.4. Comparison of left (left plot) and right (right plot) ventricular pressure-volume
loops between original (black line) and modified (gray dashed line) models. Plv and Vlv, left
ventricular pressure and volume, respectively; Prv and Vrv, right ventricular pressure and
volume, respectively.
(Ve), and alveolar CO2 and O2 partial pressures (PACO2 and PAO2 , respectively). To obtain
a quantitative assessment of the difference between the predicted signal trajectories from the
two models (modified versus original), we compute the coefficient of variations (CV) of the









where xo represents VT , RR, Ve, PACO2 , or PAO2 in the original CP Model (x¯o is the corre-
sponding mean value over the duration of the simulation), xm represents the same variables
in the modified CP Model, N is the total number of samples in the dataset, and i represents
the i-th sample of the dataset. Low CV(RMSD) values for all five respiratory variables in
both hypercapnia and hypoxia experiments (see Figs. 2.5 and 2.6 respectively) indicate that
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the modified CP Model can be considered equivalent to the original model.
Fig. 2.5. Comparison of the respiratory responses of the original (left column) and modified
(right column) models to a 25-minute 7% CO2 hypercapnic stimulus. From top to bottom:
tidal volume (VT ), respiratory rate (RR), minute ventilation (Ve), alveolar partial pressure
of CO2 (PACO2), and alveolar partial pressure of O2 (PAO2). The coefficient of variations
(CV) of the root mean squared deviation (RMSD) between each of the simulated variables
from the original model and those from the modified model are shown on the top right. The
arrows on the time axis represent the time instance at which the stimulus is administered
and subsequently withdrawn.
A comparison of the steady-state responses of the two models for different hypercapnic
(3, 5, and 7% F ICO2) and hypoxic (9, 8, and 7% F IO2) stimuli is shown in Tables 2.5 and 2.6
respectively. These tables report the steady-state values of VT , RR, Ve, PACO2 , PAO2 , cardiac
output (CO), heart rate (HR), and systolic, mean, and diastolic arterial blood pressures
(SBP , MBP , and DBP respectively) immediately before the administration (values inside
the parentheses in Tables 2.5 and 2.6) and the withdrawal of the stimulus. Notice that
because we ran the simulations with the same nominal parameter set (representing a healthy
individual), the steady-state response is always the same prior to the perturbation in the
inspired gas fractions. As anticipated after examining the dynamic responses in Figs. 2.5
and 2.6, the steady-state response of the modified CP Model exhibits minimal variation with
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Fig. 2.6. Comparison of the respiratory responses of the original (left column) and modified
(right column) models to a 10-minute 7% O2 hypoxic stimulus. From top to bottom: tidal
volume (VT ), respiratory rate (RR), minute ventilation (Ve), alveolar partial pressure of CO2
(PACO2), and alveolar partial pressure of O2 (PAO2). The coefficient of variations (CV) of
the root mean squared deviations (RMSD) between each of the simulated variables from
the original model and those from the modified model are shown on the top right. The
arrows on the time axis represent the time instance at which the stimulus is administered
and subsequently withdrawn.
respect to that of the original model under all conditions, whether normoxic (prestimulus),
hypercapnic, or hypoxic.
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Table 2.5. Comparison of the steady-state respiratory and cardiovascular responses
of the original and modified models to a 25-minute 3, 5, and 7% CO2 hypercapnic
stimulus
Variable F ICO2 (%) Original model Modified model
VT (l) 3 0.71 (0.53) 0.72 (0.53)
5 1.09 (0.53) 1.10 (0.53)
7 1.70 (0.53) 1.71 (0.53)
RR (breaths/min) 3 12.71 (12.00) 12.75 (12.00)
5 17.53 (12.00) 17.64 (12.00)
7 24.11 (12.00) 24.20 (12.00)
Ve (l/min) 3 9.05 (6.32) 9.13 (6.32)
5 19.05 (6.32) 19.38 (6.32)
7 40.99 (6.32) 41.31 (6.32)
PACO2 (mmHg) 3 45.58 (39.00) 45.68 (39.22)
5 46.62 (39.00) 46.77 (39.22)
7 54.54 (39.00) 54.64 (39.22)
PAO2 (mmHg) 3 118.38 (102.20) 118.67 (102.18)
5 135.82 (102.20) 135.85 (102.18)
7 143.41 (102.20) 143.40 (102.18)
CO (l/min) 3 5.25 (5.41) 5.19 (5.34)
5 5.41 (5.41) 5.35 (5.34)
7 5.45 (5.41) 5.40 (5.34)
HR (beats/min) 3 68.35 (67.59) 68.53 (67.72)
5 72.19 (67.59) 72.40 (67.72)
7 75.68 (67.59) 75.78 (67.72)
SBP (mmHg) 3 125.79 (121.95) 125.69 (121.63)
5 126.16 (121.95) 126.22 (121.63)
7 131.74 (121.95) 131.84 (121.63)
MBP (mmHg) 3 94.08 (89.39) 93.95 (89.19)
5 94.94 (89.39) 94.84 (89.19)
7 101.10 (89.39) 100.98 (89.19)
DBP (mmHg) 3 81.40 (76.18) 81.35 (76.23)
5 82.53 (76.18) 82.42 (76.23)
7 88.85 (76.18) 88.82 (76.23)
The values shown in the table are evaluated at the end of a 25-minute hypercapnic
stimulus. The values inside the parentheses indicate the steady-state normoxic
response right before the application of the stimulus and are the same across the
CO2 stimuli range, because all simulations are performed with the same nominal
parameter set. VT , tidal volume; RR, respiratory rate; Ve, minute ventilation;
PACO2 , alveolar partial pressure of CO2; PAO2 , alveolar partial pressure of O2; CO,
cardiac output; HR, heart rate; SBP , systolic arterial blood pressure;MBP , mean
arterial blood pressure; DBP , diastolic arterial blood pressure.
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Table 2.6. Comparison of the steady-state respiratory and cardiovascular responses
of the original and modified models to a 10-minute 9, 8, and 7% O2 hypoxic stimulus
Variable F IO2 (%) Original model Modified model
VT (l) 9 0.84 (0.53) 0.85 (0.53)
8 0.89 (0.53) 0.89 (0.53)
7 0.94 (0.53) 0.94 (0.53)
RR (breaths/min) 9 13.95 (12.00) 13.99 (12.00)
8 14.27 (12.00) 14.31 (12.00)
7 14.59 (12.00) 14.64 (12.00)
Ve (l/min) 9 11.68 (6.32) 11.82 (6.32)
8 12.64 (6.32) 12.79 (6.32)
7 13.65 (6.32) 13.83 (6.32)
PACO2 (mmHg) 9 29.68 (39.00) 29.85 (39.22)
8 28.60 (39.00) 28.63 (39.22)
7 27.46 (39.00) 27.65 (39.22)
PAO2 (mmHg) 9 44.33 (102.20) 44.33 (102.18)
8 40.05 (102.20) 40.10 (102.18)
7 35.91 (102.20) 35.84 (102.18)
CO (l/min) 9 6.44 (5.41) 6.37 (5.34)
8 6.72 (5.41) 6.67 (5.34)
7 6.91 (5.41) 6.88 (5.34)
HR (beats/min) 9 76.95 (67.59) 77.16 (67.72)
8 81.20 (67.59) 81.36 (67.72)
7 83.87 (67.59) 84.05 (67.72)
SBP (mmHg) 9 126.63 (121.95) 126.29 (121.63)
8 128.39 (121.95) 128.24 (121.63)
7 129.77 (121.95) 129.64 (121.63)
MBP (mmHg) 9 91.87 (89.39) 91.72 (89.19)
8 93.47 (89.39) 93.43 (89.19)
7 94.60 (89.39) 94.60 (89.19)
DBP (mmHg) 9 77.54 (76.18) 77.51 (76.23)
8 79.04 (76.18) 79.05 (76.23)
7 80.05 (76.18) 80.06 (76.23)
The values shown in the table are evaluated at the end of a 10-minute hypoxic
stimulus. The values inside the parentheses indicate the steady-state normoxic
response right before the application of the stimulus and are the same across the
O2 stimuli range, because all simulations are performed with the same nominal
parameter set. VT , tidal volume; RR, respiratory rate; Ve, minute ventilation;
PACO2 , alveolar partial pressure of CO2; PAO2 , alveolar partial pressure of O2; CO,
cardiac output; HR, heart rate; SBP , systolic arterial blood pressure;MBP , mean
arterial blood pressure; DBP , diastolic arterial blood pressure.
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2.4.3 Hemodynamic effects of respiration
Heart-lung interactions during normal breathing are evaluated in terms of the magnitude
of change in the right and left ventricular stroke volumes. Fig. 2.7 depicts the effects of
respiration on pericardial pressure (Pperi), venous return (V R), right and left ventricular
output flows (Qrv,o and Qlv,o respectively) and stroke volumes (SVrv and SVlv respectively).
Negative swings in pleural pressure (Ppl) indicate the inspiratory portion of each breath.
Pericardial pressure exhibits swings similar to the ones in Ppl superposed with deflections
due to cardiac activity. As the heart chambers expand in volume during the diastolic phase,
the pericardial space is compressed and thus Pperi increases. Moreover, negative deflections of
pleural pressure during inspiration decrease the pressure inside the thoracic veins, resulting
in a larger pressure gradient for the blood that returns back to the heart (higher venous
return). Consequently, right ventricular output flow and stroke volume increase and reach
their maximum values at the end of inhalation. Simultaneously, during inspiration, the
negative swings in pleural pressure enhance the loading capacity of the pulmonary vessels
and more blood is retained in the pulmonary circulation. Blood flow in the left atrium and
left ventricular preload are both expected to decrease, leading to a reduction of the left
ventricular output flow and stroke volume according to the Frank-Starling mechanism.
It is important to note that this phenomenon, known to as “pulsus paradoxus”, is ob-
served in both original and modified models. However, the addition of the three newly pro-
posed model components accentuates these effects (see bottom plot in Fig. 2.7 and Table 2.7)
and allows the model to reproduce the literature data more accurately. More specifically,
the septum has a major contribution to the diastolic ventricular interdependence, where an
inspiratory increase in the right ventricular end-diastolic volume induces a change in left
ventricular pressure-volume relationship. Nevertheless, in the modified CP Model, we as-
sume that during inhalation the diastolic ventricular elastance remains constant and we only
consider the reduction in left ventricular volume that is caused by the leftward movement of
the septum. Moreover, the pericardium enhances even accentuates the effects of respiration
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Fig. 2.7. Mechanical effects of respiration on cardiovascular variables. From top to bottom:
pleural pressure (Ppl), pericardial pressure (Pperi), venous return (V R), right ventricular
output blood flow (Qrv,o), right ventricular stroke volume (SVrv), left ventricular output
blood flow (Qlv,o), left ventricular stroke volume (SVlv).
37
2.5 Validation of modified model
on cardiac function. Inspiratory reduction of left ventricular preload yields a lower than nor-
mal (at static conditions) left ventricular diastolic pressure. In addition, pericardial pressure
is on average higher than pleural pressure (see top plot in Fig. 2.7). As a result, during
inhalation, left ventricular diastolic transmular pressure is lower than that of the original
model (without pericardium), a phenomenon that leads to an additional decrease of the left
ventricular end-diastolic volume and thus stroke volume.
Lastly, similar to the study by Ruskin et al. [47], Table 2.7 categorizes the heart beats
according to their location within the breathing cycle into end-expiratory, peak-inspiratory
and early/mid-expiratory beats. Although the maximum variation in the left ventricular
stroke volume of the modified model (1.81 ml) increased compared to that of the original
model (1.23 ml), it still deviates from the experimental data in [47] (5±2 ml). Nevertheless,
the direction of change is in good agreement with the human study; the left ventricle at
peak-inspiration ejects blood with the lowest stroke volume which, in turn, attains its highest
value at the early/mid-expiratory beat. The pulse pressure is directly proportional to the
change in the stroke volume apart from a small discrepancy between the end- and early/mid-
expiratory beats of the modified CP Model, which could be the result of numerical errors.
As aforementioned, right ventricular stroke volume reaches its highest value at the peak-
inspiratory beat and then progressively decreases through early/mid- and end-expiration.
2.5 Validation of modified model
Model validation is an indispensable part of the development of any mathematical model
and a crucial step for the model’s adoption by the research community. However, the highly
interconnected and complex nature of physiological systems poses significant challenges to
model validation. It is therefore not surprising that there has not been an established
technique that provides a systematic and comprehensive evaluation of a model’s response
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Table 2.7. Hemodynamic effects of respiration
Variable Original model Modified model




Maximum variation 1.23 1.81




Maximum variation 0.59 0.54




Maximum variation 7.01 5.02
with respect to experimental data [48, 49]. Nevertheless, validation of the modified CP Model
has been conducted based on the criteria proposed by Summers et al. [49] and adopted by
our group for validating the original CP Model [19]. According to these criteria, the model-
predicted response is considered to be in good agreement with experimental data when the
simulated outputs 1) are directionally appropriate in a qualitative manner, 2) attain steady-
state values that closely match the experimental data, and 3) are fairly accurate during the
transient dynamic state of the system’s response.
We hence validate the modified CP Model based on these criteria, by comparing its
response during simulated mechanical ventilation conditions against literature data collected
on mechanically ventilated subjects. Since our goal is to demonstrate the model’s capability
to describe the main heart-lung interaction mechanisms typically observed during mechanical
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ventilation, we therefore focus our attention on changes in cardiac activity during PEEP
application and on the cyclic variations in left and right ventricular functions induced by
respiratory events. In particular, we compare the model predictions with data from human
studies under the three following scenarios: 1) changes in positive pressure ventilation (PPV)
on spontaneously breathing healthy subjects [1], 2) step changes in positive end-expiratory
pressure on sedated patients [4], and 3) constant ventilatory support on sedated patients [2].
In addition, we use simulations from the modified CP Model to analyze heart-lung interaction
phenomena and to provide a physiological explanation to a few contradicting experimental
results so that we give further credence to the capability of the model in describing the
underlying mechanisms of cardiorespiratory interactions.
As far as the model validation is concerned, it is important to point out that the nature
of the human data used in this study require a validation process different than the one
followed in earlier work by our group. Cheng et al. [19] evaluated the original model’s
response with data obtained from groups of healthy individuals. Model parameters were
hence maintained at their nominal values (reported in [18]), corresponding to a general
70-kg healthy subject. On the contrary, the validation process presented below is based
on experimental data collected from patients with either a respiratory (e.g., ARDS) or a
cardiovascular (e.g., sepsis) pathological condition. Accordingly, a subset of parameters,
pertaining to the clinical case under investigation, was modified ad hoc such that the model
outputs match the average basal values reported in the literature for each particular patient
group. For instance, a respiratory failure prompted the adjustment of parameters in the
lung mechanics model, such as the compliances and unstressed volumes of the lungs and
the chest wall, whereas a cardiovascular disease required the cardiac model parameters, like
the ventricular end-systolic and end-diastolic pressure-volume relationships, to be altered.
Note that eventually we envision the use of estimation techniques, like the one presented in
Chapter 4, to tailor the model, or parts of it, for simulation of individual patients. Instead
of adjusting the parameter values in an ad hoc manner to match average population data,
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fine-tuning using optimization techniques of the same subset of parameters can result in
a patient-specific model. Such a model can then be used to conduct virtual physiological
experiments, predict the response of the specific subject to therapeutic interventions, and
provide a patient-tailored therapy planning.
2.5.1 Comparison with experimental data
As mentioned above, for the simulation studies presented herein, a few key parameters of
the modified CP Model were modified with respect to their nominal values reported in [18].
Of major importance are the parameters of the heart model (see Table 2.1) that determine
the end-diastolic (kE and P0) and end-systolic (Emax,0) pressure-volume relationships. They
were adjusted in an ad hoc manner such that we achieve basal values (before the initiation
of the experimental protocol) of the left and right ventricular end-diastolic and end-systolic
volumes close to those reported in the literature data. Ideally, if the experimental data were
within the normal physiological ranges (see Table 2.4), we would not have to change the
parameter values in the model. However, the literature-reported cardiac volumes deviate
considerably from their normal physiological ranges based on which the nominal parameter
set of the original CP Model had been selected. We hypothesize that this discrepancy in car-
diac volumes may be attributed either to cardiac complications in the study population or to
the administration of drugs prior to the study. In addition to the above mentioned parame-
ters characterizing cardiac function, few parameters related to the respiratory mechanics and
the ventilatory control system were also modified. For example, lung and chest wall compli-
ances (CL and Ccw, respectively) and unstressed volumes (Vu,L and Vu,cw, respectively) were
reduced as compared with their original values. The objective for such parameter changes
was threefold: 1) match the average tidal volume in the experimental data, 2) reach a basal
mean value of pleural pressure similar to that reported by the study investigators, and 3)
achieve an equal, on average, magnitude of change in Ppl for each step change in ventilator
settings (e.g., pressure support level or PEEP). Further, if the response of a sedated sub-
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ject was to be simulated, we set the sensitivities of the central and peripheral chemoreflex
mechanisms, which regulate the amplitude and frequency of breathing, as well as the basal
breathing amplitude to zero. Finally, we should emphasize that the aforementioned parame-
ter changes were performed at the beginning of each simulation study and parameter values
were subsequently maintained constant for the entire duration of the experimental protocol.
The first study considered in our validation procedure is the one by Kyhl et al. [1].
This study involves 18 healthy volunteers who were asked to breath spontaneously, at the
beginning in atmospheric conditions (PPV0) and then under positive pressure ventilation
with pressure support level of 3 cmH2O and positive end-expiratory pressures (PEEP) of 9
and 19 cmH2O (labeled PPV10 and PPV20 respectively). Each of the three periods lasted
30 minutes. Cardiac magnetic resonance imaging was used to assess the volumes of the
heart chambers during short end-expiratory pauses at the end of each PPV period. Fig. 2.8
includes the mean and standard error of the mean values from the human study (literature
data) for CO, HR, left (LV) and right (RV) ventricular stroke (SV ), end-diastolic (EDV ),
and end-systolic (ESV ) volumes. In addition, Fig. 2.8 reports the corresponding model-
predicted outputs (model data) as mean values calculated over end-expiratory heart beats
at the end of each simulated PPV period. In order to attain the basal values (at PPV0)
of the stroke and end-diastolic volumes reported in the study, we set Emax,lvf0, Emax,rvf0,
kE,lvf , and kE,rvf respectively to 3.05 mmHg/ml, 0.8 mmHg/ml, 0.008 ml-1, and 0.007 ml-1.
The simulation results in Fig. 2.8 show that the model is able to mimic the effects of
positive pressure ventilation on cardiac activity as ventilator settings are adjusted from
baseline (PPV0) to PPV10 and then to PPV20—that is, during an increase in PEEP from 0
to 9 and then to 19 cmH2O respectively. In particular, all experimental and model-predicted
cardiac volumes are reduced during positive pressure ventilation (see PPV10 and PPV20),
while heart rate increases. Despite the increase in HR, there is a marked drop in LV stoke
volume as PEEP is increased, thus leading to a reduction in cardiac output. Such a drop in
CO is attributed to reduced systemic venous return caused by elevation in pleural pressure.
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In addition, notice that the model predictions, besides RV ESV , are within one standard
deviation of the sampling distribution (standard error) of the subjects in the study for all
PPV levels. Although RV ESV maintains its directionality as compared with the study
data, the absolute magnitude of the change is small, especially at PPV20.
Fig. 2.8. Cardiovascular response to step changes in the level of positive pressure ventilation
(PPV). Literature data (black points and error bars are means and standard errors of the
means respectively) are collected during a human study with 18 healthy, spontaneously
breathing, subjects and are published by Kyhl et al. [1]. Both model-simulated (gray points)
and experimental data are assessed from end-expiratory heart beats at the end of each 30-
minute PPV period. LV, left ventricular; RV, right ventricular; CO, cardiac output; HR,
heart rate (bpm, beats per minute); SV , stroke volume; EDV , end-diastolic volume; ESV ,
end-systolic volume.
Then, we analyze the cardiovascular response to step changes in the level of PEEP and
subsequently to blood infusion (volume expansion) via Table 2.8. Literature data are re-
ported by Dhainaut et al. [4] and are assessed from a group of 21 sedated ARDS patients.
The experimental data include mean and standard error values for cardiac index (CI), HR,
stroke volume index (SV I), LV and RV end-diastolic (EDV I) and end-systolic (ESV I)
volume indices, and ejection fractions (EF ); all volumetric indices are calculated by nor-
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malizing the raw volume data with respect to the body surface area (BSA). According to
the experimental protocol, the PEEP level is adjusted in increments of 5 cmH2O, covering a
range of [0–20] cmH2O (PEEP0, PEEP5, PEEP10, PEEP15, and PEEP20 respectively). Such
a process is known as “PEEP titration” and is typically used on ARDS subjects for deter-
mining the optimal level of PEEP that promotes lung recruitment and facilitates arterial
blood oxygenation [50]. All other ventilator settings (e.g., tidal volume equal to 10–14 ml/kg
of body weight and F IO2 = 0.5) were kept unchanged and no medications were administered
throughout the experimental study. Each ventilatory period lasted 20 minutes and the
hemodynamic measurements of Table 2.8 were collected within the last 10 minutes of each
interval. After the application of PEEP20, volume expansion (VE) with plasma expanders
(i.e., fluid resuscitation) was used; its purpose was to normalize the cardiac index at a level
similar to baseline at PEEP0. For our simulation study, the basal values of end-diastolic and
end-systolic ventricular volume indices were obtained by setting Emax,lvf0, Emax,rvf0, kE,lvf ,
and kE,rvf to 4 mmHg/ml, 0.4 mmHg/ml, 0.007 ml-1, and 0.0065 ml-1 respectively. Addition-
ally, to match the elevated heart rate observed in the study’s ARDS population, the basal
heart period was adjusted from its nominal value of 0.58 seconds [18, 33] to 0.27 seconds.
As for the respiratory system, we adjusted the lung and chest wall mechanical properties
as follows: CL = 0.065 l/cmH2O, Ccw = 0.1 l/cmH2O, Vu,L = 0.4 l, and Vu,cw = 1 l. Such
changes allowed us to achieve a tidal volume of about 0.75 liters (about 11 ml/kg of body
weight) and a basal mean Ppl value of -1.07 cmH2O, compared to 0±1.6 cmH2O in [4]. As
commonly observed in ARDS patients, venous admixture (pulmonary shunt fraction) and
F IO2 were higher than normal and respectively set to 0.35 (35%) and 50%.
The cardiovascular response of the modified CP Model to the aforementioned PEEP
titration scenario is also presented in Table 2.8. The model-predicted outputs are in good
agreement with experimental data. Namely, left and right ventricular EDV I are reduced as
PEEP is progressively increased, thereby leading to a decrease in cardiac index in line with
physiological understanding and the Frank-Starling relationship. Moreover, left ventricular
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ejection fraction is relatively constant across the entire PEEP range, indicating that LV
afterload is not significantly affected by PEEP application. On the contrary, right ventric-
ular EF is lower at high PEEP values in both experimental and simulation results. This
effectively demonstrates an elevated pulmonary impedance owing to the compression of the
pulmonary capillaries by the PEEP-induced lung expansion. Model outputs, however, differ
from the study data when infusion of blood is instituted (PEEP20 + VE). On one hand, sim-
ulated left ventricular function, including cardiac and stroke volume indices, return to basal
conditions (PEEP0) after volume expansion, in agreement with the experimental evidence.
On the other hand, model-predicted right ventricular EDV I and ESV I increase beyond
their baseline values. This outcome contradicts the data from Dhainaut et al. [4], which
show a complete return of right ventricular volumes to baseline after volume expansion.
According to the investigators in [4], such a phenomenon suggests that the effect of PEEP
application on the study’s population right ventricular function is primarily manifested by a
decrease in right ventricular preload (venous return). Based on this conclusion, we conjec-
ture that model simulations instead indicate right ventricular overload due to the collapse of
the pulmonary capillaries when PEEP is increased. This hypothesis is also supported by an
earlier study from Dhainaut et al. [51], which demonstrated that application of high PEEP
levels caused a marked increase in right ventricular afterload and hence RV EDV I. Such
contradicting outcomes with respect to the effect of PEEP on right ventricular activity will
be analyzed in more detail in the next section.
Finally, we examine the cyclic variations in left and right ventricular functions caused
by respiratory events during positive pressure ventilation. Fig. 2.9 compares the model-
simulated left (left column) and right (right column) ventricular volume indices, i.e., SV I,
EDV I, and ESV I, with those published by Vieillard-Baron et al. [2]. Experimental data
were collected from a group of 31 sedated patients on mechanical ventilation support. A
pressure-control mode with tidal volume of 7–9 ml/kg, respiratory rate of 15 breaths/minute,
an end-inspiratory pause of 0.5 seconds, and PEEP of 5 cmH2O were selected. The study
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investigators acquired hemodynamic measurements via a transesophageal echocardiographic
transducer and focused on the following four heart beats based on their location within a
breathing cycle: 1) an end-expiratory beat, right before the inspiratory portion of a breath,
2) a beat toward the end of lung inflation, 3) an end-inspiratory beat (at the end of the
end-inspiratory pause), and 4) a beat during the early phase of expiration. Data collected
from these four heart cycles are shown sequentially in the subplots of Fig. 2.9 (black squares).
As mentioned earlier, the experimental conditions were simulated in the modified CP Model
by adjusting the parameters of the cardiovascular and respiratory systems so that we attain
baseline values close to those observed in the patient study population [2]. Namely, we set
CL = 0.06 l/cmH2O, Ccw = 0.11 l/cmH2O, Vu,L = 0.4 l, and Vu,cw = 1 l in order to get a to-
tal respiratory system compliance of 0.039 l/cmH2O (the compliance of the study group was
0.038±0.007 l/cmH2O), a tidal volume of about 0.6 liters (about 8.5 ml/kg of body weight,
compared with 7–9 ml/kg in [2]) and a pleural pressure value of −1.75 cmH2O at the end
of expiration (Ppl = −2.04±0.14 cmH2O in [2]). In the cardiovascular component, we mod-
ified the following parameters: Emax,lvf0, kE,lvf , kE,rvf , P0,lvf , and P0,rvf to 1.9 mmHg/ml,
0.016 ml-1, 0.011 ml-1, 0.8 mmHg, and 1.5 mmHg respectively.
The results shown in Fig. 2.9 demonstrate that the model-predicted outputs follow the
trends in the experimental data for both left and right ventricular volume indices. In par-
ticular, left ventricular SV I attains its minimum value at end-expiration, while it reaches
the maximum level at the end of inhalation. Similar trend is also displayed by LV EDV I,
a behavior that is physiologically attributed to the Frank-Starling mechanism. According
to the mechanism, an increase in end-diastolic volume, which indicates a change in preload,
induces a direct increase in stroke volume. Hence, we expect that under most circumstances
(apart from cases of ventricular failure) a change in end-diastolic volume will always be
accompanied by a proportional change in stroke volume. The increase in left ventricular
EDV I with inhalation is ascribed to the compression of the pulmonary peripheral vessels
that promotes more blood into the left atrium, thereby increasing left ventricular filling.
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Fig. 2.9. Cyclic intra-breath changes in left (left column) and right (right column) ventricular
functions during positive pressure ventilation. Literature data (black squares and error bars
are means and standard errors of the means respectively) are taken from Vieillard-Baron et
al. [2], who studied 31 fully sedated patients under mechanical ventilation support. Both
model (gray circles) and experimental data are with reference to the left vertical axes in
each subfigure. Note that Vieillard-Baron et al. [2] does not report measurements for RV
EDV I and ESV I. LV, left ventricular; RV, right ventricular; SV I, stroke volume index;
EDV I, end-diastolic volume index; ESV I, end-systolic volume index; Pao (right vertical
axes), airway opening pressure.
With regard to the left ventricular end-systolic volume, Vieillard-Baron et al. [2] report that
there is a statistically insignificant change in ESV I during the breathing cycle. Although
the model-predicted variations in ESV I are not directionally appropriate with respect to
the experimental data, we notice that their magnitude is considerably smaller compared to
changes in EDV I and SV I. The inspiratory decrease in LV ESV I predicted by the modified
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CP Model is nevertheless supported by other investigators [3] and will be further analyzed
in the next section.
The right ventricle, on the other hand, is primarily affected by the increase in pleural
pressure, a direct consequence of the increase in transpulmonary pressure during positive
pressure ventilation. Elevation of pleural pressure during inhalation sequentially decreases
systemic venous return, right ventricular filling (end-diastolic volume), and hence right ven-
tricular stroke volume. RV SV I attains its minimum value during the end-inspiratory pause
and then increases back to baseline during exhalation, which is also linked to the withdrawal
of pressure support. Model predictions of right ventricular SV I are directionally appropriate
to the literature data, although the simulated beat-to-beat changes are more pronounced in
magnitude. Unfortunately, such a discrepancy cannot be sufficiently explained due to the
lack of data reported by Vieillard-Baron et al. [2] regarding RV EDV I and ESV I. Notice,
however, that in line with previous studies [52], the model-predicted intra-breath variation
in right ventricular SV I is larger than that of the left ventricle, a phenomenon that is
ascribed to the damping effect of the pulmonary circulation (i.e., pulmonary impedance).
Namely, at every breath, for any given respiratory-induced increase in RV stroke volume,
the corresponding increase in LV stroke volume is of smaller amplitude. This is because the
pulmonary circulation effectively accommodates for part of the blood volume ejected from
the right ventricle before it reaches the left heart [53].
2.5.2 Physiological heart-lung interaction phenomena
Complementary to the simulation data and figures in the previous section, some additional
aspects of the model-predicted changes in cardiovascular function during mechanical venti-
lation are worthy of further discussion. Of particular substance are simulation studies from
the modified CP Model that aim to explain a few contradicting experimental findings regard-
ing different heart-lung interaction phenomena, like the effect of PEEP on right ventricular
performance.
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As shown by Kyhl et al. [1] and Dhainaut et al. [4] and demonstrated by the modified
CP Model as well (Fig. 2.8 and Table 2.8 respectively), cardiac activity is greatly affected by
changes in the level of PEEP. The evident drop in cardiac output as a result of a step increase
in PEEP is primarily attributed to a reduction in ventricular filling (preload), determined
by the volume of blood within the ventricle at the end of diastole. This behavior in ventric-
ular function is considered to be driven by the well-known Frank-Starling mechanism that
governs the length-tension relationship in cardiac myocytes. To illustrate the consistency
of the modified CP Model to replicate such a mechanism, we plot, using the data from Ta-
ble 2.8, the cardiac index as a function of the corresponding EDV I (Fig. 2.10). Clearly, the
Frank-Starling law is well reproduced by the model outputs for both left and right ventricular
functions. As indicated in the previous section, volume expansion (i.e., fluid resuscitation)
entirely reversed the output of both ventricles. However, right ventricular EDV I after such
a volume expansion (VE) was higher than its basal value at PEEP0, an indication of right
ventricular overload. This phenomenon resulted in the obvious deviation of the “PEEP20 +
VE” point from the right ventricular function curve in Fig. 2.10. Fig. 2.10 also reveals that
the inotropic states of the two ventricles remain relatively unchanged with PEEP applica-
tion since all respective points fall close to a quadratic ventricular function curve—note that
in case of an increase in ventricular inotropy, the Frank-Starling curve would shift upward
and to the left. As demonstrated by Huemer et al. [54] and Jardin et al. [55], despite some
compensatory sympathetic activation due to the decrease in cardiac output (especially at
high PEEP levels), changes in PEEP have moderate effects on the end-systolic left and right
ventricular contractilities (i.e., inotropic state). End-systolic ventricular contractility is ex-
pected to be independent of ventricular preload and constant over a wide range of afterload
[54, 55]. Besides the preliminary evidence of a minimal inotropic change with PEEP pro-
vided by the simulated ventricular function curves in Fig. 2.10, the model-predicted maximal
ventricular elastances (Emax,lvf and Emax,rvf ) provide further proof of such a phenomenon.
Both neural-modulated elastances attain values close to their basal conditions (at PEEP0)
50
2.5 Validation of modified model
for all PEEP levels. Namely, Emax,lvf = 4.544, 4.540, 4.542, 4.554, and 4.577 mmHg/ml and
Emax,rvf = 0.723, 0.721, 0.722, 0.729, and 0.742 mmHg/ml for PEEP0, PEEP5, PEEP10,
PEEP15, and PEEP20 respectively.
Fig. 2.10. Model-simulated Frank-Starling relationships between cardiac index (CI) and
end-diastolic volume index (EDV I) for the left (LV, black curve) and the right (RV, gray
curve) ventricles. Filled circles are evaluated as PEEP was increased from 0 cmH2O to
20 cmH2O (respectively PEEP0 and PEEP20 in Table 2.8). Hollow circles represent the
state with PEEP20 and volume expansion (PEEP20 + VE in Table 2.8).
According to Kyhl et al. [1], PEEP application also contributes to a shift in blood volume
from the thoracic cardiovascular components (central blood volume), i.e., the volume of
blood in heart, pulmonary circulation, and thoracic arteries and veins, to the extra-thoracic
systemic circulation. Similar blood volume shift is also predicted by the modified CP Model.
51
2.5 Validation of modified model
For instance, simulating the experimental protocol in [1] (see Fig. 2.8), the central blood
volume decreases from 891.57 ml to 773.46 ml and finally to 670.22 ml in response to step
increases in PEEP from 0 to 9 and then to 19 cmH2O respectively. Perschau et al. [56]
described the same phenomenon and reported a decrease of about 10.1%±7.5% in blood
volume after a change of PEEP from 0 to 10 cmH2O. Such experimental observation supports
the model predictions, which show a decrease of about 13.3% for the same step increase in
the level of PEEP.
As explained in the Section 2.1, institution of PEEP is routinely recommended to patients
who suffer from ARDS. Although ARDS is typically manifested as fluid accumulation in the
lungs, the root cause of the edema can be attributed to either a pulmonary disease (ARDSp),
like pneumonia, or an extra-pulmonary disease (ARDSexp), like peritonitis [57]. Furthermore,
the specific underlying pathology of ARDS leads to alteration of the mechanical properties
of the respiratory system. For instance, Gattinoni et al. [57] reported a marked difference in
lung elastance (EL) and chest wall elastance (Ecw) values between the two groups (ARDSp
and ARDSexp), while the total respiratory system elastance (Ers) was relatively the same in
the two populations. The ARDSp group had EL = 20.23 l/cmH2O and Ecw = 5.31 l/cmH2O,
whereas the ARDSexp group had EL = 15.95 l/cmH2O and Ecw = 15.88 l/cmH2O (all values
are at zero PEEP). Such disparate values in lung and chest wall elastances are expected
to affect how an increase in airway opening pressure is transmitted into the pleural cavity
[58]. For example, a high lung compliance coupled with a low compliance value of the
chest wall, like in the case of ARDSexp, would induce a significant increase in Ppl as a
response to an increase in airway opening pressure. High lung compliance values favor a
relatively easy alveolar expansion, while the stiff chest wall (low chest wall compliance value)
does not allow the parietal pleura to enlarge at the same level as the visceral pleura. It is
important to note, however, that the tidal volume delivered to the patient depends on total
respiratory system compliance rather than the individual lung and chest wall compliance
values. As we illustrated in previous sections, right ventricular preload is influenced by
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pleural pressure via changes in systemic venous return, whereas right ventricular afterload
depends on the pulmonary system’s impedance that varies due to the compression of the
pulmonary capillaries from lung inflation. Hence, we can conjecture that the distribution of
Ers between EL and Ecw can potentially alter the effect of PEEP on both right ventricular
preload and afterload and it may be the reason behind some contradictory experimental
results regarding right ventricular performance. For instance, Dhainaut et al. [4] showed
that PEEP increments change right ventricular function via a decrease in systemic venous
return. This inevitably leads to reduced right ventricular volumes (EDV I and ESV I in
Table 2.8). On the contrary, an earlier study by Dhainaut et al. [51] as well as experimental
data by Jardin et al. [53] demonstrated an augmentation in the size of the right ventricle
when PEEP is instituted. Such a phenomenon was ascribed to the increase in pulmonary
system impedance (right ventricular afterload), thereby leading the investigators to suggest
that PEEP application induces right ventricular overloading.
Given these sometimes contradicting experimental observations, it seemed natural to
investigate if the proposed modified CP Model would be able to elucidate the mechanisms
by which the mechanical properties of the respiratory system can alter the effect of PEEP
on right ventricular function. To this end, we set up the model to replicate the two ARDS
groups mentioned by Gattinoni et al. [57]. With these simulations, we wanted to assess the
degree and direction of change in the activity of the right ventricle as PEEP is increased
from 0 to 20 cmH2O in steps of 5 cmH2O. Fig. 2.11 compares the model-simulated cardio-
vascular response (LV and RV SV I, EDV I, and ESV I) for a pulmonary ARDS (ARDSp,
black squares) and an extra-pulmonary ARDS (ARDSexp, gray circles) condition. As antici-
pated, for any given increase in PEEP, the overall decrease in systemic venous return causes
a reduction in left and right ventricular stroke volumes for both ARDSp and ARDSexp sim-
ulations. However, the loading status of the right ventricle, as reflected by the direction of
change in ESV I, highly differs between the two groups. Particularly, in the ARDSexp case,
right ventricular ESV I significantly decreases in response to the marked drop in EDV I,
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which is, in turn, due to the reduction in venous return associated with the increasing PEEP
levels. On the contrary, in the ARDSp case, the increase in PEEP generates a concomi-
tant increase in right ventricular end-systolic volume. This is a direct consequence of 1)
the increased right ventricular afterload (pulmonary impedance) caused by the compression
of the pulmonary peripheral vessels and 2) the moderate decrease in RV preload (EDV I).
Such a small decrease in EDV I is attributed to the low transmission of the airway opening
pressure to the pleural space as a result of the stiff lungs (low lung compliance). Clearly, this
response suggests that institution of PEEP on a patient with ARDSp may lead to right ven-
tricular overloading, potentially causing ventricular failure [59], despite the overall decrease
in systemic venous return.
Conflicting experimental findings have also been reported regarding the movement of
the septum in response to changes in PEEP and the associated septal influence on left ven-
tricular performance. Some researchers, like Jardin et al. [53, 55], demonstrated that PEEP
induces an increase in septal curvature (an indication of the position of the septum inside the
heart) by shifting the interventricular septum leftwards. Such a septal movement effectively
constricts the left ventricle, thereby reducing left ventricular filling and its ejection capacity.
On the contrary, studies by Dhainaut et al. [51] and Huemer et al. [54] showed negligible
ventricular interdependence with a minimal change in the radius of the septal curvature.
Similar to the approach used earlier, one could use the proposed modified CP Model to
generate physiological hypotheses regarding the potential root causes of such contradicting
experimental results. For instance, the simulation results from the ARDSp and ARDSexp
cases discussed above might provide a plausible explanation. In fact, the increased right
ventricular afterload on the ARDSp virtual patient pushes the septum toward the left ven-
tricular free wall by reducing the model-predicted septal volume. Namely, V¯spt = 2.16, 2.12,
2.06, 1.99, and 1.93 ml respectively for PEEP = 0, 5, 10, 15, and 20 cmH2O (V¯spt is calculated
by averaging the septal volume waveform over a 10-minute period at the end of each PEEP
segment). On the contrary, the ARDSexp simulation predicts an increase in septal volume
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Fig. 2.11. Cardiovascular response to step changes in the level of positive end-expiratory
pressure (PEEP) of a virtual patient with either pulmonary ARDS (ARDSp, black squares)
or extra-pulmonary ARDS (ARDSexp, gray circles). Each PEEP level is applied for a period
of 20 minutes and simulation results are averaged over the last 10 minutes of each PEEP
segment. LV, left ventricular; RV, right ventricular; SV I, stroke volume index; EDV I,
end-diastolic volume index; ESV I, end-systolic volume index.
from 2 ml at PEEP0 to 2.37 ml at PEEP20. This indicates a septal movement toward the
right ventricular free wall, ascribed to the marked reduction in the right ventricular EDV I
(see Fig. 2.11).
Furthermore, it is worth noting that the simulated movement of the septum within a heart
beat as well as over a respiratory cycle shows similar behavior in both ARDS cases and it is in
good agreement with experimental observations. In particular, Jardin et al. [53] reported an
early diastolic septal flattening (i.e., leftward movement) owing to the fact that the tricuspid
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valve opens before the mitral valve. Additionally, Mitchell et al. [60] found an increased
transseptal pressure gradient (the difference between left and right ventricular pressures)
following the inspiratory reduction in venous return. With this drop in the pressure gradient
across the septum, a rightward septal shift was observed during inhalation. Fig. 2.12 displays
the model-predicted septal movement (represented by the septal volume waveform, Vspt) for
a series of cardiac and respiratory cycles from the aforementioned ARDSexp case. Septal
flattening in early diastole is evident by the low Vspt value after the end-systolic marks
(gray crosshairs). Further, the experimentally observed rightward movement of the septum
during inhalation is shown in the simulation results by the overall increase in Vspt at the
peak-inspiratory heart beats (see, for example, around the 2-second time instance).
Ventricular interference during mechanical ventilation is primarily linked to the presence
of the interventricular septum [60]. However, as we will see in the next section, sensitiv-
ity analysis on the newly introduced model modifications highlighted the contribution of
the pericardial membrane and the pulmonary circulation to the interdependence between
left and right ventricular functions. This contribution has indeed been suggested by multi-
ple studies [31] and may play an important role in explaining the physiological changes in
ventricular functions that are typically observed during mechanical ventilation. Ventricu-
lar activity is usually described by three indices: preload, afterload, and ejection fraction.
Preload is defined as the level of stretching of the cardiac myocytes immediately before con-
traction. Afterload, on the other hand, is the maximal stress applied on the ventricular
wall during contraction and is associated to the load that the ventricle needs to overcome in
order to eject blood. Finally, ejection fraction is the proportion of blood, relative to its the
maximal volume, pumped by a ventricle per heart beat and depends on both preload and
afterload conditions. Positive pressure ventilation is known to affect all three indices. For
instance, Fig. 2.13 qualitatively summarizes, based on experimental evidence by Michard
and Teboul [3], the changes induced by mechanical ventilation in left and right ventricu-
lar function indices. Analogously, but in more quantitative terms, Fig. 2.14 depicts the
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Fig. 2.12. Model-predicted movement of the interventricular septum over sixteen cardiac
and two respiratory cycles in positive pressure ventilation. Septal volume (Vspt, left vertical
axis) models the position of the septum with respect to a vertical imaginary plane H (see
Fig. 2.2). Cardiac cycles are indicated by the end-diastolic (gray stars) and end-systolic
(gray crosshairs) marks. Respiratory cycles are represented by the pleural pressure (Ppl,
right vertical axis) waveform that increases with each positive pressure inspiration.
model-predicted beat-to-beat changes in preload, afterload, and ejection fraction computed
from the simulation data in Fig. 2.9. Preload is assumed equal to ventricular volume at
end-diastole (EDV I). Afterload, on the other hand, is assessed based on the Laplace equa-
tion. Particularly, assuming that the ventricle is a spherical compartment of radius r with
a thin—relative to its radius—wall of thickness h, the wall stress σ can be computed as:
σ = (P · r)/(2 · h), where P is the maximal transmular pressure across the wall [61]. Notice,
however, that the modified CP Model simulates ventricular pressures and volumes without
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explicitly accounting for the radius and wall thickness of each ventricle. Thus, we cannot
directly use the Laplace formula. To overcome such a modeling limitation in computing
stress, we proceed as follows: 1) we first assume that the volume of the ventricle is spherical,
V = 4/3 · pi · r3 and then 2) we calculate a quantity σp that is proportional to the actual wall
stress; namely, σp = P · 3
√
V ∝ σ, where P is the end-systolic transmular pressure and V is
the corresponding end-systolic volume [54]. σp is expressed in mmHg·cm, or alternatively in
dynes/cm, and it can be considered as the linear force applied across the ventricular wall per
unit length of the wall. Lastly, the ejection fraction is defined as the ratio of stroke volume to
end-diastolic volume, i.e., EF = SV I/EDV I. It is evident that the model-generated data in
Fig. 2.14 are in good agreement with the qualitative representation of the ventilation-induced
changes in left and right ventricular functions in Fig. 2.13. In particular, positive pressure
inhalation induces lung expansion by increasing transpulmonary and, consequently, pleural
pressures. As mentioned in previous sections, positive swings in pleural pressure reduce sys-
temic venous return and hence right ventricular preload (see Fig. 2.13 and black bars in right
plot of Fig. 2.14). Such pleural pressure swings also increase pericardial pressure, which, in
turn, prompts a decrease in left ventricular transmular pressure. Since afterload depends
on the pressure across the ventricular wall, a reduction in transmular systolic pressure is
anticipated to lower the afterload of the left ventricle (see Fig. 2.13 and gray bars in left plot
of Fig. 2.14). At the same time, inspiratory elevation of alveolar pressure and compression
of the pulmonary peripheral vessels due to lung inflation have two consequences. 1) First,
they increase the pulmonary system impedance and hence the afterload of the right ventri-
cle (see Fig. 2.13 and gray bars in right plot of Fig. 2.14). This is clearly indicated by the
model simulation shown in Fig. 2.14, which predicts an increase in RV afterload of about
17% during the first heart beat right after the beginning of the positive pressure inhalation
phase. Note that subsequent transient drop in right ventricular afterload, following the first
inspiratory heart beat, can be attributed to the decrease in right ventricular filling since
afterload depends on both pressure and volume. 2) Second, they promote blood flow into
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the left ventricle, thereby increasing left ventricular preload (see Fig. 2.13 and black bars in
left plot of Fig. 2.14). The decrease in right ventricular preload during inhalation, along with
the concomitant increase in right ventricular afterload, in turn, generate a reduction in right
ventricular ejection fraction (see Fig. 2.13 and white bars in Fig. 2.14). Analogously, the
increased preload of the left ventricle, accompanied by a decrease of its afterload, generate
a transient increase in LV ejection fraction toward the end of inhalation. During exhalation,
due to the inspiratory reduction in right ventricular ejection that lowers the filling of the left


















Fig. 2.13. Hemodynamic effects of mechanical ventilation in relation to changes in airway
opening pressure (gray waveform). White dashed boxes indicate changes in respiratory sys-
tem variables, whereas light and dark gray boxes respectively refer to changes in right (RV)
and left (LV) ventricular functions. Transpulmonary pressure is defined as the difference
between alveolar and pleural pressures. The figure is adapted from [3].
Changes in cardiac function, such as those induced by mechanical ventilation and sum-
marized in Figs. 2.13 and 2.14, are usually observed through variations in left ventricular
stroke volume, which is undoubtedly the primary indicator of cardiac performance. Such
variations are propagated into the systemic circulation, causing changes to the arterial pulse
pressure, the difference between systolic and diastolic pressures. Respiratory-related changes
in stroke volume as well as in pulse pressure can then be directly associated to the interac-
tions between heart and lungs in mechanically ventilated conditions. As a result, intra-breath
variability in stroke volume and primarily in pulse pressure, thanks to its less invasive nature,
have recently been proposed as dynamic predictors of a patient’s response to two clinical
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Fig. 2.14. Percent change (left vertical axes) in left (left plot) and right (right plot) ventricular
preload (black bars), afterload (gray bars), and ejection fraction (white bars) with reference to
a ventilatory event represented by the airway opening pressure waveform (Pao, right vertical
axes). Ventricular function indices have been computed based on the simulation results in
Fig. 2.9. The gray horizontal dotted line indicates the zero percent level of the change in
preload, afterload, or ejection fraction.
interventions: PEEP application [62] and fluid resuscitation (or volume expansion) [63, 64].
As previously mentioned, the detrimental hemodynamic effects of PEEP are of profound
significance, especially in ARDS patients who require institution of high PEEP levels. It is
thus crucial that these effects are assessed prior to PEEP application. Volume expansion,
on the other hand, is considered a means to restore cardiac output in patients with reduced
blood volume (hypovolemic). Since direct assessment of volume status is not possible with
current technology, physicians typically rely on hypotension as a clinical manifestation of
hypovolemia. Hypotension, however, is a common clinical symptom that can be attributed
not only to the presence of an underlying hypovolemic condition, but also to many other
pathological conditions, including sepsis and cardiac failure. As a result, a significant num-
ber of hypotensive patients, who are suspected of also having hypovolemia, are administered
with fluids with the hope that their cardiac output will increase. However, volume expansion
is beneficial only to those patients who are truly in a hypovolemic state, whereas it can have
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detrimental effects in those who are not hypovolemic, potentially causing congestive heart
failure and ultimately pulmonary edema. Hence, prediction of fluid responsiveness has the
potential to prevent the adverse consequences induced by volume expansion in patients with
hypotension that is not caused by an underlying hypovolemic condition.
Given the clinical relevance of PEEP and volume expansion therapies, as well as the
popularity of recent technologies that monitor ventilation-induced variations in stroke volume
and pulse pressure as a way to assess the patient’s response to these therapies, we evaluate
the capability of the modified CP Model to reproduce the ventilation-induced pulse pressure
variations. To this end, we simulate both PEEP and VE therapies and measure the percent






where PPmax and PPmin are the maximum and minimum pulse pressure values within a
breathing cycle respectively. Pulse pressure is known to be directly proportional to stroke
volume. Thus, based on our previous analysis (see Fig. 2.14) and assuming a constant
arterial compliance, PPmax is expected to occur at peak inspiration, while PPmin is observed
on heart beats during exhalation. For both PEEP and volume expansion scenarios, we
simulated two patient groups: one with low blood volume (hypovolemia) and one with low
systemic vascular resistance (sepsis). The model parameters were selected such that the
two groups have the same—low—mean arterial blood pressure, at basal conditions, in spite
of the differences in the underlying clinical case (i.e., low blood volume or low resistance).
The simulation results demonstrated a good agreement with the experimental findings from
literature studies [62, 64]. Namely, a high ∆PP value, prior to intervention, is indicative
of a hypovolemic subject whose cardiac performance is significantly affected by institution
of PEEP or volume expansion. For instance, the hypovolemic virtual patient in the first
scenario (PEEP application) had a ∆PP of about 15.5% with an average cardiac index of
3.15 l/min/m2 at zero PEEP. On the other hand, for the septic case, ∆PP was initially
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9.5% and CI was 4.15 l/min/m2. When PEEP of 10 cmH2O was applied, the hypovolemic
subject showed a decrease in CI of about 10% to 2.83 l/min/m2 (∆PP was increased to
19.2%), while the cardiac index of the septic virtual patient was reduced by only 2.6% to
4.04 l/min/m2 (∆PP was increased to just 9.9%). Obviously, there is a clear correlation
between the ∆PP at zero PEEP and the magnitude of change in cardiac index with PEEP
application. This is in agreement with what was observed in [62]; namely, the level of ∆PP
at zero PEEP was directly related to the magnitude of drop in CI after PEEP was increased
(i.e., the higher the ∆PP at zero PEEP, the larger the drop in CI). It is worth noting that
the model-predicted increase in ∆PP with PEEP application for both cases is in agreement
with the experimental observations reported by Michard et al. [62] and Kubitz et al. [65].
Such an increase is ascribed to the fact PEEP reduces cardiac volumes, effectively forcing the
heart to work on a steeper portion of the Frank-Starling curve (see Fig. 2.10, for example).
Under these conditions, a change in left ventricular filling (preload) will induce a much
larger change in stroke volume, and thus pulse pressure, compared to that at zero PEEP
[24]. Similar conclusions with regard to the ∆PP prediction capability can also be drawn in
reference to the fluid resuscitation scenario. In particular, for the hypovolemic case, ∆PP
and CI were initially 18.2% and 2.93 l/min/m2 respectively. After volume expansion, ∆PP
was reduced to 11.7%, while CI was increased to 3.41 l/min/m2, a 16.4% increase. On the
contrary, the septic virtual patient showed much smaller changes in both∆PP and CI; ∆PP
was initially 9.8% and then reduced to 7.5%, while cardiac index increased by only 9.2%,
from 4.1 to 4.48 l/min/m2. We can therefore conclude that the model predictions adhere
to the 13% threshold in the ∆PP value before volume expansion that allowed Michard et
al. [62] to discriminate between responders (increase in CI after blood infusion greater than




The introductions of the pericardial membrane, the interventricular septum, and the mod-
ified pulmonary circulation to the original CP Model—as per Section 2.3—were based on
experimental evidence that these three elements have a significant contribution to the in-
teractions between the heart and the lungs, especially during mechanical ventilation [31].
Indeed, comparison with human studies from literature demonstrated that the modified
CP Model can adequately replicate the effects of positive pressure ventilation on cardiac
function. However, despite the physiological basis for introducing these three elements and
the evident agreement of the model predictions with experimental data, it is nevertheless of
great importance to analyze their individual contribution to the overall cardiovascular model
response during mechanical ventilation. To this end, we replicated the scenario described
by Vieillard-Baron et al. [2] using the following models: 1) the original CP Model, which
does not include the pericardium, the septum, nor the VA-dependent pulmonary peripheral
resistance (original model), 2) the original CP Model with the addition of the pericardium
only (pericardium-only model), 3) the original CP Model with the addition of the septum
only (septum-only model), and 4) the modified CP Model. Fig. 2.15 shows left and right
ventricular stroke volume indices (SV I) from the aforementioned four models during one
breathing cycle. The breathing cycle is represented by the airway opening pressure (Pao) on
the right vertical axis scale. The experimental data reported in [2] and shown in Fig. 2.9 are
also included in Fig. 2.15 for reference. Additionally, Fig. 2.15 displays the percent change
(∆SV I) in left and right ventricular SV I over a breathing cycle. ∆SV I is computed as
∆SV I =
SV Imax − SV Imin
SV Imin
· 100, (2.14)
where SV Imax and SV Imin represent the maximum and minimum SV I values within a
breathing cycle respectively. Focusing primarily on the ∆SV I values, we observe that each
individual model component (i.e., pericardium, septum, modified pulmonary circulation)
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improves the response of the original CP Model with respect to the experimentally observed
left ventricular ∆SV I. Specifically, the simulated ∆SV I values are 8.2%, 9.0%, 11.5%, and
21% respectively for the aforementioned four models as compared with the experimental
∆SV I of 16.7%±4%. Right ventricular ∆SV I, on the other hand, displays a minor change
with respect to the proposed model additions. This can be ascribed to the fact that the
respiratory-induced changes in right ventricular stroke volume are primarily driven by the
cyclic variations in venous return that are secondary to the intrathoracic pressure swings
associated with breathing. Since the original CP model already incorporates the effect of
intrathoracic pressure on systemic venous return, it is not surprising then that none of
the three additions (i.e., pericardium, septum, modified pulmonary circulation) affect right
ventricular ∆SV I substantially.
Few additional observations about the effects of the newly introduced model elements
on left ventricular ∆SV I can be demonstrated. 1) In the simulation scenario presented in
Fig. 2.15, the effect of the septum on ∆SV I is considerably higher than that of the peri-
cardium. When only the pericardium is added to the original model, ∆SV I is increased
from 8.2% to 9.0%, while the corresponding increase in ∆SV I for the septum-only model is
about 3.3% (from 8.2% to 11.5%). Such an observation is supported by human studies that
have demonstrated the septum’s predominant role in affecting left ventricular performance
via the direct ventricular interdependence phenomenon [31]. However, the relative contri-
butions of septum and pericardium on LV ∆SV I are notably altered in cases of excessive
cardiac volumes (e.g., hypervolemia). Under such pathological conditions, the heart operates
on a less steep part of the Frank-Starling curve (rightward shift); namely, any given change
in preload will induce a smaller change in stroke volume compared to that under normo-
volemia. Hence, since the septum affects left ventricular preload through the ventricular
interdependence, the septal influence on LV stroke volume will be attenuated when cardiac
volumes are increased. At the same time, the elevated cardiac volumes cause a consider-
able increase in the amplitude of the restraining forces that the pericardium exerts on the
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Fig. 2.15. Cyclic changes in left (LV) and right (RV) ventricular stroke volume indices (SV I)
during positive pressure ventilation for selective introduction of each of the proposed model
additions, i.e., pericardial membrane (pericardium), interventricular septum, and modified
pulmonary circulation. Top plots show, beat-by-beat, the values for LV and RV SV I from the
original CP Model (black bars, original model), the CP Model when only the pericardium has
been included in the cardiac model (dark gray bars, pericardium-only model), the CP Model
when only the septum has been included in the cardiac model (gray bars, septum-only
model), and the modified CP Model (light gray bars, modified model) that includes all three
model additions. A single respiratory cycle is represented by the airway pressure waveform
(Pao, right vertical axis). Literature data (white bats) from Vieillard-Baron et al. [2] are also
presented for reference. Bottom plot displays the corresponding percent change (∆SV I) in
LV and RV SV I values for the data presented in the top graphs.
heart to prevent cardiac over-dilatation [35]. Consequently, pericardial pressure is increased,
leading to a reduction in LV afterload (pericardial pressure is the external pressure for the
ventricles) and hence to improved left ventricular output. It is then apparent that in hyperv-
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olemic conditions, septal contribution on left ventricular ∆SV I will be lower than that of the
pericardium. This physiological phenomenon is also observed in simulation studies with the
modified CP Model. Simulating, for instance, a volume overload condition by administering
1.5 liters of fluid to the virtual patients that produced the results in Fig. 2.15 has the follow-
ing outcome: the ∆SV I from the septum-only model is 1.4%, whereas the pericardium-only
model predicts a higher value that is equal to 1.8%. As previously explained, the ∆SV I
values from these two models (septum-only and pericardium-only) remain higher compared
with that from the original CP Model (0.6%). Nevertheless, notice that the absolute ∆SV I
values from all model simulations are markedly lower in comparison to those in Fig. 2.15, a
result that is attributed to the heart’s different operating point on the Frank-Starling curve
(rightward shift). 2) Multiple studies [66, 67] have shown that a closed pericardium accentu-
ates the interference between left and right ventricles. Simulation results from the modified
CP Model confirm this experimental observation. As mentioned earlier, the inclusion of only
the pericardium contributes to a 0.8% increase in ∆SV I (from 8.2% of the original model
to 9.0% of the pericardium-only model). However, a CP Model that includes both septum
and pericardium predicts a ∆SV I value of 12.6%, a 1.1% increase relative to the ∆SV I of
the septum-only model. Such a 1.1% increase in ∆SV I is higher than the corresponding
∆SV I increase (0.8%) when only the pericardium was included into the original model, thus
indicating that the pericardium does accentuate the septum-induced ventricular interdepen-
dence. 3) Fig. 2.15 clearly shows that in order to reproduce a ∆SV I of similar magnitude
as that reported in the experimental data by Vieillard-Baron et al. [2], it is necessary to
include all three model components (i.e., pericardium, septum, modified pulmonary circu-
lation). Particularly, since the magnitude of ∆SV I attained by the pericardium-only and
septum-only models are substantially smaller than that reported in [2], the inclusion of the




Despite the proven capability, based on the analyses in previous sections, of the proposed
modified CP Model in describing heart-lung interaction mechanisms, it is necessary to point
out some of its limitations. These can also serve as a basis for future work.
First, the modified CP Model does not consider the effects of PEEP on alveolar recruit-
ment and gas exchange. For instance, it is well known that institution of PEEP on ARDS
patients is recommended as a way to improve gas exchange and increase arterial PO2 . This is
achieved because PEEP aims to inflate the collapsed alveoli and reduce the edema and the
intrapulmonary shunt [68]. Alveolar recruitment is typically represented via a respiratory
mechanics nonlinear pressure-volume relationship [69], whereby lung compliance is expected
to increase as the collapsed lung regions are being recruited with PEEP application. As a
consequence, the recruited alveoli can participate in gas exchange, effectively prompting a
reduction in the intrapulmonary shunt. However, the modified CP Model assumes a linear
pressure-volume relationship (linear lung compliance) and a constant value for the shunt
fraction, the proportion of blood that does not participate in gas exchange. If, for example,
the PEEP-induced alveolar recruitment was to be modeled via a nonlinear compliance and
a varying shunt fraction, the increased tidal volumes (for the same level of pressure support)
due to the higher compliance value along with the reduction in shunt would allow more
oxygen-rich air to participate in gas exchange, thereby leading to better blood oxygenation
and higher model-simulated P aO2 values. Besides gas exchange, having a constant lung com-
pliance also has disadvantages with respect to the mechanism that describes the effects of
PEEP on cardiac output (see Fig. 2.16). Specifically, Dhainaut et al. [4] found a curvilinear
relationship between PEEP values and cardiac index (black squares in left plot of Fig. 2.16),
whereas the modified CP Model predicted a linear relationship between the two (gray circles
in left plot of Fig. 2.16). At the same time, CI and pleural pressure were linearly related
for both simulated and experimental data (right plot in Fig. 2.16). Noticeable is, however,
the effect of PEEP on pleural pressure. Each step increase in PEEP resulted in a constant
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step increment of pleural pressure in the modified CP Model, whereas the experimental data
showed larger step increments at higher PEEP levels (compare the x-axis increments in the
right hand-side plot of Fig. 2.16). Similar to the conclusion by Dhainaut et al. [4], we con-
jecture that the varying levels of change in pleural pressure with PEEP are attributed to
the nonlinear lung compliance. The increased compliance at higher PEEP levels allows for
a larger lung expansion. This, in turn, leads to a more profound compression of the pleural
space, a fact that is translated to a larger increase in Ppl compared to that at low PEEP
values. We can therefore conclude that since pleural pressure directly affects venous return,
the varying step increments in Ppl due to the nonlinear lung compliance are responsible for
the curvilinear relationship between CI and PEEP reported in literature [4].
Fig. 2.16. Comparison of the effects of positive end-expiratory pressure (PEEP, left plot)
and pleural pressure (Ppl, right plot) on cardiac index (CI) between model-predicted (gray
circles) and experimental (black squares) data. Literature data are taken from Dhainaut et
al. [4] and are reported with their mean and standard error of the mean values. Notice that
each Ppl point represents the average pleural pressure (or esophageal pressure—a surrogate
of pleural pressure—for the human study) at each respective PEEP level of the left plot.
Second, certain limitations also exist in the heart model. 1) As indicated in Section 2.3,
the modified CP Model does not account for any mechanical interdependence between the
two atria [38]. 2) Furthermore, a constant left ventricular diastolic pressure-volume relation-
ship is used. Although some studies [40, 53] have shown that right ventricular overload may
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lead to a decrease in left ventricular diastolic elastance, the current model implementation
only considers the leftward movement of the septum as the sole reason for right-to-left ven-
tricular interference that causes a decrease in left ventricular volume. 3) Finally, activation
of the left and right ventricular free walls is assumed to happen simultaneously. Such a choice
is based on the ambiguity in experimental evidence with regard to the temporal relationship
between left and right ventricular contractions in healthy individuals [70, 71, 72]. Neverthe-
less, attention has been taken so that simulation of contraction delays due to pathological
conditions, such as left or right bundle branch blocks, can be readily performed.
Lastly, there exist a few additional mechanisms that could contribute to the hemody-
namic effects of ventilation and are not included in the modified CP Model. For instance,
systemic venous return depends on the gradient between the pressure in the extra-thoracic
veins (upstream pressure) and that in the venae cavae inside the thorax (downstream pres-
sure). These two pressure points are, in turn, affected by abdominal and pleural pressures
respectively. While mechanical ventilation induces positive swings in pleural pressure, it
also causes the diaphragm to descend, thereby raising abdominal pressure [73, 74]. Pleu-
ral pressure swings are considered the primary determinants in decreasing venous return.
However, the concomitant increase in abdominal pressure is expected to minimize the ef-
fect of Ppl in reducing venous return. In the modified CP Model though, we assume that
abdominal pressure is equal to atmospheric pressure (zero), and thus the model-predicted
changes in venous return depend solely on changes in the pleural pressure. This assumption
could result in a model-predicted venous return that is larger than in real clinical scenarios,
particularly if diaphragmatic descent is significant. Two more physiological mechanisms are
not considered in the modified CP Model. 1) We did not model the effects of spontaneous
ventilation on metabolic activity. Spontaneous ventilation is perceived as exercise, especially
in lung disease states [75]. In such pathological conditions, the patient’s work of breathing
as well as their O2 metabolic demands are drastically increased. Albeit the absence of such
a mechanism in the modified CP Model, we do not expect that it would have a major im-
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pact in the simulation results presented herein. With the exception of the study by Kyhl et
al. [1] who analyzed healthy individuals, all other subjects were completely sedated. 2) As
presented in Section 2.3, we assumed that the pulmonary vascular resistance of the modified
CP Model is a function of alveolar volume only. However, Madden et al. [76] showed that
the resistance of the pulmonary circulation is also affected by the level of alveolar PO2 . It was
demonstrated that such a phenomenon, referred to as hypoxic pulmonary vasoconstriction
[75], causes a decrease in the blood flow through the pulmonary vascular bed (i.e., increased
vascular resistance) once PAO2 falls below 60 mmHg.
2.8 Conclusion
In conclusion, in this chapter, we presented a modified CP Model where we appended the
pericardial membrane and the interventricular septum to the cardiac component of a pre-
viously developed and validated cardiopulmonary model [18, 19]. In addition, we modified
the original pulmonary circulation model to account for the compression of the pulmonary
peripheral vessels due to lung inflation. Such modifications were adopted in an effort to
better model the heart-lung interactions that are of profound importance, especially in me-
chanical ventilation conditions. The introduction of the pericardium was also intended to
allow for simulation of cardiac disease states, such as pericarditis and cardiac tamponade.
We then verified the consistency of this modified CP Model with respect to its original ver-
sion. Comparison of the outputs from the modified CP Model with experimental data in
reference to the ventilation-induced changes in cardiac function showed promising results,
both in transient (intra-breath) and steady-state conditions (PEEP application). Moreover,
simulations from the proposed modified model were able to provide physiologic explanations
to a few contradicting experimental observations, thus providing credence to the benefits
of using such a model. We therefore believe that this modified CP Model can serve as an









Mechanical ventilation (MV) is a commonly used life-saving procedure in intensive care units.
It is required when a patient is not able to breathe on their own. Positive-pressure ventilation,
a form of MV, has been available for more than a century [17] and has become the standard
practice for mechanically ventilated patients in the clinical setting. Despite the existence of
many modes of MV being offered by ventilator manufacturers [77], new ventilation modes are
constantly being proposed in an attempt to reduce operator’s time, favor patient-ventilator
interactions and synchrony, and ultimately improve patient outcomes. These ventilation
modes differ from one another in the way they control the flow and/or pressure of the
air delivered to the patient. In an effort to demonstrate the effects of each mode on patient
outcomes, extensive clinical trials have been performed comparing all the available ventilation
modes together. However, the results of these clinical trials have often been inconclusive [78,
79]. One of the major limitations of human clinical trials is the difficulty of creating controlled
experimental conditions and isolating the effects of the ventilation mode under investigation
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from other possible factors that could affect patients’ responses and clinical outcomes. Thus,
there is a clear unmet need for devices that would allow standardized testing as well as
comparison between existing and new ventilation modes, possibly leading to reducing the
number of human and animal trials. In this chapter, we will first provide a brief description
of the devices currently available in the market for testing ventilation modes and highlight
their limitations. Then, we will present our developed patient emulator system, a novel
system for in-silico ventilation therapy testing, that is based on the cardiopulmonary model
(CP Model) presented in Chapter 1 interfaced with a physical ventilator via a controlled
piston-cylinder actuator.
3.2 State-of-art testing devices
Until recently, preclinical testing of ventilation modes has been primarily based on passive
mechanical devices trying to mimic the inflation of a patient’s lungs. These devices are
available in two configurations: 1) bag-style test lungs, and 2) bellows-type systems. On
one hand, bag-style test lungs, like the Linear Test Lung (Fig. 3.1a) from IngMar Medical,
Ltd. (Pittsburgh, PA), offer easy portability and simple usage. They operate by means
of inflation of a fixed elastic balloon placed within a plastic encasing. Thus, their testing
capabilities are limited to the specific range of pressure-volume relationships describing the
balloon’s elastic properties, which cannot be configured in a precise way. In other words,
they are able to replicate the respiratory mechanics within an approximated and limited
range of the respiratory system’s elastance1. On the other hand, bellows-type systems,
like the Dual Adult Test Lung Simulator (Fig. 3.1b) by Michigan Instruments, Inc. (Grand
Rapids, MI), are equipped with a bellows configuration for simulating the human respiratory
1Respiratory system elastance comprises the lung and chest wall elastic mechanical properties. The
elasticity of the lungs is attributed to pulmonary tissue’s elastic properties and to lung’s surface tension,
whereas chest wall elastance is ascribed to the structure and properties of the rib cage. Practically, the
combination of lungs and chest wall engenders the elastic recoil pressures that must be overcome for breathing
to occur.
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mechanics. Compared to bag-style test lungs, bellows-type simulators offer a wider range
of operation in terms of the simulated respiratory system compliance and tidal volumes.
The desired compliance value can be accurately set by a steel alloy spring, whose position
(along the device’s length) determines the extension to which the bellows are inflated (i.e.,
compliance) and hence the inspired tidal volumes. Even though bellows-type systems are not
portable, they are quite versatile as they provide additional gas and pressure sensor ports
for monitoring the oxygen content and pressures inside the bellows2. As for the respiratory
system resistance3, both bag-style and bellows-type systems use fixed-orifice flow restrictors
placed at the entry point of either system. Such restrictors can then be readily interchanged
according to the desired testing procedure. For instance, obstructive diseases, like asthma,
can be simulated by applying a restrictor with a smaller orifice and thus higher resistance
to air flow.
(a) Linear Test Lung. Image courtesy of In-
gMar Medical, Ltd.
(b) Dual Adult Test Lung Simulator. Image
courtesy of Michigan Instruments, Inc.
Fig. 3.1. Passive mechanical simulators of the respiratory mechanics.
The aforementioned devices present great advantages in testing and verifying the ac-
curacy of the ventilator under examination in delivering the prescribed levels of pressure
2Notice that the volume of air inside the bellows approximates the volume in the alveolar space
3Respiratory system resistance is typically ascribed to the resistive properties of the upper airways as
well as to the viscosity of the pulmonary tissues.
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and volumes4. However, it is evident that they lack the ability to simulate spontaneously
breathing patients under mechanical ventilation support5. Such patients are able to initiate
breathing events and inflate the lungs, but not fully capable to sustain their breathing ef-
forts for a prolonged period of time. Hence, external ventilation support via a mechanical
ventilator is necessary. The ventilator essentially shares the work performed on the respi-
ratory system to expand the lungs with the patient. One way to simulate spontaneously
breathing patients and the ensuing patient-ventilator interactions is via physiology-based
mathematical models, like the one presented in Chapter 1. The comprehensiveness of such
models allows the development of virtual patients that replicate a wide range of clinically
observed patient-ventilator interaction phenomena. Accordingly, the software-implemented
virtual patient can interface with a mechanical ventilator via a computer-controlled hardware
apparatus.
Currently, there are few high-fidelity simulators that use physiological models of the
combined cardio-respiratory system and respond to external ventilatory input. One partic-
ular example is the Human Patient Simulator (Fig. 3.2a) from CAE Healthcare, CAE Inc.
(Sarasota, FL). It is a sophisticated simulation platform designed to support anesthesia and
medical gases, interface with real clinical monitors and ventilators, and even respond to the
administration of drugs and anesthetic gases. However, it is expensive and typically reserved
for training of clinical personnel within dedicated simulation centers of specialized hospitals.
As a consequence, ventilator manufacturers are using simpler breathing simulators that only
consider the respiratory mechanics as their mathematical model engine. The ASL 5000
Breathing Simulator, developed by IngMar Medical, Inc. (Pittsburgh, PA), (Fig. 3.2b) is
probably the most popular one and is extensively used for testing ventilation therapies. The
main drawback of such breathing simulators is that they do not account for gas exchange or
4Pressure and volume levels are determined based on the mechanical properties of the patient’s respiratory
system. Such properties are, in turn, defined as the system’s resistance and compliance.
5Michigan Instruments, Inc. do offer a module to transform the Dual Adult Test Lung Simulator into a
spontaneously breathing system. However, this system is not very intuitive to use and has limited features
in regard to simulating spontaneous breathing events.
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the interactions between the respiratory and cardiovascular systems. For instance, it is well
known that elevated pressure in the lungs, which is typically developed when high values
of positive end-expiratory pressure (PEEP) are used, can negatively affect cardiac output.
Furthermore, the level of pressure support, which is one of the ventilator settings when pres-
sure support ventilation is used, directly affects respiratory drive and determines the degree
of unloading of the respiratory muscles. An appropriate degree of respiratory muscle un-
loading is required to prevent muscle atrophy and fatigue and thus it is a key determinant of
successful weaning and liberation from the ventilator. Hence, all these physiological interac-
tions cannot be demonstrated by simple breathing simulators without gas exchange, neural
feedback, and cardiovascular components. For this reason, we leveraged the power of the
cardiopulmonary model of Chapter 2 to describe physiological cardio-respiratory dynamics
and developed our patient emulator system.
3.3 The patient emulator system
The current state of affairs for ventilator testing relies on extensive human and animal trials.
These experimental studies are costly, time-consuming, and cause discomfort to the in-vivo
subjects. Patient emulators, which are based on large-scale integrated mathematical models
of the human cardiopulmonary system, can then provide a more efficacious design and testing
of ventilation therapies. In particular, the physiological models within such emulator systems
can be considered as virtual patients on which ventilation modes can be tested and evaluated.
Not only will this permit testing and comparison to be performed in a highly controllable
environment and without requiring animal or human experimentation, but it will also save
time and money during the development phase. Additionally, the use of a patient emulator
system can lead to the formulation of new and improved standardized testing protocols. The
advantages offered by this system are essentially attributed to the comprehensiveness of the
physiological model in use. It is then necessary for the system’s model-engine to accurately
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(a) Human Patient Simulator. Image courtesy of CAE Healthcare, CAE, Inc.
(b) ASL 5000 Breathing Simulator.
Image courtesy of IngMar Medical, Ltd.
Fig. 3.2. State-of-art model-based breathing simulators.
describe the dynamics of the cardiovascular and pulmonary systems, tissue and alveolar
gas exchange, as well as the main mechanical and short-term neural control mechanisms
between the cardiovascular and respiratory functions. To this end, our proposed patient
emulator system is based on the comprehensive multi-compartment CP Model presented
in Chapter 2. An overview of the advantages of using our patient emulator for testing
ventilation therapies as compared to the current practice, summarized in the previous section,
is presented in Fig. 3.3. Fig. 3.3 schematically shows that testing ventilation therapies using
such an emulator system can potentially shorten the duration of testing by reducing the time
spent on human and animal trials.
Fig. 3.4 displays the patient emulator system connected to a mechanical ventilator. Fun-
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Fig. 3.3. A schematic illustration of the advantages of the proposed patient emulator system
for testing mechanical ventilation therapies in comparison to the current practice.
damentally, the system comprises two main components: 1) a mathematical model engine,
namely the modified CP Model proposed in Chapter 2 (see Fig. 2.2), with its graphical
user interface and 2) a piston-cylinder arrangement (ASL 5000 Breathing Simulator, IngMar
Medical, Ltd., Pittsburgh, PA) that serves as a two-way electrical-to-hydraulic transducer
and allows the CP Model to communicate with a physical mechanical ventilator.
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Fig. 3.4. The patient emulator system (CP Model and ASL 5000 Breathing Simulator)
connected to a mechanical ventilator. Image courtesy of Philips Respironics.
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3.3.1 Software-hardware interface
In more detail, Fig. 3.5 shows a high-level block diagram of the patient emulator, including
the system’s main hardware components: 1) a dedicated computer that runs the Simulink®
Real-Time environment (The MathWorks, Inc., Natick, MA), 2) an ASL 5000 Breathing



















Fig. 3.5. A high-level block diagram of the patient emulator system. AIN, analog input
port of the ASL 5000 Breathing Simulator; A/D and D/A, analog-to-digital and digital-to-
analog converters of the dedicated computer, respectively; GUI, graphical user interface for
interacting with the CP Model (virtual patient).
The primary purpose of the dedicated computer is to provide a computing framework
for the Simulink® Real-Time environment to run the modified CP Model (virtual patient)
in real-time at a pre-defined step size. As mentioned in Chapter 2, Simulink® is a compu-
tational software specialized in high-accuracy numerical integration of ordinary differential
equations, such as those that describe the CP Model’s dynamic response. In turn, Simulink®
Real-Time environment converts the Simulink®-implemented model into executable code
and deploys it in dedicated hardware for real-time execution. For example, in our imple-
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mentation, the dedicated computer is equipped with a high performance Intel® Core™ i7
processor, which is capable of solving the differential equations of the CP Model at a rate
of 5 kHz (step size of 0.0002 s). Additionally, the computer includes a data acquisition card
(NI-6529, National Instruments Corp., Austin, TX) for analog-to-digital conversion of the
pressure transducer’s measurements and for interfacing with the breathing simulator and,
in turn, with the ventilator via a digital-to-analog converter. In particular, the ASL 5000 of
our setup runs in a non-feedback mode, called “flow pump mode” that ignores the pressure
reading from the built-in sensor. In this mode, the piston is exclusively controlled by the
flow profile commanded through the simulator’s analog input port (AIN). Notice that al-
though the default ASL 5000 configuration uses its piston-cylinder arrangement to simulate
respiratory mechanics (see Section 3.2), we instead use it merely as a two-way transducer. In
addition, we have incorporated a separate pressure transducer within the device casing that
allows us to read the pressure at the ASL 5000 orifice, the connection point with the ven-
tilator. The CP Model that is deployed in the dedicated computer then reads the pressure
at the simulator’s orifice, which now serves as the virtual patient’s airway, and calculates
an instantaneous flow value based on the selected model parameters (e.g., resistances, elas-
tances). The simulated flow signal is then transmitted through the AIN to the ASL 5000
motion controller that assures that the piston follows the commanded flow. As a result, this
dedicated computer and ASL 5000 arrangement constitutes the patient emulator system that
can be hydraulically connected to any ventilator via a standard breathing circuit6.
It is also worth mentioning that the choice of the patient emulator’s hardware compo-
nents and, particularly, the selection of the pressure transducer was done after a thorough
evaluation of the sensor’s performance with reference to the system’s requirements. We
tested three different pressure designs, as depicted in Fig. 3.6. The Validyne PS309 (Vali-
dyne Engineering, Northridge, CA) in Fig. 3.6a is a portable, completely self-contained
pressure manometer. Despite the easy accessibility of such an external device, its location
6Such a system was deployed at two Philips Healthcare facilities that manufacture mechanical ventilators
and is currently being used for testing purposes.
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(a) Validyne PS309.
Image courtesy of Validyne
Engineering.
(b) Honeywell TruStability®.
Image courtesy of Honeywell
International, Inc.
(c) Omega PX140.
Image courtesy of Omega En-
gineering, Inc.
Fig. 3.6. Pressure transducers.
with reference to the pressure measurement point (inside the cylinder of the ASL 5000 sim-
ulator) necessitates a long connecting tube. The ensuing large hydraulic delays due to the
long tubing as well as the sensor’s relatively high time constant7 (about 10 ms) rendered
the Validyne sensor incompatible with our application. Delays either due to long hydraulic
connections or due to the sensor’s slow dynamic response are known to have detrimental
effects on closed-loop systems, including our patient emulator. Accordingly, we decided to
evaluate the Honeywell TruStability® (Honeywell International, Inc., Morris Plains, NJ) and
Omega PX140 (Omega Engineering, Inc., Norwalk, CT) sensors (Figs. 3.6b and 3.6c respec-
tively) which both feature a fast response with a 1 ms time constant. In addition, their
small form factor allowed us to place them inside the ASL 5000 casing, thus reducing any
excess tubing. The final selection of the Omega pressure sensor, which includes a hybrid
integrated circuit and temperature compensation, was selected due to its more robust design
and accurate pressure measurements. For example, Fig. 3.7 shows a comparison between the
Honeywell TruStability® and Omega PX140 sensors in terms of noise levels (Fig. 3.7a) and
dynamic responses to a step change in the pressure reading (Fig. 3.7b). It is evident that the
Omega pressure transducer (blue line in both plots) has a lower measurement noise—about
0.1 cmH2O versus about 0.2 cmH2O of the Honeywell (red line in both plots)—and a faster
response with its tracing leading in time the one from Honeywell by about 1 ms.
7The time constant of a pressure transducer indicates how fast it responds to step changes in pressure at
the measurement point.
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(a) Measurement noise in ambient pressure conditions.
(b) Response to a step change in pressure.
Fig. 3.7. Comparison of Honeywell TruStability® and Omega PX140 pressure transducers.
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3.3.2 Graphical user interface
Interaction with the CP Model engine inside the dedicated computer is accomplished by
means of a custom-made graphical user interface (GUI) that runs on a host computer (e.g.,
the laptop in Fig. 3.4). Via the GUI, a user, like a testing engineer or a physician, can easily
change parameters of the CP Model as to introduce pathological conditions, and display and
log model-simulated waveform data.
Fig. 3.8 shows sample screenshots of our custom-made GUI that was developed in C#
.Net programming language. It comprises six physiological system tabs corresponding to
the following organ/systems: heart (Fig. 3.8a), lungs (Fig. 3.8b), circulation (Fig. 3.8c),
neural feedback (Fig. 3.8d), metabolism (Fig. 3.8e), and gas exchange (Fig. 3.8f). Each
physiological system tab offers a set of numeric up/down controls8 (see the right-most two-
thirds of each screenshot in Fig. 3.8) for changing parameter values, i.e., for modifying the
physiology of the virtual patient or instilling specific pathologies/diseases. As explained in
Chapter 2, the CP Model is a lumped-parameter model, where parameters (e.g., compliances,
resistances, etc.) represent the material properties and geometries of different physiological
organs/systems. While the structure of the ordinary differential equations is the same for
all humans, it is the parameter values that make people differ from one another and that
distinguish a healthy person from a sick one. Hence, by changing the parameters of the
model, one can control its behavior without changing the model’s structure. Notice some of
the model parameters are constants, i.e., their values are determined as part of the model
design process and cannot be changed at run-time. Others can be changed via the GUI at
run-time to facilitate changes in the virtual patient’s behavior, e.g., instilling a pathological
condition. For example, an ARDS disease can simulated (like in the simulation studies in
Section 2.5) by selecting the lungs tab (Fig. 3.8b) and accordingly modifying the compliance
and unstressed volume values of lungs and chest wall.
8Here, “control” is a software design term that refers to a graphical user interface element.
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(a) The heart tab. (b) The lungs tab.
(c) The circulation tab. (d) The neural tab.
(e) The metabolism tab. (f) The gas exchange tab.




Plotting of the model-simulated outputs can be easily performed via the GUI. The model
plot window can host up to four plots, as shown in the sample screenshot of Fig. 3.9. Each
plot can show one or two signals, selectable from the “Plot selection” section on the lower left
of the main GUI window (see Fig. 3.8). Signals are shown in an oscilloscope-light manner,
i.e., as a moving time window. The length of the displayed time window (horizontal time
axis span) can be adjusted within a range of 10 to 600 seconds via the up/down control at
the top of the plot window.
Fig. 3.9. Sample screenshot of the plot window of the patient emulator’s GUI.
3.4 System validation
3.4.1 Standardized tests
The ISO standard 80601-2-12 [80] prescribes requirements for basic safety and essential
performance of critical care ventilators. Even though such standardized tests are designed for
testing critical care ventilators on isothermal test lungs9, we decided to evaluate the behavior
of the patient emulator for the settings prescribed in the ISO document for the pressure-
9Isothermal test lungs are chambers filled with copper to ensure constant temperature levels, thereby
allowing a highly accurate volume measurement [81].
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Table 3.1. ISO standardized tests for pressure-controlled breaths
Test
#
IDV DV Crs Rrs RR I-time PCV PEEP
1 500 571 0.05 5 20 1 10 5
2 500 390 0.05 20 20 1 15 10
3 500 655 0.02 5 20 1 25 5
4 500 514 0.02 20 20 1 25 10
5 300 303 0.02 20 20 1 15 5
6 300 310 0.02 50 20 1 25 10
7 300 315 0.01 50 20 1 30 5
8 200 308 0.01 20 20 1 25 10
9 50 71 0.003 20 30 0.6 15 5
10 50 61 0.003 50 30 0.6 15 10
11 50 75 0.003 200 30 0.6 25 5
12 30 39 0.003 50 30 0.6 10 5
13 30 46 0.003 200 30 0.6 15 10
14 30 82 0.001 50 30 0.6 30 5
15 30 84 0.001 200 30 0.6 30 10
16 20 42 0.001 200 60 0.4 20 5
17 15 36 0.001 200 60 0.4 15 10
18 10 27 0.001 50 60 0.4 10 5
19 5 44 0.0005 50 60 0.4 15 10
20 5 27 0.0005 50 30 0.4 10 5
21 5 39 0.0005 200 60 0.4 15 10
IDV, intended delivered volume (ml); DV, actual delivered volume (DV); Crs,
respiratory system compliance (l/cmH2O); Rrs, respiratory system resistance
(cmH2O·s/l); RR, respiratory rate ventilator setting (breaths/min); I-time,
inspiratory time ventilator setting (s); PCV, pressure control ventilator setting
(cmH2O); PEEP, positive end-expiratory pressure (cmH2O).
controlled breath type testing, as documented in Table 3.1. Accordingly, one should not
interpret the results literally, but rather analyze the overall behavior of the patient emulator
under such ventilator settings. For example, an increase in the model’s respiratory system
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compliance is associated with a reduced delivered volume for the same level of supplied
pressure (PCV level in Table 3.1). Notice also that because there was no oxygen supply to
the ventilator, the tests were done with a fixed F IO2 ventilator setting (i.e., at the normal
room air level of 21%) instead of the values prescribed in the standard.
3.4.2 Comparison with experimental data
In this study, we have assessed the capability of the proposed patient emulator to simulate
a typical physiological response that is observed in patients subjected to different levels of
pressure support. Pressure support ventilation (PSV) is a ventilation mode that allows the
patient to actively breathe and hence share the work performed on the respiratory system
with the machine. Thus, appropriate selection of the PSV level can effectively load or offload
the patient’s respiratory muscles according to the physician’s desired therapeutic path. For
example, there are several clinical protocols that employ decreasing sequences of PSV levels
in order to exercise the respiratory muscles and ultimately prepare the patient for liberation
from the mechanical ventilator.
In the proposed experimental scenario, the patient emulator was connected to a Philips
Respironics V200 ventilator (Koninklijke Philips N.V., Andover, MA), configured to provide
pressure support with a triggering sensitivity of−2 cmH2O and PEEP of 5 cmH2O. According
to the study by VandeGraaff et al. [5], we induced both positive and negative changes of the
PSV level in steps of 10 cmH2O, covering a range of [0–30] cmH2O. In order to match the
average population data from the human study in [5], a few key parameters of the CP Model
were modified relative to the nominal values reported in [18]. In particular, the respiratory
system resistance and compliance were set to 9 cmH2O·s/l and 0.06 l/cmH2O, respectively.
The virtual patient’s O2 metabolic demand was reduced to about 130 ml/min in agreement
with the low average consumption measured in the human study. Additionally, in order to
set the F IO2 to 35% as in [5], we assumed a higher than normal pulmonary shunt percentage
and dead space volume. Finally, we adjusted the chemoreceptors’ sensitivity and the basal
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breathing amplitude and frequency in order to achieve baseline values (at 0 cmH2O PSV) of
mean arterial oxygen and carbon dioxide partial pressures similar to those published in [5].
The patient emulator-predicted response to the PSV-step protocol described above is
summarized in Fig. 3.10 for airway opening pressure (Pao), respiratory muscle pressure
(Pmus), and work of breathing (WOB). The results are in good agreement with several
studies [5, 82, 83] that have investigated the effect of PSV on patient’s effort and WOB. In
short, increasing the PSV level decreases WOB and vice versa. Fig. 3.10 also reveals that
the steady-state value ofWOB after each PSV step is independent of whether or not we have
previously applied a negative or positive change in the PSV level. A similar observation was
also made by the investigators in [5] who concluded that the order of PSV change (increasing
or decreasing) does not affect the patient’s work.
Fig. 3.11 shows a zoomed-in view of the Pmus profile changes predicted by the virtual
patient in response to a PSV increase from 10 to 20 cmH2O. It reveals two distinct rates
of decrease in the amplitude: a sudden drop on the first breath right after the PSV was
increased (around 19.15 min), followed by a further, but gradual, decrease throughout the
subsequent breaths. The former effect is attributed to the Hering-Breuer (HB) reflex, which
is an inhibitory reflex triggered to prevent overinflation of the lungs10. As illustrated in the
left-hand side plot of Fig. 3.11, not only does the HB reflex reduce the maximal negative
inspiratory pressure (Pmus,max) but it affects the duration of inspiration as well [84, 85].
For this particular case, the neural inspiratory time decreased from 1.38 s to 0.96 s. The
secondary gradual decrease of the Pmus amplitude, on the other hand, can be ascribed to a
reduced stimulation of the central and peripheral chemoreceptors. The increased ventilation,
which is generated by the increased PSV level, leads to increased oxygen and reduced carbon
dioxide tensions in blood. These changes in gas tensions are then sensed by the chemorecep-
tors that, in turn, cause the gradual reduction of Pmus,max illustrated at the bottom right
plot of Fig. 3.11 (after the 19 min mark).
10For more information about the Hering-Breuer (HB) reflex, see Section 2.2.
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Table 3.2 and Fig. 3.12 show an extensive comparison between the results from the patient
emulator and the human study in terms of WOB, tidal volume (VT ), respiratory rate (RR),
minute ventilation (Ve), and arterial oxygen and carbon dioxide partial pressures (P aO2 and
P aCO2 respectively). The mean and standard error of the mean values in both Table 3.2
and Fig. 3.12 are calculated across subjects (n in number) for the human study and across
breaths (b in number) for the patient emulator. According to these, the emulator-predicted
WOB values are within the range of the corresponding data from the human study for all
four PSV levels. This indicates that the main physiological effects of PSV on patient’s effort,
as mediated by the HB reflex and the activation of the chemoreceptors, are well captured
by the proposed patient emulator system. Furthermore, all the other physiologic variables
exhibit similar trends as in [5]; as PSV increases from 0 to 30 cmH2O, VT and Ve increase,
RR decreases, whereas P aO2 and P aCO2 remain relatively constant.
Finally, to verify the consistency of the patient emulator’s response with respect to the
simulation results from the software version of the CP Model in Chapter 2 (i.e., having the
model run on a host computer where a simplified ventilator model is implemented), we repli-
cated the experimental protocol reported by Dhainaut et al. [4] and presented in Section 2.5.
According to that protocol, the PEEP level was first adjusted in increments of 5 cmH2O,
covering a range of [0–20] cmH2O (PEEP0, PEEP5, PEEP10, PEEP15, and PEEP20 respec-
tively) and then volume expansion (VE) with plasma expanders (i.e., fluid resuscitation)
was administered. Each ventilatory period lasted 20 minutes, and the hemodynamic study
measurements collected within the last 10 minutes of each interval were presented in Ta-
ble 2.8. Fig. 3.13 accordingly shows the predicted response of the patient emulator, in terms
of cardiac index (CI), heart rate (HR), and stroke volume index (SV I), over the course
of such an experimental protocol. Comparison of the emulator’s steady-state response at
the end of each ventilatory period with the data in Table 2.8 demonstrates the consistency











































































































Fig. 3.11. Effect of a PSV step change (from 10 cmH2O to 20 cmH2O, top right plot) on
the duration of inspiration (left plot) and on the amplitude of Pmus (Pmus,max, bottom right
plot) as a result of the Hering-Breuer reflex and the chemoreceptors’ feedback (slow decay
of Pmus,max in the right plot). Airway opening pressure Pao is also included in the left plot
for reference to the Pmus profile.
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Fig. 3.12. Comparison between patient emulator (red bars, mean values) and experimental
data from a human study involving 33 patients and reported by VandeGraaff et al. [5] (blue
bars, mean±standard error of the mean values). WOB, work of breathing; VT , tidal volume;
RR, respiratory rate; Ve, minute ventilation; P aO2 and P aCO2 , arterial oxygen and carbon

















































































































































































































































































































































































































































































































































































































































































































































The patient emulator system is a versatile device that leverages the computational power
of a dedicated computer and the mathematical rigor of physiological models to emulate the
behavior of a real mechanically ventilated patient. Its user friendly GUI allows for easy
experimentation of different patient classes and a variety of pathological conditions. The
patient emulator, hence, presents itself as a platform for research, educational, and clinical
applications in addition to permitting a more efficacious testing of mechanical ventilators.
First, it allows research investigators to understand physiological mechanisms, interpret ex-
perimental observations, and generate physiological hypotheses. It can also be used as a test
bench for the development and validation of parameter estimation algorithms aiming to infer
clinical variables and parameters noninvasively (as for example the one presented in Chap-
ter 4). Second, its comprehensive mathematical model engine allows medical personnel to use
the patient emulator system as an education tool to understand physiological cardiorespira-
tory interaction phenomena and as a clinical tool to formulate more personalized therapies.
Lastly, such a system can potentially be suitable for testing different medical devices—
besides mechanical ventilators—in-silico, before or in place of costly, time-consuming, and
complicated human and animal trials.
3.6 Conclusion
In this chapter, we introduced the patient emulator system, a novel device that is based
on the large-scale integrated mathematical model of the cardiopulmonary system presented
in Chapter 2. Despite the system’s plethora of potential applications, as summarized in
the previous section, we focused on investigating its effectiveness for testing mechanical
ventilation therapies as it represents a clear improvement as compared with the commercially
available simple breathing simulators.
The proposed patient emulator was demonstrated under a realistic clinical scenario, where
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the level of PSV provided by the ventilator is changed in a step-wise fashion to induce vari-
ations in patient’s respiratory effort. Such a physiologic response is driven by mechanisms
that are primarily respiratory-related, like the HB reflex, and by mechanisms that depend on
complex interactions between the cardiovascular and respiratory systems, like the chemore-
flex. This clinical scenario, hence, clearly demonstrates the importance of using an integrated
model of the cardiorespiratory system when one wants to simulate patients under mechanical
ventilation. We also illustrated the consistency of the patient emulator system with respect
to the software version of the CP Model as per Chapter 2. In particular, we replicated a
“PEEP titration” procedure (i.e., gradually increasing the level of PEEP), typically used
on ARDS subjects for determining the optimal level of PEEP that promotes lung recruit-
ment and facilitates arterial blood oxygenation. The results of this study demonstrated the
equivalence of the two model implementations. Last but not least, with the “PEEP titra-
tion” study, we evaluated another important mechanism of patient-ventilator interaction,
i.e., the effect of PEEP on the cardiac function (e.g., cardiac index), which is of paramount
importance in mechanically ventilated patients.
Despite these promising results, our validation presents some limitations. For instance,
the comparison with human data was performed in terms of steady-state values only. Due
to lack of available data in the literature, we did not carry out any validation on the tran-
sient dynamic response. Therefore, additional studies are envisioned to further extend the
validation of the proposed patient emulator system and promote its use as a valid tool for





System identification has recently drawn great attention, particularly in fields of engineer-
ing where mathematical models are employed to describe the dynamics of physical systems.
It is considered the counterpart of modeling by first principles (or forward modeling [86])
that was used in Chapter 2 for the development of the cardiopulmonary model. Forward
modeling determines, based on physical laws and the structure of the system under consider-
ation, a set of mathematical equations that describe the system’s dynamics. These dynamic
equations essentially contain variables, which are physical quantities that vary with time
and can potentially be measured, and parameters, which are elements that depend on the
geometry and material properties of the physical system. Most of the times, though, the
structure of the system of interest is not readily apparent to an external observer. Further-
more, practical difficulties in assessing the physical attributes (i.e., geometry and material
property) of different parts of the system render the quantification of the system parameters
virtually infeasible. System identification techniques lend themselves to addressing such is-
sues. In fact, the primary objective of system identification is to obtain from experimental
data a mathematical model that characterizes the dynamic response of the system under
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investigation. System identification techniques practically find the order of such a model
and determine the corresponding model coefficients, which are respectively associated with
the structure and the physical attributes of the real system.
Fig. 4.1 shows a schematic diagram of a dynamic system that is excited by an input signal
u(t) and, in turn, generates an output y(t). Notice that although Fig. 4.1 schematically
represents a single-input single-output (SISO) system, physical systems may have multiple
excitation signals and more than one outputs—the number of system outputs is practically
determined by the number of sensors installed on the real physical system.
Fig. 4.1. A schematic block diagram of a dynamic system that is excited by input u(t) and
generates output y(t).
A dynamic system of order n is commonly modeled via two mathematically equivalent
representations: 1) a nth-order differential equation that maps the dynamics of the input
signals to those of the outputs, or 2) a set of n coupled first-order differential equations that
combines input, output, and state variables and is commonly referred to as the system’s
state-space representation. Assuming a multiple-input multiple-output linear time-invariant




























where u ∈ Rmx1 is the input vector, y ∈ Rqx1 is the output vector, and αi and βj are constant
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matrices. The equivalent continuous-time state-space representation is
x˙(t) = Ax(t) +Bu(t) (4.2a)
y(t) = Cx(t) +Du(t), (4.2b)
where A ∈ Rnxn is the system matrix, B ∈ Rnxm is the input matrix, C ∈ Rqxn is the output
matrix, and D ∈ Rqxm is the direct influence matrix (all matrices are constant with time
since the system is assumed to be time-invariant). (4.2a) is the state equation, while (4.2b)
is called the output (or observation) equation. Even though (4.2), and correspondingly (4.1),
refer to the deterministic case of a system’s representation as it is derived, for instance, by
modeling by first principles, in practical scenarios process and measurement noises corrupt
(4.2a) and (4.2b) respectively, owing to the presence of unmodeled phenomena, disturbances,
and noise in the sensors.
Physical systems are typically associated with their continuous-time dynamic responses
represented by either (4.1) or (4.2). However, most contemporary data processing algorithms,
such as system identification techniques, operate in digital platforms, where physical signals
are recorded via data acquisition devices, i.e., analog-to-digital converters. As a result, most
of the work presented in this chapter is focused on discrete-time models which are suitable for
digital implementation. In that regard, the discrete-time counterpart of (4.1) is a nth-order
difference equation defined as
a¯ny[k − n] + a¯n−1y[k − n− 1] + . . .+ a¯2y[k − 2] + a¯1y[k − 1] + a¯0y[k] =
b¯nu[k − n] + b¯n−1u[k − n− 1] + . . .+ b¯2u[k − 2] + b¯1u[k − 1] + b¯0u[k], (4.3)
where a¯i and b¯j are constant matrices as well. Such a discrete-time input-output mapping—
that is, the output at every time step k is a linear combination of past input and output
values—is known in the literature as an autoregressive model with exogenous input (ARX
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model). It is typically introduced as:
y[k] = a1y[k − 1] + a2y[k − 2] + . . .+ any[k − n]+




aiy[k − i] +
n∑
j=0
bju[k − j] + w[k]. (4.4)
The matrix coefficients in the ARX model of (4.4) can be readily derived from those in (4.3)
according to the following equations: ai = −(a¯0)−1a¯i and bj = (a¯0)−1b¯j for i = 1, . . . , n and
j = 0, . . . , n. Notice also that (4.4) now includes a noise term w[k], thereby representing the
stochastic form of an ARX model.
The discrete-time linear time-invariant state-space model is accordingly defined as:
x[k + 1] = Adx[k] +Bdu[k] +wp[k] (4.5a)
y[k] = Cdx[k] +Ddu[k] +wm[k], (4.5b)
where Ad ∈ Rnxn, Bd ∈ Rnxm, Cd ∈ Rqxn, and Dd ∈ Rqxm are the discrete-time system, input,
output, and direct influence matrices, respectively. wp ∈ Rnx1 and wm ∈ Rqx1 represent the
process (or state) and output noises, respectively. Process noise typically indicates the
presence of system dynamics that have not been included in the model. Despite the best
of our efforts to accurately model the most prevalent dynamic characteristics of the real
physical system, simplifications made either consciously or due to insufficient knowledge of
the system will eventually lead to the existence of unmodeled phenomena. On the other
hand, the output noise term includes any measurement noise in the sensors along with
any potential environmental disturbance affecting the system (e.g., electrical interference).
Finally, it is worth pointing that under the zero-order hold assumption for the analog-to-
digital conversion (assuming Ts is the sampling period), the relationship between discrete-




ATs , Bd = B
∫ Ts
0
eAξdξ, Cd = C, and Dd = D.
4.1.1 System identification and parameter estimation
As mentioned earlier, system identification algorithms aim to find from experimental data
a mathematical model that describes the dynamics of the system of interest. For example,
Fig. 4.2 schematically shows the identification process for a state-space identification tech-
nique; it accepts discrete-time input and output sequences ({u[k]} and {y[k]} respectively),
which are measured and collected from the system under investigation (see Fig. 4.1), and
then determines a state-space representation of the physical system, in terms of a set of Ad,
Bd, Cd, andDd matrices. The main advantage of system identification lies in the fact that the
order of the system is not necessary to be known a priori. Identification methods determine
the dimensions of the system matrix Ad which are, in turn, indicative of the system’s order.
This feature is also the primary difference with the field of parameter estimation, which
shares the same objective as system identification. In particular, parameter estimation tech-
niques operate with the underlying assumption that the order of the system is known prior
to the algorithmic execution. Determining the system’s order requires the knowledge of the
system’s structure along with the physical phenomena that dictate its dynamic response.
With such an understanding, the system’s differential (4.1) or difference (4.3) form can then
be cast, allowing for parameter estimation algorithms to estimate, as the name suggests, the
coefficients (parameters1) of these dynamic equations.
Nevertheless, the primary advantage of parameter estimation techniques—provided that
the system’s dynamic model can be determined a priori—pertains to their capability in es-
timating the coefficients of nonlinear models. In such a case, one can represent the model’s
dynamics in a differential (4.1), or difference (4.3), form with nonlinear-in-variables terms,
1Note that the coefficients of the differential and difference forms are not necessarily directly associated
with the system’s parameters, i.e., elements that depend on system’s geometry and material properties. Such
coefficients could be a nonlinear combination of different parameters, as well as of the sampling time in the
case of the discrete-time difference equations.
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Fig. 4.2. A schematic diagram of a state-space identification technique. u[k], input sequence;
y[k], output sequence; Ad, Bd, Cd, and Dd, matrices of discrete-time state-space model.
such as, for example, a flow-squared term if we were to model a flow-dependent resistance2.
Estimation of the coefficients of such nonlinear terms does not bear any difference as com-
pared to their linear counterparts; that is, any estimation algorithm can be readily applied,
with no additional modifications, on the model’s nonlinear dynamic equation and hence
estimate the coefficients of both linear and nonlinear terms.
In conclusion, state-space identification is typically preferred in cases where there is
insufficient knowledge of the system’s underlying dynamics3. In such cases, state-space iden-
tification techniques are employed to determine the system’s order, and hence structure,
via the information embedded in the measured input and output experimental data. As
mentioned above, state-space techniques have been developed with the inherent assumption
of a linear system model. It is, nevertheless, worth pointing out that most systems tend
to behave linearly in a limited range operation. As such, state-space identification schemes
become a powerful tool in finding the best linear approximation of a model that optimally
describes the system’s dynamic response. On the other hand, parameter estimation tech-
niques are utilized when the model’s dynamic equations can be specified a priori, whether
such equations contain linear- or nonlinear-in-variables terms. Estimation algorithms are
then capable of finding the model’s coefficients, which are, in turn, related to the system’s
physical attributes.
2The constitutive equation of a linear resistance is: P1(t) − P2(t) = R · V˙ (t), where P1 and P2 are the
upstream and downstream pressures respectively and V˙ is the flow over the constant-valued resistance R.
If we were to model a flow-dependent resistance value, i.e., R(V˙ ) = k1 · V˙ + k2, the constitutive equation is
then formulated as: P1(t)− P2(t) = k1 · V˙ 2(t) + k2 · V˙ (t), where k1 · V˙ 2(t) is the nonlinear-in-variable term.
3Note that state-space identification, via estimation of the system’s state vector, is also a critical compo-
nent in state-feedback controllers where the knowledge of the state is necessary in closing the loop.
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4.2 The cardiovascular system
The human cardiovascular (CV) system is typically viewed as a transport system and is
considered an indispensable element for the proper function of body organs. Its primary
function is the delivery of nutrients, like oxygen (O2), to the various body tissues, while
guaranteeing the removal of waste products, such as carbon dioxide (CO2), of the tissue
metabolic activity. The cardiovascular system (Fig. 4.3) consists of three main components,
which are connected in a series configuration: the heart and the systemic and pulmonary
circulations. Each of the two circulatory subsystems comprises three distinct, in terms
of material properties and structure, vascular elements; namely, the arteries, the peripheral
circulation (including the capillaries), and the veins [87]. Systemic arteries carry the oxygen-
rich blood to the capillary level of the various body organs, where tissue gas exchange takes
place. That is, O2 is absorbed by the tissues which, in turn, release CO2 into the bloodstream
of the systemic capillaries. The deoxygenated blood is then transported back to the heart via
the venous circulation and subsequently propagated into the pulmonary circulation for the
alveolar gas exchange. In particular, the capillaries of the pulmonary circulatory system are
in direct contact with the lung alveoli so that O2 and CO2 can be exchanged between blood
and air (i.e., the carbon dioxide in the deoxygenated blood of the pulmonary capillaries is
exchanged for oxygen in the alveoli).
4.2.1 The heart as a source
Movement of blood through the entire vascular system cannot occur passively without any
energy expenditure. The heart hence serves as the primary source of energy within the human
cardiovascular system by propelling blood into both systemic and pulmonary circulations. As
explained in Chapter 2, the heart pumps blood by means of the contractile activity of the two
ventricles4. Practically, the cyclic electrical stimulation of the ventricular myocardium, which
4A schematic representation of the anatomy of the heart is shown in Fig. 2.2.
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Fig. 4.3. A schematic representation of the human cardiovascular system. Red lines indicate
vessels that transfer oxygenated blood (e.g., arteries and arterioles), whereas blue lines are
vessels with deoxygenated blood (e.g., veins). Magenta areas represent the vascular beds
involved in either alveolar or tissue gas exchange (capillaries). Image distributed under a
CC BY-SA 3.0 license.
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triggers the cardiac contraction, is responsible for generating adequate levels of pressure to
drive the flow of blood through the circulatory system. Left ventricular activity determines
systemic blood flow, whereas the right ventricle pumps blood into the pulmonary circulation.
In that sense, the heart ought to be considered a pressure source which generates, via its
periodic contraction, the pressures inside the two ventricles.
Despite such a physiologic understanding of the nature of cardiac function, an external
observer, who views the heart from the aortic (or pulmonary) root, can indistinguishably
assume that the output of the heart’s pumping action could either be a pressure or a flow
signal. For example, Fig. 4.4 shows pressure and blood flow waveforms at the aortic root
level (Psa and Qlv,o, respectively) in addition to the ventricular pressure (Plv) generated by
ventricular contraction (all signals are simulated by the CP Model introduced in Chapter 2).
Clearly, Plv is the source that drives Qlv,o and hence induces changes in Psa. However, one
can realistically consider that the excitation, which propagates the blood and engenders
the dynamics of the systemic circulation, can equally be produced by either Psa or Qlv,o
since both are defined at the beginning of the arterial vascular tree. Moreover, one can also
argue that the closure of the aortic valve during diastole practically dissociates Plv from
the circulatory dynamics, thus making Plv incompatible as the system’s source during the
diastolic phase5. It is hence reasonable to associate either Psa or Qlv,o as the driving source
of the systemic bloodstream. The choice between Psa or Qlv,o is up to the investigator’s
discretion and the particular modeling assumptions, as we will explain in Section 4.3.
4.2.2 The systemic circulation as a dynamic system
The systemic circulation, as previously mentioned, comprises three major components: the
arteries, the peripheral circulation (or microcirculation), and the veins. The division of ves-
sels within the circulatory tree into these three categories is based on their distinct functional
5It is important to note that there exist significant difficulties—both practically and clinically—in getting
access to the ventricular cavity without major complications on cardiac function. This, in fact, prohibits
measurement of ventricular pressures in clinical practice.
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Fig. 4.4. Pressure and flow waveforms simulated by the CP Model over three cardiac cycles.
Plv, left ventricular pressure (top plot, black line); Psa, systemic aortic pressure (top plot, red
line); Qlv,o, left ventricular output blood flow (bottom plot, red line).
role in blood transport and gas exchange. Such functional differences, in turn, determine the
structure and mechanical properties of each vascular component [87]. For instance, arteries
have a high composition of elastin fibers which are easily stretched. The high elasticity
of the arterial vessels significantly contributes to the aortic pressure pulse dampening and
subsequently to the distribution of blood to the various body organs6. On the other hand,
veins are primarily composed of collagen fibers, which have high resistance to stretching.
This particular composition allows the venous circulation to hold a large portion of the total
blood volume—for this reason, veins are referred to as the capacitance vessels. Lastly, in
6Note that arterial elasticity is a crucial element of cardiovascular function. Firstly, it dampens the
pressure pulse during contraction and, secondly, it contributes to blood propagation in diastole when the
aortic valve is closed. Practically, the arterial tree assures a continual flow of blood toward the peripheral
circulation during the entire heart beat, whether heart is actually pumping (systole, open aortic valve) or
not (diastole, closed aortic valve).
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the peripheral circulation, the pre-capillary arteriolar bed consists of a dense network of
smooth muscle cells, whereas the capillaries include only a thin layer of endothelial cells
that permits the exchange of gases with the surrounding tissues. The smooth muscle of the
arteriolar compartment is highly innervated via the autonomic nervous system’s sympathetic
pathways. These efferent signals are responsible for constricting or dilating the arteriolar
vessels, thereby regulating the level of arterial blood pressure and the amount of blood flow
within the body organs.
It is apparent that the systemic circulation is a complex system whose dynamic behavior
does not depends only on the pumping action of the heart but also on changes in the mechan-
ical properties of the vasculature. For example, aging leads to changes in the composition
of arteries, thus resulting in arterial stiffening and increased blood pressure [88, 89]. On
the contrary, infectious diseases, like sepsis, induce vascular inflammation, which results in
peripheral vasodilation—particularly in the systemic arteriolar level—and hence in hypoten-
sion [90]. Accordingly, the systemic circulatory system, as any other dynamic system, can
be defined mathematically via its input-output relationship; that is, the system’s output is
dependent upon the dynamics of the input signal as well as those of the system itself. A sim-
plified version of the systemic circulation of Fig. 4.3 is depicted in Fig. 4.5a. The output of
the heart, and hence the input (forcing function) to the circulatory system7, is represented by
either the aortic blood pressure (Psa or ABP) or the ventricular output flow (Qlv,o). Anatom-
ically, the systemic circulation terminates at the right side of the heart, and in particular at
the right atrium. Hence, one can reasonably assume that the output of the corresponding
dynamic system is the right atrial pressure (Pra), which is clinically approximated by the
central venous pressure (CVP) waveform. Following the schematic representation of a dy-
namic system introduced in Section 4.1, Fig. 4.5b shows the input-output block diagram of
the circulatory system.
7Although the term “circulatory system” physiologically refers to both pulmonary and systemic circula-
tions, we will henceforth use it as a reference to the systemic circulation and thus the terms “circulatory
system” and “systemic circulation” will be used interchangeably.
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(a) A simplified representation.
(b) A block-diagram representation.
Fig. 4.5. Representations of the systemic circulation. The coloring scheme in Fig. 4.5a
follows that of Fig. 4.3. Note that Fig. 4.5a follows the clinically accepted convention for the
arterial compartment (i.e., input) being on the right-hand side, whereas Fig. 4.5b adheres
to the engineering community’s approach where the input is placed on the left-hand side of
the schematic. Psa, systemic aortic pressure; Qlv,o, left ventricular output blood flow; Pra,
right atrial pressure (or central venous pressure).
4.3 Mathematical models of systemic circulation
Mathematical models of the human physiology offer remarkable insights in describing and
elucidating the dynamics of the cardiopulmonary system, as clearly demonstrated by our
analysis in Chapter 2. Inevitably, the systemic circulation, as a major component of the car-
diopulmonary system, has drawn special attention by the research community—particularly
since its dynamics profoundly affect the circulation of blood between the heart and the vari-
ous body organs. Translating such dynamics into mathematical equations dates back to 1878
and the work by Moens [91] and Korteweg [92] who studied and modeled the propagation
of the pressure pulse inside the arterial tree; they formulated, for instance, the well-known
Moens-Korteweg relationship between the wave propagation velocity within a vascular com-
partment and the elastic modulus of the vascular wall [93]. Thereafter, the research focus
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naturally broadened out to the development of physiological models that aim to describe the
dynamic response of the entire circulatory system. Various mathematical models have since
been proposed; from the work by Frank [94], who introduced the concept of “windkessel” (or
elastic reservoir), to the analog electrical model of the systemic arterial tree from Westerhof
et al. [95]. The pioneering work by these two investigators essentially established two distinct
families of circulatory models; namely, the lumped- and the distributed-parameter models.
4.3.1 Lumped-parameter models
Lumped-parameter models are formally defined as systems with lumped-parameter elements.
Under such a definition, one considers that the system of interest can be divided into re-
gions whose geometry and material properties are assumed to be locally uniform. Hence, a
lumped-parameter model consists of 1) parameters that are lumped in space and 2) variables
which, at a given spatial point, represent the variables in the near vicinity of that point. Such
variables are functions of time only and are thus described by ordinary differential equations
with respect to time. It is also worth pointing out that lumped-parameter models are funda-
mental components of both parameter estimation and system identification algorithms. The
equations introduced in Section 4.1 (see (4.1)–(4.5)) implicitly assumed a lumped-parameter
system, whose parameters or structure are to be assessed by a parameter estimation or an
identification method, respectively.
One of such lumped-parameter models is the Windkessel model. The Windkessel model,
as first proposed by Frank [94], was the result of the effort to simplify the complex nature of
the circulatory system in order to describe the load imposed by the latter on the heart. To this
end, many assumptions had to be made; the most important of these was related to the fact
that the concepts of wave reflection and pulse wave propagation were neglected. Implicitly,
Frank [94] assumed that pulse wave velocity was infinite8 and thus no wave reflections could
8The assumption of an infinite pulse wave velocity practically means that the pressure pulse is able
to travel instantly through the entire systemic circulation. Consequently, the same pressure waveform is
assumed to be observed at any point along the arterial tree.
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occur. More specifically, he suggested that the elastic arteries behave like an elastic reser-
voir which, in turn, serves a resistive conduit representing the microcirculation (peripheral
circulation). That is, a Windkessel model, as per Frank [94], is a combination of a compli-
ance element followed by a hydraulic resistor, as depicted in the electrical analog of Fig. 4.6.
The compliance Ct reflects the total compliance of all arteries9, whereas Rt is the equivalent
summed resistance of all peripheral vessels, such as arterioles and capillaries—accordingly,
the original Windkessel model is typically referred to as a two-element Windkessel model.
Despite the aforementioned simplifying modeling assumptions, the two-element Windkessel
model was capable of reproducing the low-frequency dynamics of the arterial tree, including
the mean and pulse10 pressures [96]. These values were considered to be of great significance
in assessing the clinical status of the cardiovascular system. As a result, the Windkessel
model gained great traction by both research and clinical communities primarily due to its






Fig. 4.6. Electrical analog of the two-element Windkessel model of the systemic circulation.
P , arterial pressure; Q, arterial blood flow; Ct, total arterial compliance; Rt, peripheral (or
terminal) resistance.
As mentioned above, the purpose for the development of the Windkessel model was to an-
alyze the load imposed on the heart. For this reason, the pressure (P ) and flow (Q) variables
9Note that due to the assumption of an infinite pulse wave velocity, all arteries are considered to attain
the same pressure simultaneously. Hence, they can be thought as being in a parallel arrangement.
10Pulse pressure is defined as the difference between the maximum (systolic) and the minimum (diastolic)
arterial pressure values within a heart beat. For example, the systolic Psa value in Fig. 4.4 is about 121 mmHg,
whereas the diastolic value is 76 mmHg. Hence, pulse pressure is equal to 121− 76 = 45 mmHg.
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in Fig. 4.6 were initially considered to be the aortic pressure (Psa) and the left ventricular
output flow (Qlv,o), respectively (as per Fig. 4.5). Nevertheless, in the electrical analog of
Fig. 4.6, we used the generic P and Q variable labels because such a lumped-parameter
model can be applied to explain the low-frequency dynamics of any arterial segment in ad-
dition to the aorta. Further, notice the absence of CVP (or Pra) in Fig. 4.6. As explained
earlier (see Fig. 4.5a), the veins are anatomically located after the peripheral circulation and
thus CVP is expected to be the pressure downstream of Rt. However, a few reasons can
justify the decision by Frank [94] to ignore the central venous pressure in the Windkessel
model. First and foremost, CVP values are notably lower than the corresponding ABP sig-
nal. Hence, one can reasonably assume, without significant model prediction errors11, that
CVP is approximately zero with respect to the arterial pressure. Second, technical difficul-
ties in venous-side catheterization along with high infection risks render the measurement of
CVP not readily available in both clinical and experimental settings. Third, central venous
pressure is a low-power signal and thus easily corrupted by additive measurement noise; that
is, the CVP signal has a low signal-to-noise ratio. Finally, physiological phenomena, such
as the contraction of skeletal muscles that propels venous blood toward the heart as well
as the right atrial contractile activity, are associated with the presence of additional distur-
bances in the CVP waveform. Such disturbances complicate the dissociation of the actual
circulatory system dynamics from the effects of these physiological reflex mechanisms. Con-
sequently, based on these reasons, it is sensible for one to assume that the effect of CVP on
circulatory dynamics is negligible, especially when analyzing the response of simple models,
such as the Windkessel model. Additionally, in Section 4.5.1 we will demonstrate that, even
from a system identification point of view, the use of CVP as a signal additional to regular
ABP monitoring is not sufficient to provide a more accurate and detailed description of the
systemic circulation dynamics.
Since the time of the work by Frank [94], the advancements in computing technologies
11Recall that the goal of forward modeling is to replicate the dynamic response of the system under
investigation.
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have greatly facilitated the analysis of the circulatory system’s frequency response (i.e.,
impedance) [97]. This, in turn, lead to the expansion of the original Windkessel model
and to the development of derivative models, known as Windkessel-type models. In fact,
such newly developed models were designed to provide a more accurate representation of
the circulatory load on the heart by adding additional elements to the original two-element
Windkessel model. For example, the three- and four-element Windkessel models are among
the most popular ones and are depicted in Fig. 4.7; they were proposed byWesterhof et al. [98]
and Stergiopulos et al. [96], respectively. Rt and Ct in Fig. 4.7 are defined as in the two-
element model of Fig. 4.6. On the other hand, Rc and Lc represent the circulatory system’s
characteristic (or proximal) impedance which describes the system’s frequency response at
high frequencies. Despite the differences among these three Windkessel-type models, it is
important to note that all of them exhibit a homogeneous response12 which is characterized
by an exponential decay with the same time constant τ , equal to RtCt. The time constant
is practically the main determinant for the system’s low-frequency dynamics that were well
captured by the two-element Windkessel model [99, 100, 101, 102]. This is the reason why the
development of the new models focused on better replicating the high-frequency components
of the circulatory system’s impedance (i.e., load on the heart) via the addition of Rc and Lc
that were not part of the original model. Multiple studies [96, 97, 98] have since demonstrated
that such three- and four-element Windkessel models can more accurately represent the
dynamics of the systemic arterial tree.
Windkessel-type models also served as the basis for more elaborate circulatory models,
like the one included in the CP Model of Chapter 2. Besides our group [18, 19], several
other investigators [29, 30, 33, 37, 48, 103, 104] have developed mechanistic physiological
models of the circulatory system. Even though their purpose was to understand and explain
the complex dynamics and inter-connections of the entire human cardiopulmonary system,
they further illustrate the remarkable importance of the seminal work by Frank [94] and his
12Homogeneous response is the system’s response when input is zero.
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Fig. 4.7. Electrical analogs of Windkessel-type models. P , systemic arterial pressure; Q,
blood flow; Rc, characteristic resistance; Lc, characteristic inertance; Ct, total arterial com-
pliance; Rt, peripheral (or terminal) resistance.
original Windkessel model.
4.3.2 Distributed-parameter models
Distributed-parameter models, on the other hand, include variables that are continuous func-
tions of not just time but also of space; that is, their dynamic responses change with respect to
both temporal and spatial locations. Hence, distributed-parameter models are described by
partial differential equations (PDEs). More specifically, such models comprise infinitesimally
small—in space—elements which are necessary in order to replicate the distributed nature
of the system’s attributes (i.e., geometry and material properties) throughout the system’s
medium. The dynamic behavior of each infinitesimally small element is characterized by a
set of PDEs that depend on the properties of the specific element as well as the dynamics of
both preceding and succeeding elements. Inevitably, distributed-parameter models are more
complicated than their lumped counterparts, although more accurate in their representation
of the dynamics of the real physical system under investigation. Moreover, the complexity
in their mathematical formulation via partial differential equations and the distributed pa-
rameter nature preclude the development of parameter estimation and system identification
methods that would obtain from experimental data a distributed-parameter model. As a
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result, distributed models are primarily used for forward modeling schemes, where the ob-
jective is to generate synthetic (simulated) data that offer a better representation of the
system’s true dynamics and the underlying physical phenomena.
In fact, distributed-parameter models of the systemic arterial tree provide great insight
into the circulatory system’s dynamics. These models allow the study of pressure wave prop-
agation13 and the analysis of wave reflections along the arterial circulation. Such distributed
models are also capable of simulating pressure and flow profiles at different locations of the
arterial tree (e.g., at the aorta and the radial and femoral arteries). Multiple experimental
studies [105, 106, 107, 108] have demonstrated that physiological phenomena, such as wave
reflections and arterial viscoelasticity, induce profound variations in the pressure and flow
waveforms at different points of the circulatory system. Therefore, it is of significant impor-
tance if we are able to replicate the physiological dynamics of the arterial system via the use
of a distributed-parameter model.
Westerhof et al. [95] was the first to propose a distributed model of the systemic cir-
culation. Due to the limited availability of digital computers at that time, the model by
Westerhof et al. [95] (Fig. 4.8a) was comprised of analog circuit components, like resistors,
capacitors, and inductors, arranged in such a way to mirror the structure of the systemic
arterial tree. Subsequently, the advances in computing technologies allowed the research
community to digitally program the PDEs of distributed-parameter models. For example,
Avolio [109] proposed a model that was based on the transmission line theory, a well-known
area in communications where distributed models are used for describing the transmission
of digital information via alternating current. On the other hand, the distributed model by
Stergiopulos et al. [6] was derived according to the one-dimensional blood flow equations,
describing the conservation of mass (4.6) and momentum (4.7) for each of the 55 arterial
13Note that analysis of pressure wave propagation implicitly indicates that pulse wave velocity is finite, in
contrast to Windkessel models that assume, as explained earlier, an infinite wave velocity.
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where Q is the blood flow through the vascular segment, P , A and r are the pressure, cross-
sectional area and radius of the vascular segment respectively, ρ is the viscosity of blood,
and τw is the shear stress of the vascular wall.
(a) The analog electrical model proposed by
Westerhof et al. [95].
(b) The human arterial model proposed
by Stergiopulos et al. [6].
Fig. 4.8. Schematic representations of two distributed-element models of the systemic arterial
tree.
Fig. 4.9 shows blood flow and pressure waveforms at two different locations of the ar-
14The one-dimensional conservation of mass and momentum equations used by Stergiopulos et al. [6] are
simplified forms of the general equations developed by Navier and Stokes that describe the motion of a
viscous fluid—such equations are also known as Navier-Stokes equations.
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terial tree: the ascending aorta15 and the femoral artery. They are simulated from the
distributed-parameter model by Stergiopulos et al. [6]. As anticipated, there are marked dif-
ferences between the simulated waveforms from these two arterial segments due to the finite
wave velocity and wave reflections along the arterial system model. Further, such model-
predicted spatial differences in blood flows and pressures were shown to in good agreement
with experimental data [6]. For these reasons, we deemed necessary to implement the dis-
tributed model16 by Stergiopulos et al. [6] in order to generate high-fidelity simulated data
for evaluating our proposed estimation technique (see Section 4.6.2).
Fig. 4.9. Sample pressure and flow waveforms simulated from the distributed arterial model
by Stergiopulos et al. [6] over three cardiac cycles. Qasc (left plot, left vertical axis) and Pasc
(right plot, left vertical axis) are the ascending aortic blood flow and pressure, respectively.
Qfem (left plot, right vertical axis) and Pfem (right plot, right vertical axis) are the femoral
blood flow and pressure, respectively. Note that the two axes in the left plot are on different
scales, whereas the ones in the right plot have the same limits.
15Note that the ascending aorta is the same anatomical location as the aortic root. Thus, the CP Model-
predicted Qlv,o and Psa of Fig. 4.4 are the lumped-parameter counterparts of the ascending aortic flow and
pressure profiles in Fig. 4.9.
16The development of the distributed-parameter model of the arterial tree was done according to the work
presented in [110].
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4.4 Cardiac output assessment
Cardiac output (CO) describes the amount of blood pumped by the heart per minute of time
and it is formally defined as the product between heart rate (HR) and stroke volume (SV ),
CO = HR·SV 17. In practical terms, CO depends on a combination of factors, affecting both
cardiac and circulatory functions. For instance, autonomic innervation regulates the firing
frequency of the sinoatrial node, thereby directly altering heart rate. Moreover, sympathetic
efferent fibers affect myocardial contraction (inotropy), effectively influencing the pumping
efficiency of the heart. Lastly, the autonomic nervous system modulates arterial vasodilation
and vasoconstriction which, in turn, change the systemic arterial load on the heart (the higher
the circulatory load, the lower the pumping efficiency of the heart). It is therefore reasonable
that cardiac output is considered the most reliable clinical indicator of cardiac performance.
Beyond the aforementioned reasons, assessment of cardiac output is of paramount im-
portance for hospitalized patients, whether mechanically ventilated or not. For example,
an acute drop in arterial blood pressure (i.e., acute hypotension), referred to as shock, is a
frequent clinical symptom in intensive care units. However, its underlying root cause is not
readily apparent by solely relying on blood pressure monitoring. In particular, a circulatory
shock can be categorized into the following four types, based on the underlying pathological
condition [111]: 1) distributive shock, when blood distribution is impaired either due to an
infectious disease (subcategorized as septic shock), like a virus, or due to noninfectious in-
flammatory conditions (subcategorized as non-septic shock), like burns, 2) cardiogenic shock,
when the heart’s pumping action is impaired, like in the case of myocardial infarction, 3)
hypovolemic shock, when there is blood loss in the circulation and blood volume is reduced,
like during bleeding conditions (subcategorized as hemorrhagic hypovolemic shock), and 4)
obstructive shock, when the pulmonary circulation is obstructed, like in pulmonary embolism.
17In equation CO = HR · SV , stroke volume typically refers to the volume of blood pumped into the
systemic circulation by the left ventricle. Notice, however, that even though left and right ventricular stroke
volumes may differ in transient conditions, like, for example, during a breathing cycle (see Fig. 2.9), mass
balance dictates that in steady-state conditions the outputs of the two ventricles ought to be the same.
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Even though the above pathological conditions are all manifested by hypotension, each
one of them is related to different attributes in the function of the cardiovascular system.
For instance, both hypovolemic and septic shocks are associated with low SV values (hence,
low pressure) and a high HR. However, the reason for the reduced cardiac stroke volumes
pertains to different factors. On one hand, blood loss during a hypovolemic shock leads to
a reduction in cardiac preload and thus to reduced stroke volumes according to the Frank-
Starling mechanism. Peripheral resistance, though, remains at nominal levels18. On the other
hand, a septic shock, typically caused by an infectious disease, is linked to a reduction in
peripheral resistance due to the disease-induced peripheral vasodilation. Blood distribution
is thus impaired, leading to reduced venous return and hence stroke volume. Undoubtedly,
distinguishing the underlying cause of a shock is critical to the patient’s survival because
different therapeutic interventions are required for each specific root cause. For example,
as briefly explained in Chapter 2, fluid resuscitation is typically considered as a means to
restore CO even though it may not always be the appropriate action. It is beneficial only
to truly hypovolemic patients, but it can have adverse consequences in those who are not
hypovolemic, potentially causing congestive heart failure.
To this end, knowledge of the direction of change (trend) in cardiac output, in addition
to the routine blood pressure monitoring, would allow the evaluation of the patient’s clinical
condition (i.e., determining the type of shock) and the prediction of their response to poten-
tial interventions. In mechanically assisted patients, evaluation of cardiac output is equally
important. As demonstrated by both experimental and simulation studies in Chapter 2,
mechanical heart-lung interactions have a significant effect on cardiac function. Therefore,
assessment of cardiac output prior to a ventilatory intervention can help determine any
ensuing detrimental effects on cardiac function.
18Recall the meaning of peripheral resistance in the Windkessel model proposed by Frank [94] and shown
in Fig. 4.6.
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4.4.1 Current clinical methods
Invasive techniques
Until recently, measurement19 of cardiac output in the clinical setting has mostly relied on
invasive techniques. Two of the most commonly used invasive methods are 1) the direct Fick
method and 2) the thermodilution method [112]. Their invasive nature pertains to the fact
that both require pulmonary artery catheterization, which has been linked to major compli-
cations, such as pulmonary artery perforation, pulmonary infarction, and thromboembolism.
The Fick method20, which is considered the “gold standard” approach to assess cardiac
output [113], is based on the principle that each body organ consumes a certain amount of
oxygen per unit of time. By substituting the notion of a single organ with the function of the
entire human body, we can then evaluate the total oxygen consumption (V O2). Specifically,
conservation of mass dictates that, in steady-state conditions, the total oxygen consumption
is equal to the product of cardiac output (i.e., the volume of blood per unit of time) and
the O2 concentration difference between arterial (CaO2) and mixed venous (CvO2) blood;
namely, V O2 = CO · (CaO2 − CvO2). CaO2 and CvO2 practically represent the amount of
oxygen before and after its uptake by the body tissues (tissue gas exchange), respectively.
That is, the arteriovenous oxygen difference (CaO2 − CvO2) indicates the amount of oxygen
consumed by the tissues of the entire human body. It is typically determined by gas analysis
on blood samples from a systemic and a pulmonary arterial line catheter. Note that a
pulmonary artery, rather than a venous, catheter is necessary to compute CvO2 . In such a
way, we can evaluate the oxygen consumption from both upper and lower body parts, whose
deoxygenated blood returns to the right atrium via the superior and inferior venae cavae,
respectively21. Consequently, one can readily use the Fick equation and compute a cardiac
19Note that the word “measurement” is used loosely in this particular context. Most of the presented
techniques do not measure cardiac output directly. Instead, they measure a quantity that is related to
cardiac output and can then be used to provide a cardiac output value.
20The Fick method is named after Adolf Eugen Fick who conceptualized the technique in 1870.
21Despite potential errors in computing the arteriovenous oxygen difference, some investigators do use
intravenous cannulation to assess CvO2 due to its less invasive and potentially less harmful nature.
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output value [114], provided that, besides the arteriovenous oxygen difference, the total body
O2 consumption is also measured. However, V O2 measurement is technically demanding,
especially at the bedside. It requires spirometry, an elaborate measurement method, which
limits the direct use of the Fick method for CO computation in clinical practice [115].
Nevertheless, if the direction of change in cardiac output is only of interest (rather than its
actual value), the Fick equation can be used without requiring a V O2 measurement. Under
the assumption that V O2 remains relatively constant22, one can associate the arteriovenous
oxygen difference, measured by gas analysis from arterial and mixed venous blood, with a
relative cardiac output value that is able to track changes in the actual CO.
Thermodilution23, on the other hand, uses a special triple-lumen pulmonary artery
catheter, commonly referred to as Swan-Ganz catheter. Since the catheter’s introduction
in 1971 [117], the thermodilution method has been extensively used to measure cardiac
output despite the skepticism about its accuracy, the ensuing cardiovascular complications,
and the need of skilled personnel for inserting the catheter [118]. As its name conveys, the
thermodilution method computes cardiac output by measuring change in temperature via a
thermistor located at the distal tip of the catheter inside the pulmonary artery. In particular,
the operator injects, through the catheter, a bolus of cold or warm indicator into the right
ventricle. Mixing of the indicator with blood changes the temperature of the intraventricular
blood, which is, in turn, pumped into the pulmonary artery. Temperature change is then
recorded as the blood passes over the thermistor and the measured temperature time profile
is used to determine a cardiac output value. Specifically, the area under the temperature-
time curve is inversely proportional to the flow rate (i.e., cardiac output) in the pulmonary
artery. The accuracy of the thermodilution method depends on multiple factors, such as the
position of the catheter, the volume and temperature of the indicator, the patient’s body
position, as well as the phase in the respiratory cycle at which the injection is administered
22This assumption will be invalid if tissue metabolism, and hence oxygen consumption, is altered, like in
cases of fever or excessive work of breathing.
23The thermodilution method was originally proposed by Fegler [116].
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[119, 120]. Thus, in clinical practice, particular attention has to be paid on the reliability of
thermodilution-based cardiac output measurements which, even under ideal circumstances,
may have a 10% error [121]. To minimize potential measurement errors, it is advised to
perform more than one injections—typically three—and then average their values, a process
that complicates even further the overall method.
Lastly, it is worth mentioning the ultrasonic flowmeter, a highly invasive technique that
is rarely used in clinical applications. Because the flowmeter is placed around the aorta,
such a method requires an incision into the pleural space of the chest (thoracotomy) in
order to gain access to the heart and the aorta. This surgical procedure is prone to major
complications, thereby limiting the use of the ultrasonic flowmeter solely to experimental
studies. Nevertheless, this method provides a real-time waveform of aortic volumetric blood
flow, thus making it the most accurate way to assess cardiac output at every single heart
beat24.
Minimally invasive and noninvasive techniques
The adverse consequences associated with the invasive nature of pulmonary artery catheter-
ization prompted the development of techniques that would assess cardiac output in a min-
imally invasive or even noninvasive way [122, 123]. For example, pulse contour and trans-
esophageal Doppler devices are minimally invasive methods, whereas partial carbon dioxide
rebreathing and transthoracic Doppler are completely noninvasive techniques.
Doppler-based methods, whether transesophageal or transthoracic, employ ultrasound
imaging and the Doppler’s principle to measure an instantaneous blood flow velocity (v(t))
on the descending aorta. Since Doppler ultrasound gives flow velocity, computation of vol-
umetric flow, and therefore of stroke volume, requires the knowledge of the cross-sectional
area (A) of the aorta. That is, SV = A
∫ te
to
v(t) dt, where to and te are the time instances
24Assuming, as previously mentioned, that Qlv,o is the aortic (or left ventricular) output flow, then a
beat-by-beat stroke volume can be computed as: SV = ∫ te
to
Qlv,o(t) dt, where to and te are the time instances
of the onset and end of a heart beat, respectively. Then, the formula CO = SV ·HR can be readily applied.
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of the onset and end of a heart beat, respectively. The aortic cross-section area is typically
derived from published nomograms based on age, sex, weight, and height. It can be also
directly measured via pulsed ultrasound, if such modality is available at the bedside [124].
Notice, however, that ultrasound methods assume a cylindrical aorta, an assumption that
can potentially lead to errors in the computed stroke volume. Even though both methods
are based on the same working principle, transesophageal and transthoracic Doppler devices
differ on their respective implementation. On one hand, flow velocity from a transesophageal
probe is measured via the catheter inserted into the patient’s esophagus. This is a minimally
invasive procedure which offers cardiac output monitoring as long as the catheter remains
inside the esophagus. On the other hand, a transthoracic Doppler probe is placed externally
on the thorax and hence is completely noninvasive. However, because placement of such
a probe on the thorax requires a human operator, a transthoracic device provides inter-
mittent cardiac output measurements. Nevertheless, both transesophageal or transthoracic
techniques require an expensive external apparatus for the analysis of the ultrasound images
and expert personnel for the accurate placement of the probe, whether inside the esophagus
or on the patient’s chest25.
Partial carbon dioxide rebreathing is another noninvasive approach to assess cardiac out-
put. It requires, however, an adjustable dead space26 component that is attached to the
patient’s breathing circuit [126], thus making the technique applicable only to mechanically
ventilated patients. Its operation is practically based on the Fick principle for the CO2 mass
balance. Similar to the invasive O2 Fick method, cardiac output can also be computed us-
ing the total carbon dioxide production (V CO2) and the corresponding arterial and mixed
venous CO2 concentrations, i.e., CO =
V CO2
CvCO2 − CaCO2
(note that CvCO2 is greater than
CaCO2). V CO2 is measured via volumetric capnography27, CaCO2 is approximated by the
25Note that placement of the probe is typically considered the primary reason for the low accuracy of
ultrasound methods, as reported by multiple clinical studies [125].
26Dead space is the volume of inhaled air that does not participate in gas exchange.
27Capnography is a technique for analyzing and monitoring the concentration of CO2 in air during breath-
ing.
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CO2 concentration in the exhaled air at the end of every breathing cycle (end-tidal CO2),
while the airway dead space component is employed for estimating the CvCO2 through partial
breathing of the exhaled air [127]. Hence, cardiac output can only be assessed intermittently,
whenever partial rebreathing is performed. Despite the fact that the partial CO2 rebreathing
method has shown reasonable accuracy as compared to invasively measured cardiac output
values acquired via thermodilution [118], the requirement of mechanical ventilation has lim-
ited its use in the clinic.
Finally, pulse contour methods provide cardiac output values by analyzing the time
profile of arterial blood pressure measured via an arterial line catheter (typically placed in a
femoral or radial artery). The reason why such methods are categorized as minimally invasive
pertains to the fact that (systemic) arterial catheterization is routinely used for continuous
hemodynamic monitoring in most intensive care units, especially in critically ill patients.
In addition, it is important to note that, in contrast to pulmonary artery catheterization,
arterial catheterization has not been associated with significant cardiovascular complications.
Measurement of cardiac output based on a pulse contour method was first proposed by
Warner et al. [128], but it was the work by Wesseling et al. [129] that described a clinically
usable technique. In particular, Wesseling et al. [129] used the transmission line theory
and suggested that stroke volume is proportional to the area under the systolic portion of
the arterial pressure (P ) curve and inversely proportional to the characteristic impedance





P (t) dt, where tos and tes are the time
instances of the onset and end of systole, respectively. Based on transmission line theory,
the characteristic impedance28 is the impedance of an infinitely long transmission line that
does not generate any reflected waves—this is equivalent to the assumption of an infinite
pulse wave velocity used for the development of Windkessel-type models. To overcome
the presence of wave reflections in practical applications, Wesseling et al. [129] suggested
the use of correction factors, computed from pressure waveform analysis, to replace the
28As introduced by the three- and four-element Windkessel models in Fig. 4.7, characteristic impedance
is also associated with the system’s impedance at high frequencies.
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unknown arterial characteristic impedance, thereby allowing beat-by-beat computation of
stroke volume and hence cardiac output. The main advantage of pulse contour methods
in providing continuous cardiac output measurements without additional instrumentation—
besides the arterial line—sparked the interest of the clinical community. Nevertheless, it
was later indicated that bedside calibration is indeed necessary for improved measurement
accuracy, particularly if absolute, rather than relative, cardiac output readings are of interest.
4.4.2 Model-based estimation methods
Another promising family of methods to assess cardiac output involves the use of parameter
estimation, or system identification, algorithms. As explained in Section 4.1, these algorithms
are developed based on lumped-parameter models of the system under investigation, cast
either in an input-output (e.g., differential (4.1) or difference (4.4) forms) or in a state-space
(4.5) representation. However, when applied to the systemic arterial system, most of such
estimation techniques are based on the simplistic Windkessel-type models (see Figs. 4.6 and
4.7) due to the following reasons [130]: 1) the limited number of unknown parameters to
be estimated, 2) the physiological and clinical interpretability with respect to the models’
dynamic response and parameters, and 3) the models’ widespread acceptance by the medical
community.
Model-based estimation methods typically rely on the dynamics of arterial pressure (e.g.,
peak-to-peak amplitude and diastolic decay) and thus necessitate the use of a continuous
pressure signal acquired via an arterial line catheter. As mentioned above, arterial catheter-
ization is routinely used in intensive care units. As such, these estimation techniques are
categorized as part of the minimally invasive approaches for cardiac output assessment. De-
spite, however, their direct clinical interpretability and applicability, estimation methods
face a significant challenge; namely, cardiac output, the unknown quantity to be estimated,
is directly related to the aortic blood flow Qlv,o24, the forcing function of the systemic cir-
culation (recall the schematic representations of Fig. 4.5). If we represent, for instance, the
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systemic arterial tree as a two-element Windkessel model, as per Fig. 4.6, with Q = Qlv,o
being the circulatory system’s input, then the arterial pressure (P = Psa) can be considered










where Rt and Ct are the peripheral (or terminal) resistance and total arterial compliance,
respectively. By examining (4.8), it becomes apparent that the P is the only measurable
variable. The system’s input, Q, along with the system’s parameters, Rt and Ct, are un-
known elements. Undoubtedly, the task of estimating any quantity, whether that being
the cardiac output (i.e., blood flow, Q) or the system’s mechanical properties (i.e., model
parameters), constitutes an ill-posed problem due to the lack of adequate information, in
terms of measurable elements.
To overcome such an underdetermined nature of the estimation problem at hand and
make it somewhat feasible29, past researchers [7, 131, 132, 133, 134, 135] have relied on two
main assumptions on the aortic blood flow profile.
1. According to the first assumption, the heart’s pumping action is a periodic impulse
flow generator which, at the nth heart beat, ejects a total volume of blood equal
to stroke volume, SVn. Thus, Qlv,o can be depicted as an impulse train function
with the amplitude of each Dirac delta function being equal to SVn, i.e., Qlv,o(t) =∑
n
SVn · δ(t − tn), where tn is the time instance of the nth Dirac delta function. For
example, the left-hand side plot of Fig. 4.10 shows such an impulse train Qlv,o function
over three cardiac cycles (three Dirac delta functions). Note that each SVn value is
equal to about 79 ml—a value that is within the normal physiological range observed in
healthy subjects. The right-hand side plot of Fig. 4.10 accordingly shows the pressure
waveform simulated by a two-element Windkessel model, whose response is described
29As we will see later, the notion of “somewhat feasible” refers to the fact that even when the proposed
assumptions are satisfied, only a relative cardiac output value can be derived.
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by (4.8), for Rt = 1.15 mmHg·s/ml and Ct = 1.50 ml/mmHg30.
Fig. 4.10. Sample pressure and flow waveforms simulated from a two-element Windkessel
model over three cardiac cycles. Qlv,o, left ventricular output blood flow (left plot); Psa,
systemic arterial pressure (right plot).
Under the impulse flow assumption, (4.8) can be solved as:
dP (t)
dt
· et/Rt Ct + P (t)
RtCt
























· eξ/Rt Ctdξ︸ ︷︷ ︸
0




















+ P (t−n )
)
· e−(t−tn)/Rt Ct , (4.9)
30The values of peripheral resistance, Rt, and total arterial compliance, Ct, are taken from Segers et
al. [136] and represent parameters from subjects with normal blood pressure values (normotensive).
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where t−n and t+n are infinitesimal time instances before and after the onset, tn, of the
Dirac delta function, respectively and time t spans the interval between two consecutive
delta functions. Notice that (4.9) demonstrates that the response of a Windkessel
model has indeed an exponential nature with time constant equal to RtCt, thereby
supporting our comments in Section 4.3.1.
Accordingly, if we evaluate the pressure output at t+n , (4.9) becomes:




+ P (t−n )
)
· e−(tn−tn)/Rt Ct
⇒P (t+n ) =
SVn
Ct
+ P (t−n )




where the difference, P (t+n ) − P (t−n ), is defined as the pulse pressure (PPn) at t = tn
(i.e., the difference between systolic and diastolic values). The simulation results in
Fig. 4.10 agree with the mathematical derivation in (4.10); namely, the pulse pressure






= 52.67 mmHg31. So, the assumption of impulsive cardiac pumping action
establishes a direct relationship between pulse pressure and stroke volume. That is,
beat-to-beat stroke volume, SVn, is directly proportional to both pulse pressure, PPn,
and the total arterial compliance, Ct.
2. The second assumption claims that the aortic blood flow during diastole is zero. Notice
that such consideration is part of the first assumption as well, because the impulsive
cardiac function implicitly assumes that diastolic blood flow is zero (see Fig. 4.10).
Nevertheless, this second assumption can also be used independently. In particular, if
Q(t) = 0 for t ∈ [t0, t), it can be derived from (4.8) that the system’s homogeneous
31The small difference in the two values pertains to the fact that the simulated response in Fig. 4.10 is
derived from a discrete-time Windkessel model (difference form) rather than a continuous-time one as per
the ODE in (4.9).
128
4.4 Cardiac output assessment
response is expressed by an exponential decay of the form
P (t) = P (t0) · e−(t−t0)/Rt Ct , (4.11)
where P (t0) is the pressure at t = t0 (i.e., onset of diastolic phase at which blood flow
becomes zero). Further, notice that in the case of the impulse train blood flow, (4.11) is
equivalent to (4.9) with P (t0) =
SVn
Ct
+P (t−n ). Hence, under the second assumption and
since arterial pressure is a measurable quantity, one can readily extract the circulatory
system’s time constant. However, it is not feasible to independently assess Rt and Ct.
Early model-based methods to estimate cardiac output using arterial blood pressure
measurements were developed based on the first assumption [131, 132]. Particularly, such
methods relied on the fact that stroke volume is directly proportional to pulse pressure
(4.10). Despite that assessment of arterial compliance, Ct, was not possible (it is still not
easily measured), Erlanger and Hooker [131] proposed the use of pulse pressure as a surrogate
of stroke volume by realizing that SV ∝ PP ⇒ CO ∝ PP ·HR, where HR is the heart (or
pulse) rate. Therefore, they were able to compute a relative cardiac output value, COrel =
k · PP · HR, where k is an unknown proportionality factor—under the impulsive cardiac
function assumption, k is equal to Ct. Later, Liljestrand and Zander [132] suggested an
improvement on the relative cardiac output computation by taking into consideration that
the arterial compliance (i.e., k) is not constant but varies as a function of arterial pressure
(nonlinear compliance). Hence, according to Liljestrand and Zander [132], COrel can be
computed as: COrel =
k1
Psys + Pdias
·PP ·HR, where k1 is a different proportionality constant,
and Psys and Pdias are the systolic and diastolic values of arterial pressure, respectively.
Clearly, the approach by Liljestrand and Zander [132] established a heuristic method to
account for the physiologically varying nature of Ct (and thus of k in the original equation)
in an effort to provide better estimates of COrel.
Even though such estimation methods were not designed to provide absolute cardiac out-
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put values, assessment of a relative cardiac output proved to be equally important in clinical
practice. A relative value can track changes in the actual quantity; that is, it is expected
that COrel can follow changes in the true CO value, provided that the proportionality factor
remains constant with respect to the underlying physiological reasons that caused such a CO
change. Tracking changes in the cardiovascular system’s function and mechanical properties
is of paramount clinical importance, especially in intensive care units with hemodynamically
unstable patients. Such a clinical significance of such an information maintained the interest
of the research community toward a more accurate and robust estimation of relative cardiac
output values.
The more recent model-based estimation methods by Bourgeois et al. [133], Mukkamala
et al. [7], and Parlikar et al. [135] utilize either just the second assumption or a combination
of both in order to find a relative cardiac output. Bourgeois et al. [133] proposed a two-step
approach by considering only the second assumption (that is, assuming that blood flow is
zero during diastole): 1) a time constant value would first be estimated during the diastolic
phase of the cardiac cycle, and 2) a relative stroke volume value would then be computed by
considering that, during systole, portion of the blood volume pumped by the heart is stored
in the elastic arterial vessels (arterial compliance) while the rest is being propagated into the
peripheral circulation (peripheral resistance). Bourgeois et al. [133] validated their method
on central aortic (e.g., ascending or descending aortic) pressure waveforms, whose diastolic
phase is known to resemble an exponential decay. Aortic pressure, though, is rarely measured
at the beside due to the risk of formation of blood clots, hence making this technique not
clinically applicable.
To overcome such a limitation and be able to use arterial pressure waveforms (instead
of central aortic), Mukkamala et al. [7] proposed a more sophisticated method to estimate
the system’s time constant by combining the impulsive cardiac function assumption with
a novel exponential fitting approach. In particular, they suggested that, as we explained
in Section 4.3, the complexity of the arterial tree renders the effects of wave reflections on
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pressure and flow waveforms quite significant. Consequently, they asserted that simple fitting
methods, such as that in [133], would fail to find a reasonable (and accurate) time constant
value due to the fact that the typically measured femoral and radial pressure signals do not
exhibit a discernible exponential decay (compare, for example, Pasc and Pfem in the right-
hand side plot of Fig. 4.9). According to their method, the high complexity of the arterial
system can be modeled by an nth-order ARX model, like in (4.4), where blood flow Q is the




aiP [k − i] +
n∑
j=0
bjQ[k − j] + w[k], (4.12)
where w is the residual unmeasured error, and ai and bj are constant scalar coefficients that
are related to the system’s mechanical properties. Notice that the output coefficients ai are
also associated with the poles of the system’s transfer function that characterize its dynamic
response32. For instance, the differential equation describing the function of the two-element
first-order Windkessel model in (4.8) can be written in an equivalent ARX form as follows
(using the first-order Taylor approximation for the derivative term and assuming Ts is the
sampling period):












P [k − 1] + Ts
Ct
Q[k − 1]. (4.13)
32The transfer function can be derived by taking the Z-transform of the system’s nth-order discrete-time
state-space representation in (4.5). It can then be shown that the poles of the discrete-time transfer function
are the same as the eigenvalues, λd,i (i = {1, . . . , n}), of the system matrix Ad. Each eigenvalue λd,i (or
pole) is associated with a component of the system’s homogeneous response, yh[k] =
∑n
i=1 cd,i · λkd,i. It is
worth mentioning that the discrete-time eigenvalues are related to their continuous-time counterparts, λc,i,
according to the formula: λd,i = eλc,i·Ts , where Ts is the sampling period. Hence, the system’s continuous-
time homogeneous response is: yh(t) =
∑n
i=1 cc,i ·eλc,i·t, since t = k ·Ts. Accordingly, any real eigenvalue λc,i
would represent a pure exponential response with time constant equal to the reciprocal of that eigenvalue,
i.e., τi = 1/λc,i (if the eigenvalues have negative real parts, then the response will be stable).
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Comparing (4.13) with (4.12), we realize that a1 = 1− Ts
RtCt






is the first-order Taylor expansion of the exponential function e−Ts/(Rt Ct). This
indicates that without any simplifying approximations a1 = e−Ts/(Rt Ct), thereby illustrating
that the discrete-time response of the two-element Windkessel model is indeed characterized
by the same time constant, τ = RtCt, as its continuous-time counterpart.
Ideally, if both P and Q waveforms are known, one can easily estimate the coefficients
of the ARX model in (4.12) and correspondingly assess the system’s dynamic response. In
practice, though, blood flow Q is unknown. Mukkamala et al. [7] addressed this issue with
the following proposition. As per our first assumption, they assumed that blood flow is
a train of Dirac delta functions. However, they did not follow the typical consideration
for the delta functions’ amplitudes (i.e., equal to SV ) but they rather assumed that each
impulsive heart beat has an amplitude equal to the corresponding pulse pressure value. Such
a consideration is supported by two mathematical aspects. 1) Under the impulsive cardiac
function, PP is proportional to SV within a scaling factor equal to the inverse of the total
arterial compliance; namely, PP = SV
Ct
. 2) As seen in (4.9) and (4.11), the amplitude of an
impulse forcing function does not affect the time constant of the ensuing exponential decay,
but only the decay’s initial condition (P (t0) in (4.11)). Thus, since estimation of the system’s
time constant is what Mukkamala et al. [7] were after, the amplitude of each impulsive heart
beat in the blood flow impulse train is not expected to have an impact on time constant
estimation.
As such, Fig. 4.11 represents, in a schematic way, the estimation method proposed by
Mukkamala et al. [7], which can be summarized as follows:
1. Assume that the system’s input (u) is an impulse train whose Dirac delta functions have
amplitudes equal to each heart beat’s pulse pressure, PPn. Following the Windkessel
model concept, the system’s output is considered to be the measured arterial blood
33The direct influence term, b0, is zero because the two-element Windkessel is a strictly proper system,
whose transfer function has more poles than zeros.
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pressure, P .
2. Estimate, via least squares, an ARX model using input, u, and output, P , data over a
segment that spans multiple heart beat—notice that, for illustration purposes, Fig. 4.11
shows only three cardiac cycles. It is important to note that the proposed estimation
scheme does not require the order of the ARX model to be selected a priori. Instead, it
determines the model order by minimizing the minimum description length criterion34.
Essentially, such a criterion provides a way to optimally find the model that has the
best trade-off between output prediction error (goodness of fit) and model complexity
with respect to the number of estimated parameters (the higher the model order, the
higher the number of parameters to be estimated).
3. Evaluate the impulse response of the estimated ARX model and estimate the time
constant from the ensuing exponential decay35.
According to Mukkamala et al. [7], the time constant estimated by their proposed method
corresponds to the time constant, RtCt, of a Windkessel model. This is despite the fact
that the optimal ARX model is typically of order higher than first due to the complexity
of the arterial tree and the presence of wave reflections. Such a consideration is attributed
to the experimental evidence that the Windkessel model can capture the low-frequency
dynamics of the arterial tree, as mentioned earlier. Low-frequency dynamics are associated
with the system’s eigenvalue with the slowest exponential decay (i.e., high time constant
value). Hence, it is reasonable that Mukkamala et al. [7] conjectured that the estimated
time constant (assessed after the estimated model’s high-frequency dynamics have vanished)
is theoretically equivalent to that of a Windkessel model.
34The minimum description length criterion introduced by Rissanen [137] defines a value for each model
under consideration based on the formula: N · log(SSR/N) + p · log(N), where N is the number of samples
in the segment, SSR is the sum of squared residuals between measured and model-predicted outputs, and p
is the model order. SSR determines the model’s goodness of fit, whereas p indicates the model complexity.
35Typically, the exponential decay of a system’s impulse response is characterized by the time constant of
the largest eigenvalue, whose exponential component has the slowest decay and thus dominates the response
after the high frequency dynamics (associated with small eigenvalues) have vanished.
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Fig. 4.11. A schematic representation of the estimation method proposed by Mukkamala et
al. [7]. u, impulse train input; P , systemic arterial pressure (system’s output); aˆi and bˆj,
estimates of the optimal ARX model; τˆ , estimated time constant.
Finally, after such a time constant is estimated, a relative cardiac output value can be
computed using the formula: COrel =
P¯
τˆ
, where P¯ is the average arterial pressure over a
segment of data and τˆ is the estimated time constant. This formula is derived by taking the




























P [k − 1]



















P [k − 1], (4.14)
where we have hypothesized that at steady-state conditions P [0] = P [N ]. Notice that we
implicitly assumed that the segment under consideration does not contain partial heart beats,
meaning that k = 0 and k = N respectively correspond to the first sample of the first heart
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beat and the last sample of the last heart beat within the segment. By dividing (4.14) by













since CO can also be seen as the average flow over a time interval36. Because we can only












P¯ = COrel. (4.16)
According to (4.16), we can appreciate that the relative cardiac output (COrel) computed by
taking the ratio of P¯ over τ is related to the true CO value within a scaling factor equal to
the inverse of the total arterial compliance, Ct. Thus, if Ct remains constant throughout the
course of the experimental studies, COrel will accurately track changes in the true CO. It is
worth pointing out that if continuous monitoring of the true cardiac output is of interest, the
estimated COrel can be calibrated with respect to techniques that measure cardiac output
intermittently, such as thermodilution—if available—or transthoracic Doppler ultrasound
[138].
Lastly, the estimation method proposed by Parlikar et al. [135] was based on a beat-to-
beat averaged Windkessel model that accounts for both inter- and intra-beat variability in
the arterial pressure waveform. Inter-beat variability refers to pressure dynamics within a
heart beat, such as pressure peak-to-peak amplitude (pulse pressure) and diastolic decay,
whereas intra-beat variability represents the pressure difference at the onset of consecutive
36From a continuous-time perspective, we have defined CO = SV · HR. But, SV = ∫ T
0
Q(t)dt and
HR = 1/T , if, for instance, T is the duration of a heart beat. Then, CO = ∫ T0 Q(t)dt/T = Q¯, where Q¯ is the
average flow.
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heart beats, attributed to changes in patient’s hemodynamic status. According to Parlikar
et al. [135], the differential equation of (4.8) can be averaged by integration over the nth














































where SVn and P¯n respectively are the stroke volume pumped by the heart and the average
arterial pressure over the nth cardiac cycle, and ∆Pn is the pressure difference at the onsets
of two consecutive heart beats. Notice that Parlikar et al. [135] introduced the inter-beat
variability concept by relaxing the typical assumption of the circulatory system being at
steady state, whereby arterial pressure returns to its initial value at the end of every heart
beat. Combining (4.17) with the impulse train blood flow assumption, which expresses pulse












∆Pn, Tn, P¯n, and PPn can be readily obtained from the measured arterial pressure waveform.
Hence, the only unknown in (4.18) is the time constant τ , which can be estimated in a least
squares sense over a window where it is assumed to be constant or slowly varying. Then, a
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cardiac output value that is related to the true COn within a scaling factor equal to the
inverse of the total arterial compliance37.
Limitations
As mentioned above, the two main assumptions used by most current estimation methods to
make the circulatory system identification task somewhat feasible rely on Windkessel-type
models, whether on a two- (Fig. 4.6), a three- (Fig. 4.7a), or a four-element (Fig. 4.7b)
model. Such models assume an infinite pulse wave velocity and thus are not able to replicate
the complex dynamics of the systemic arterial tree, such as the wave propagation delay and
wave reflections. Nevertheless, it has been shown [107] that in the ascending aorta and
central arteries (e.g., thoracic and abdominal aorta), the blood flow during diastole can be
adequately approximated as zero, likely due to the fact that wave reflections (from peripheral
circulation) and re-reflections (from the closed aortic valve) are effectively cancelling one
another. Consequently, estimation techniques that use central aortic pressure waveforms
and estimate the circulatory system’s time constant have proved to be quite accurate. It is
worth pointing out, though, that in a clinical setting, pressure manometry is rarely performed
at these vessels due to high risk of catheter-associated complications, like blood clots. As a
result, clinical pressure monitoring is typically conducted on either femoral or radial arteries.
However, the flow profile at these arterial segments significantly deviates from the zero
value assumption. This phenomenon is primarily attributed to the wave reflections that are
generated by the closely located peripheral vessels, thereby presenting a major challenge for
current estimation approaches that are based on Windkessel-type models and end up using
femoral or radial pressure waveforms to estimate the circulatory system’s time constant.
37Notice the difference between the formula (4.19) suggested by Parlikar et al. [135] and the one in (4.16)
which is typically used. The absence of the term ∆Pn/Tn in (4.16) is ascribed to the steady-state condition




4.5.1 A feasibility study with central venous pressure
It is clear from our discussion in previous sections that monitoring of physiological variables
at the bedside can offer significant advances in the diagnosis and tracking of cardiovascular
diseases. Undoubtedly, arterial blood pressure (ABP) is the most commonly measured vari-
able due to its profound importance in monitoring the status of the cardiovascular system. In
addition to ABP, central venous pressure (CVP) is another variable that is often measured
in critical care units. It is considered a close proxy of right atrial pressure (Pra) and thus
typically used by the medical community as an indirect index of cardiac preload38. Even
though studies [139] have shown that CVP poorly correlates with such index and despite
the adverse consequences of venous catheterization [140], CVP monitoring can still offer
an indication of the interaction between cardiac function and circulatory system [141], as
portrayed by the well-known Frank-Starling curves. In addition, although CVP is, from a
dynamic point of view, less rich as a signal compared to ABP, it still contains physiological
information on the dynamics of the circulatory system. Therefore, we want to investigate
the potential benefits of using both ABP and CVP signals for the identification of the cir-
culatory system. The analysis is conducted in two parts: 1) we analyze the identifiability of
the circulatory system’s state-space representation by considering the theoretical concepts
of controllability39 and observability40 and 2) we evaluate the performance of a state-space
identification technique on simulated data with and without the influence of noise.
38As explained in Chapter 2, ventricular preload describes the level of stretching in cardiac myocytes,
therefore indicating the pumping capacity of the ventricle. Myocardial stretching is a function of end-
diastolic ventricular volume. However, ventricular volumes are not easily measured in clinical scenarios. As
a result, end-diastolic ventricular pressure, which is approximately equal to atrial pressure at the end of
diastole, is typically used as a surrogate of ventricular preload.
39Controllability is a property of a state-space model for which there exists input u(t) that can transfer
any initial state x(t0) to any final state x(t1) in a finite time.
40Observability is a property of a state-space model for which the knowledge of input, u(t), and output,
y(t), for t ∈ [t0, t1] (t1 finite) suffices to uniquely determine any unknown initial state, x(t0).
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Simplified systemic circulation model
To simplify the analysis, we propose a simplified version of the systemic circulation model
presented in Chapter 2 as part of the cardiopulmonary model. In particular, we lump the
two parallel compartments, representing the splanchnic and extra-splanchnic circulations (see
Fig. 2.2), into a single one and accordingly compute the equivalent values for the hydraulic
resistances and compliances. The derived fourth-order model is shown in Fig. 4.12. As
analyzed in Section 4.2.2 and illustrated in Fig. 4.5, we assume that ABP, measured in the
aorta and denoted as Psa, is the driving pressure source and Pra is the right atrial pressure
(CVP signal) and the output of the system. The nodes Psp and Psv represent the pressures














Fig. 4.12. Electrical diagram of the simplified fourth-order model of the systemic circulation
system. ABP, arterial blood pressure; CVP, central venous pressure; P , pressure; Q, blood
flow; R, resistance; L, inertance; C, compliance. Subscripts: sa, systemic arteries; sp,
systemic peripheral circulation; sv, systemic veins; ra, right atrium. Patm is the atmospheric
pressure which is assumed equal to zero.
The simplified model of Fig. 4.12 has the following limitations. First, it does not account
for the contractions of the right atrium and right ventricle. Hence, the dynamics owing to any
of these phenomena, which profoundly affect a clinically measured CVP waveform, are absent
in the simulated Pra signal. Second, atmospheric pressure is the common reference pressure
for all pressure nodes. Thus, the effect of pleural pressure on CVP, which as described in
Chapter 2 is quite significant, is herein assumed to be negligible. Third, the function of
the atrioventricular valve is not appropriately considered. To be specific, Rra effectively
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represents the resistance of the tricuspid valve that opens and closes based on the pressure
difference between the right atrium and the right ventricle. However, with this model, we
assume that the valve is always in an open state with flow exiting the high pressure point,
Pra, towards the atmospheric downstream pressure. Mitigation of this limitation can be
ensured by splitting the identification into two portions; one made of segments when the
tricuspid valve is open, the other when it is closed. Nevertheless, for our study, such a
complication is not deemed necessary. In fact, it will be shown later that the identifiability
of the system in Fig. 4.12 is independent of the value of Rra.
The continuous-time state-space representation, as in (4.2), of the simplified model in





























































+ 0 · Psa. (4.20b)
The values of the parameters in (4.20) are computed based on the ones reported by Albanese
et al. [18]: Lsa = 0.220 · 10−4 mmHg·s2/ml, Rsa = 0.0600, Rsp = 0.595, Rsv = 0.0112, Rra =
0.0250 mmHg·s/ml, and Csp = 3.72, Csv = 77.8, Cra = 31.3 ml/mmHg. The eigenvalues (or
poles of the system’s transfer function) of the continuous-time A matrix in (4.20), which will
be used for evaluation of the identification performance, are λ1,2,3,4 = −0.31039, −4.9570,
−5.0481, −268.17. Thus, the corresponding time constants (in seconds) are equal to τ1,2,3,4 =
−1/λ1,2,3,4 = 3.22180, 0.20173, 0.19810, 0.0037290.
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The reason why we are interested in the eigenvalues of the A matrix is attributed to the
fact that a state-space model is unique within a similarity transformation41. It is then usual
that, in state-space identification, the identified model will not necessarily be in the same
coordinate frame as the original system. Thus, a common and convenient way of judging
the identified model is via eigenvalue analysis, since the eigenvalues of the system matrix A
are invariant under similarity transformation.
Theoretical considerations
Identifiability of state-space models is determined by the rank of the controllability and
observability matrices. Full-rank matrices signify that all states of the system are controllable
and observable and thus the corresponding model can be identified. Because (4.20) is a SISO
model, both controllability and observability matrices are square. Hence, they will have full
rank if and only if their determinant is non-zero, regardless of the magnitude. For the model
in (4.20), the determinants of the continuous-time controllability and observability matrices
Q and O are given by























It is apparent that for any finite values of the parameters, the determinants in (4.21) and
(4.22) are non-zero. We can then infer that the assumed model is controllable and observable.
Hence, all states can be identified using input and output data, provided that the input is
sufficiently rich to excite the system’s dynamics. Besides, based on (4.21) and (4.22), we
observe that the identifiability of the system does not depend on the right atrial resistance,
Rra, since the determinants are invariant of its value.
41A similarity transformation is considered when the state x(t) of the state-space model in (4.2) gets
multiplied by a nonsingular matrix T ∈ Rnxn, i.e., z(t) = Tx(t). The corresponding state-space model





For the simulation studies, we use the novel and robust-to-noise observer Kalman filter
identification with deterministic projection (OKID/DP) algorithm proposed by Vicario et
al. [142]. Such a non-parametric state-space system identification technique is preferred over
parameter estimation methods, because it is designed to optimally assess the system’s order
without any prior knowledge of its actual structure. Instead of estimating the parameters
of an a priori assumed model, identifiability is then evaluated based on whether the correct
order of the system is identified and how precisely its eigenvalues are estimated. This is
important, as in practical scenarios noise may significantly affect the dynamics associated
with some of the eigenvalues and make their estimates highly uncertain. To this end, we
use Monte-Carlo (MC) numerical simulations to take into account noise in the data and
assess the system’s identifiability under varying levels of noise. Additionally, note that
most identification techniques, like the one adopted here (OKID/DP), are formulated for
implementation in a digital machine and thus they identify a discrete-time state-space model.
Nevertheless, under the standard zero-order-hold assumption, the identified discrete-time
model can be readily converted into its continuous-time counterpart in (4.20).
Specifically, we want to verify via numerical simulations whether OKID/DP can correctly
identify the fourth-order model depicted in Fig. 4.12 and represented by the state-space form
in (4.20). The ABP waveform generated by the comprehensive cardiopulmonary model of
Chapter 2 is taken as the input signal and the output CVP pressure is then simulated via
the model in (4.20). A segment, for instance, of the simulated ABP and CVP signals is
illustrated in Fig. 4.13. Subsequently, such input and output data are passed on to the
OKID/DP algorithm. Like any state-space identification method, a key step in OKID/DP is
the singular value decomposition (SVD) of a data matrix. The number of non-zero singular
values indicates the order of the model whose A, B, C, and D matrices the algorithm would
then identify. In more practical terms, the presence of a noticeable gap between two groups of
singular values (e.g., zero and non-zero) in the SVD plot demonstrates that the identification
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algorithm is able to determine, from the available data, that the system is of order equal to
the number of singular values before such a gap. It is worth mentioning that the algorithmic
performance with regards to the true model will be assessed, as described earlier, via the
eigenvalues of the system matrix A.
Deterministic case When noise-free simulated input and output data are used in OKID/
DP, the singular value plot (blue dots in Fig. 4.14) shows a significant gap between the fourth
and fifth singular values. Note that the small singular values are in magnitude very close
to zero (within Matlab’s working precision). As predicted by the theoretical indicators and
shown in Fig. 4.14, the fourth-order model is correctly identified since the eigenvalues of the
identified A matrix closely match the true ones.
Fig. 4.13. Sample ABP (left plot) and CVP (right plot) waveforms simulated under noise-free
conditions from the fourth-order model presented in Fig. 4.12 and described in (4.20).
Stochastic case In the stochastic case, zero-mean Gaussian-distributed random noise is
added to corrupt both input and output data before they are passed on to OKID/DP. The
standard deviation (SD) of input and output noise is chosen proportional to the SD of the
corresponding uncorrupted signal. We thus intend to keep the signal-to-noise ratios of both
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Fig. 4.14. Singular value plot of OKID/DP for the noise-free (σ% = 0) and noisy data with
levels of noise standard deviation σ% = 1, 5, 10, 20. Notice that the number of non-zero—
with reference to the noise level corrupting the data—singular values indicates the order of
the model.
input and output data at relatively the same levels, while we analyze the effects of noise
with its standard deviation (σ%) ranging from 1% up to 20% of the original signal’s SD.
For instance, Fig. 4.14 compares the singular value plot for σ% = 1 (red squares) with the
one of the deterministic case (blue dots). It is apparent that even such a relative small noise
level renders the model not fully identifiable as the fourth singular value can no longer be
distinguished from the rest. This phenomenon can also be conjectured from the deterministic
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case (blue dots) since the first three singular values are dominant relative to the fourth one,
whose value is considerably smaller. Similar conclusion can be inferred from a theoretical
perspective as the time constant associated with the smallest eigenvalue λ4 is significantly
smaller (at least two orders of magnitude) than the other three. As a consequence, the
corresponding dynamics decay very fast and they are difficult to be identified. Further,
mathematical derivation shows that the fourth and smallest eigenvalue is associated with
blood inertance. Simplification of the model shown in Fig. 4.12 by removing the inertance
Lsa and assuming that the differential pressure across the resistive element Rsa is equal
to Psa − Psp eliminates the above-unidentified eigenvalue with the fastest response. The
remaining eigenvalues of this simplified third-order model, i.e., λ1,2,3 = −0.31028, −4.9106,
−5.0105, are minimally affected as compared with those of the fourth-order model. Hence,
since noise is always present in real-case scenarios, we can conclude that inertial effects of
the blood, which are predominant in the aorta, cannot be effectively determined by using
only ABP and CVP signals.
Moreover, Fig. 4.14 clearly illustrates that as the noise level increases, the gap between
the non-zero singular values and the ones that are supposed to be zero reduces. For σ% = 20
(magenta circles), for instance, the singular value plot suggests that the gap is minimal and
the order of the identified model can be anything between first and third. Essentially, the
singular value plot does not provide any clear indication that the dynamics of the system
could be generated by a model of an order higher than one.
To further illustrate this point, we execute MC simulations in order to assess the preci-
sion of the estimated eigenvalues in the presence of random noise in the input-output data
generated by the fourth-order model. For each run, we get singular value plots similar to the
ones in Fig. 4.14 and we pick only the three largest singular values, as the fourth eigenvalue
is clearly obscured by the noise. Table 4.1 shows the eigenvalues of the 3x3 A matrix in
terms of mean and standard deviation of the results from 100 runs for each noise level. It
is evident that the dynamics of λ1 are dominant in the noisy simulated data as the SD of
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λ1 estimate is, in relative terms, one order of magnitude smaller than the SD of λ2 and λ3
estimates. Similar conclusion was drawn from Fig. 4.14, where the small separation gap
between the zero and non-zero singular values confirmed the difficulty in identifying a model
of an order higher than one.
Table 4.1. Eigenvalue comparison between true and identified A matrices
λ1 λ2 λ3
Noise level (σ%) Mean SD Mean SD Mean SD
(True) (−0.31028) — (−4.9572) — (−5.0479) —
1% −0.31048 0.00128 −4.7740 0.18477 −5.2455 0.20456
5% −0.30778 0.00579 −4.7553 0.32977 −5.2563 0.41156
10% −0.29773 0.01101 −4.8096 0.27239 −5.0834 0.39558
20% −0.26423 0.01827 −4.6777 0.18347 −4.6899 0.20720
Mean and standard deviation (SD) of the estimated A matrix’s eigenvalues have been com-
puted from 100 Monte-Carlo simulations for each noise level.
In conclusion, the results of this study suggest that the use of CVP as a signal additional
to regular ABP monitoring is not sufficient to provide a more accurate and detailed de-
scription of the circulatory system. Even from data numerically generated from a simplified
fourth-order model of the systemic circulation, part of its dynamics is not correctly (if at all)
identified under the influence of input and output noise. Moreover, the simulations showed
that, even if it were possible to measure the ABP in the aorta, where the inertial effects of
the blood flow are the highest, the dynamics attributed to the inertance could be extracted
only in the ideal case of noise-free data. The presence of noise renders the corresponding
eigenvalue completely unidentifiable. Finally, noise in the data considerably narrows the
gap in the singular value plot that is necessary to distinguish between zero and non-zero
singular values. Even third- or second-order models are not easily, or accurately, identified
as illustrated by the ambiguous separation in the singular value plot and by the relatively
large SD of the λ2 and λ3 estimates.
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4.5.2 Proposed estimation algorithm
The feasibility study, delineated above, clearly demonstrated that even under ideal and
simplified conditions (i.e., a simplified fourth-order model of the systemic circulation, no
effects of atrial or ventricular contraction on central venous pressure), the dynamics of the
CVP waveform are not adequate in providing a more detailed description of the circulatory
system (i.e., a model with order higher than first). Accordingly, our efforts focused on
estimation techniques that would only use the ubiquitously monitored arterial (femoral or
radial) blood pressure.
Similar to the model-based techniques analyzed in Section 4.4.2, the proposed cardiac
output estimation method is designed according to the typical consideration that blood flow
is the forcing function (input) to the arterial tree, which, in turn, generates the measured
arterial blood pressure waveform. On the contrary, though, to most existing estimation
methods that are based on the impulsive cardiac function assumption, we instead intend
to use more appropriate physiological assumptions on the shape of the circulatory system’s
forcing function. Formulation of such assumptions requires a thorough understanding of
the complex dynamics of the arterial circulation (e.g., wave reflections phenomena) as well
as a substantial exposure to real-time pressure and flow waveform data. However, an ex-
tensive collection of such data is an enormously challenging task due to the invasiveness of
a continuous and real-time measurement of blood flow42. Hence, one way to acquire such
hemodynamic data is by creating a high-fidelity in-silico model of the arterial tree. This
model ought to be able to generate realistic synthetic data, reflecting physiological phenom-
ena observed in the measured arterial blood pressure under different clinical conditions (i.e.,
different arterial material properties).
To this end, we developed a high-order distributive model of the arterial system based on
the work reported in [6] and briefly introduced in Section 4.3.2 (see Fig. 4.8b). A sample of
42Notice that blood flow waveforms can be continually collected only via an ultrasonic flowmeter placed




Fig. 4.15. Sample pressure and flow waveforms simulated from the distributed arterial model
by Stergiopulos et al. [6] over three cardiac cycles. Qasc (top left plot) and Pasc (top right
plot) are the ascending aortic blood flow and pressure, respectively. Qfem (bottom left plot)
and Pfem (bottom right plot) are the femoral blood flow and pressure, respectively. The
yellow and purple vertical lines respectively indicate the systolic and diastolic portions of
the second cardiac cycle.
the simulation results from the distributive model is displayed in Fig. 4.15, where flow and
pressure waveforms in the ascending aorta and femoral artery are compared43. As reported
in literature studies [143, 144] and evident from the simulated waveforms in Fig. 4.15, the
femoral flow shows prominent swings in the diastolic phase, whereas, at the same time, the
43Note that the model-predicted variables in Fig. 4.15 are the same as those in Fig. 4.9. Nevertheless,
they are presented again here in reference to the development process of the estimation algorithm.
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ascending aortic flow is very close to zero because of the closed aortic valve (i.e., no cardiac
pumping activity). As a consequence, the diastolic profile of the pressure at the ascending
aorta follows an exponential trajectory [99, 100, 101, 102]. On the contrary, femoral pressure
is clearly disturbed from the wave reflections and no clear exponential decay is discernible
during diastole. Hence, estimation algorithms that use femoral arterial pressure but rely
on the diastolic exponential decay assumption are expected to have poor performance, in
terms of their accuracy in estimating the circulatory system’s time constant. It is also worth
noting the delay on the foot of the waves44 between the femoral artery and the ascending
aorta—compare, for instance, the two waveforms at the time instance of the onset of positive
blood flow in the ascending aorta (marked by the first yellow line). This is a characteristic
feature of a physiological phenomenon according to which the pressure wave travels through
the arterial system at a certain finite wave velocity that depends on the elasticity, thickness,
and radius of the arterial vessels as well as the density of the blood [145].
Moreover, the physiological contractile behavior of the heart results in blood flow pro-
files that do not arbitrarily change over the systolic portion of a cardiac cycle; they typically
monotonically increase in early systole, following the cardiac contraction (ventricular de-
polarization), then monotonically decrease in late systole during cardiac muscle relaxation
(ventricular repolarization) [87]. It is therefore expected that the profile of blood flows in
systole can be satisfactorily parametrized via a piecewise quadratic function. For example,
Fig. 4.16 shows the blood flow in ascending aorta (Qasc) and femoral artery (Qfem) over
a single cardiac cycle—they are simulated, as before, from the distributed arterial model
by Stergiopulos et al. [6]. Both blood flow waveforms have been superposed with piecewise
quadratic functions (black dashed lines in Fig. 4.16) that are described based on the actual
44We define the foot of the pressure wave in a beat-by-beat fashion as the point of the pressure waveform
with the lowest value at every heart beat. This typically precedes the steeper upward pressure slope associated
with the systolic phase of cardiac function.
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waveform’s onset (to), peak (tp), and return (tr) time instances45. In particular, a generic




(tp − to)2 · (t− to)
2 +
2 · (Qp −Qo)
tp − to · (t− to) +Qo, t ∈ [to, tp)
Qo −Qp
(tr − tp)2 · (t− tp)
2 +Qp, t ∈ [tp, tr]
(4.23)
where Qp is the maximum flow value at t = tp and Qo is the flow value at the beat onset, to.
Fig. 4.16. Sample ascending aortic (Qasc, left plot) and femoral (Qfem, right plot) flow
waveforms simulated from the distributed arterial model by Stergiopulos et al. [6] over a
single cardiac cycle. The black dashed lines on both plots represent piecewise quadratic
profiles derived from parametrization of the corresponding flow waveforms during systole.
Notice that the time axis is normalized with respect to the beginning of the heart beat. to,
tp, and tr are the onset, peak, and return time instances of the piecewise quadratic functions
respectively and te represents the end of the heart beat.
Notice that we introduce the concept of flow parametrization during systole only (see (4.23)
45Such time instances are defined with respect to the systolic portion of blood flow, i.e., to indicates the




and Fig. 4.16). As shown above, wave reflections are prominent in femoral artery during
the diastolic phase46. Consequently, parametrization of the flow profile in diastole cannot
be generally performed, with the only exception being at the aorta where flow is close to
zero. In addition, the absence of wave reflections on systolic flow and pressure waveforms
allows us to assume that the dynamics of the arterial tree during systole can be adequately
described by Windkessel-type models (i.e., first- or second-order models) [143].
As schematically represented in Fig. 4.17, the proposed estimation algorithm follows the
overall scheme introduced by Mukkamala et al. [7], whereby a series of cardiac cycles are
utilized as inputs to the estimation algorithm (signals u and P in Fig. 4.17) and the arterial
system’s time constant (τˆ) is then estimated from the impulse response of the optimal ARX
model. However, the proposed algorithm differs from that in [7] because it accounts for
the aforementioned two physiological considerations; namely, 1) the parameterization of
blood flow profile during systole with a piecewise quadratic function and 2) the absence of
wave reflections in systole allowing the system to be described by low-order models. More
specifically and in reference to Fig. 4.17, the algorithm can be summarized as follows:
• Construct many sets of onset (to), peak (tp), and return (tr) time instances, defined
with respect to the foot (onset) of the arterial pressure waveform, P .
• For each set, generate a quadratic piecewise quadratic waveform corresponding to the
systolic portion of every heart beat in the data segment47.
• For each piecewise quadratic input waveform, construct the corresponding least squares
(LS) problem using only the systolic portions of input and output waveforms (notice
the thick u and P lines in Fig. 4.17).
• Solve each LS problem to estimate the coefficients (a¯i and b¯j) of a low-order autore-
46In fact, wave reflections are prominent in diastole not only in femoral artery but in all small arteries,
such as radial and brachiocephalic arteries.
47Note that estimation of the system’s time constant is independent of the amplitude of the system’s input
and thus we set the latter equal to pulse pressure, as per Mukkamala et al. [7].
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gressive model with exogenous inputs (ARX).
• For each ARX model (and, correspondingly, for each piecewise quadratic input), com-
pute the sum of squared residuals (SSR) between the model-predicted output and
system’s true output signal (i.e., measured arterial pressure P ).
• Select the ARX model (optimal ARX model with coefficients aˆi and bˆj) that attains
the minimum SSR among all LS solutions.
• Compute an estimated time constant (τˆ) from the optimal ARX model’s impulse re-
sponse.
• Repeat the same procedure progressively for all segments in the dataset.
Fig. 4.17. Schematic diagram of the proposed estimation algorithm. u, piecewise quadratic
input based on the selected onset (to), peak (tp), and return (tr) time instances; P , systemic
arterial pressure (system’s output); a¯i and b¯j, estimates of ARX model for each flow profile;
aˆi and bˆj, estimates of the optimal ARX model (with minimum SSR); τˆ , estimated time




An indispensable component in the development of any parameter estimation, or system
identification, algorithm pertains to its validation against synthetic (simulated) and experi-
mental datasets. Validation with synthetic data generated via simulations from an in-silico
mathematical model is a fundamental step before any clinical validation. In-silico simulations
provide significant advantages over human (or animal) studies. 1) They offer a controlled
“environment” that permits the generation of data under various clinical conditions, attained
by selecting specific sets of model parameters (e.g., a decrease in arterial compliance would
represent the hemodynamic response of elderly hypertensive patients). Such an environment
also allows easy reproducibility of the simulated experimental conditions, a critical com-
ponent for algorithmic validation and comparison with existing techniques. 2) The direct
interpretability of the model-simulated data, in reference to the associated model parameters,
allows researchers to draw conclusions with respect to potential limitations and, eventually,
to the clinical applicability of the estimation algorithm at hand.
For these reasons, we herein focus on evaluating the performance of the proposed esti-
mation algorithm under two distinct types of simulation studies: 1) studies with data from
a lumped-parameter Windkessel-type model and 2) studies with data from a distributed-
parameter model. It is important to point out that despite both studies are performed on
synthetic data, the use of a distributed-parameter model presents three challenges to the
estimation method:
1. The distributed model used for data generation is a high-order model with nonlinear
parameters. The estimation algorithm, on the other hand, assumes a linear low-order
lumped-parameter model. Such a disparity between the model for data generation
and the one used for estimation, typically referred to as modeling error, resembles




2. Simulated pressure and flow waveforms from a distributed model exhibit realistic dy-
namics that include physiological characteristics, such as finite wave velocity and wave
reflections, typically observed in experimentally collected data.
3. The distributed model comprises multiple arterial segments. This allows us to test
the parameter estimation method on waveforms from different locations of the arterial
tree, as if we were collecting data from different arteries. For example, we can evalu-
ate the algorithmic performance on data representing the dynamics in the aorta (e.g.,
ascending or descending aorta) or in the femoral artery. We could also be able to inves-
tigate whether the location of the arterial line (femoral versus radial artery) can affect
the estimation results. Femoral catheterization was traditionally preferred for pressure
monitoring but recently radial pressure manometry is gaining wider acceptance due to
fewer complications associated with it [146].
The algorithmic performance will be assessed with regard to the true model parameters,
selected for the generation of the synthetic data, as well as in comparison to the method
proposed by Mukkamala et al. [7], which is considered a novel and promising model-based
cardiac output estimation algorithm.
4.6.1 Simulation studies on Windkessel-type models
As opposed to a distributed model, Windkessel-type models (such as the two-, three-, and
four-element Windkessel models introduced in Section 4.3.1 or even the systemic circulation
component of the CP Model in Chapter 2, which comprises Windkessel-type subcomponents)
are rather simple low-order lumped-parameter models. Nevertheless, they present themselves
48Notice that this type of error is different than the frequently considered measurement error due to noise
corrupting the sensors. In particular, modeling error refers to the process noise term wp in (4.5a), whereas
measurement (or output) error is related to the term wm in (4.5b).
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as a necessary first step to evaluate the estimation algorithm on simplistic simulated data,
where modeling errors and high-order nonlinear dynamics are neglected.
For the present simulation studies, we will generate synthetic data from the two-element
Windkessel model of Fig. 4.6 using as its forcing function the blood flow waveform predicted
by the CP Model in Chapter 2. For example, Fig. 4.18 shows the flow waveform (Q) predicted
by the CP Model and herein used as the input function of the two-element Windkessel model.
The pressure waveform (P ) is the corresponding output signal simulated by the Windkessel
model. It is worth mentioning that with such a selection of the model for data generation and
the type of forcing function, we want to evaluate the estimation algorithm with respect to
the following aspects. 1) The two-element Windkessel model is a simple lumped-parameter
model that abides by the underlying limitation of estimation methods according to which
they are only able to estimate parameters of lumped models (e.g., ARX model). 2) The
selected blood flow profile has a parabolic shape during systole and a zero value during
diastole. Even though this decision may seem to work better for our proposed method
(Mukkamala et al. [7] assume a pulse train input function), it is worth pointing out the
algorithm by Mukkamala et al. [7] is considered a more sophisticated exponential fitting
method and thus it primarily relies on the zero flow assumption during diastole.
As mentioned earlier, simulation studies offer the possibility to generate data from specific
sets of parameter values allowing us to simulate different pathological conditions. Such sets
of parameter values can also be applied sequentially in the data generation process, thereby
allowing the evaluation of the estimation algorithm’s ability to track changes in the model
parameters. Accordingly, the dataset to be used herein for the simulation studies includes
changes in both parameters, Rt and Ct, of the two-element Windkessel model such that we
induce changes in the system’s time constant (the quantity we want to estimate). Fig. 4.19
then shows the main pressure features—namely, pulse (PP , red dots in upper plot) and mean
(P¯ , blue dots in upper plot) pressures calculated in a beat-by-beat fashion—over the entire
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Fig. 4.18. Sample flow (Q, top plot) and pressure (P , bottom plot) waveforms generated by
the two-element Windkessel model. Q is used as input to the model and P is the corre-
sponding simulated output.
simulated dataset of length equal to about 8100 s (or 135 min)49. Fig. 4.19 also illustrates
the induced changes in Rt and Ct values along with the corresponding time constant (τ).
The nominal parameter set at the beginning of the dataset (i.e., Rt = 1.15 mmHg·s/ml and
Ct = 1.50 ml/mmHg; hence, τ = 1.725 s) was selected based on the values reported by
Segers et al. [136] for normotensive subjects. Subsequently, we cycle through increases and
decreases (each by 50% with respect to the nominal value), first in the compliance (see red
line in middle plot of Fig. 4.19) and then in the resistance (see blue line in middle plot of
Fig. 4.19). As expected, a change in compliance induces a similar-in-direction change in
pulse pressure. The same behavior is observed between changes in resistance and in mean
pressure.
49We omit to present the actual pressure and flow waveforms in Fig. 4.19 due to the minimal visual
information that is provided over such a long dataset.
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Fig. 4.19. Pressure features and model parameters of the dataset used for the simulation
studies on a two-element Windkessel model. P¯ and PP (upper plot), beat-by-beat mean
and pulse pressures, respectively; Rt and Ct (middle plot), peripheral resistance and total
arterial compliance of the two-element Windkessel model, respectively; τ (lower plot), time
constant (equal to RtCt).
Deterministic case
We first evaluate the proposed estimation algorithm under noise-free (deterministic) condi-
tions, i.e., with no additive noise in the model-generated pressure waveform which is the
single input to the estimation routine. Fig. 4.20 compares the time constant estimated from
the proposed algorithm (τˆprop, blue crosshairs) with its true value (τtrue, black line) and the
one estimated from the method by Mukkamala et al. [7] (τˆmuk, red stars). Notice that the
sporadic nature of the estimates is attributed to the fact that the two methods do not operate
in a beat-by-beat fashion. Instead, as explained in Section 4.5.2, they analyze an interval
of data that spans multiple heart beats. For the present simulation studies, we follow the
convention in [7] and select the interval to be of length equal to 6 minutes. The estimation
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results in Fig. 4.20 clearly illustrate that both methods are able to perfectly estimate the
time constant, apart from the intervals that include the transition points. This latter ob-
servation is expected since the transition intervals include data segments generated under
different model parameters50.
Fig. 4.20. Comparison of the estimated time constant values from noise-free data simulated
by the two-element Windkessel model. τtrue, true time constant value; τˆprop, estimated time
constant from the proposed algorithm; τˆmuk, estimated time constant from the algorithm by
Mukkamala et al. [7].
Fig. 4.21 shows a sample segment of three cardiac cycles for comparison of the optimal
piecewise quadratic function (Qprop, red dashed line in right plot) found by the proposed
algorithm with the true flow (Q, blue line in right plot), which was used as forcing function
to generate the data. In addition, the noise-free model-simulated pressure waveform (P , left
plot) is also depicted in Fig. 4.21. It is important to note that the depicted flow waveforms
have been normalized with respect to their maximum value51. Nevertheless, the shape of the
50Notice also that the change in parameter values is instantaneous and quite significant, thereby creating
an additional challenge to the estimation.
51As described in Section 4.5.2, the amplitude of the flow profile, although unknown, does not affect the
estimation of the time constant.
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optimal Qprop shows excellent agreement with that of the true flow profile, indicating that
the algorithm has determined the correct set of onset, peak, and return time instances.
Fig. 4.21. A sample segment of three cardiac cycles showing the noise-free pressure waveform
(P , left plot), the true flow signal (Q, blue line in right plot), and the optimal piecewise
quadratic function (Qprop, red dashed line in right plot) found by the proposed estimation
algorithm. Notice that the flow waveforms are normalized with respect to their maximum
values.
Stochastic case
Subsequently, we evaluate the performance of the algorithm under noisy (stochastic) con-
ditions, where the model-simulated pressure waveform is corrupted by gaussian distributed
white noise with zero mean and standard deviation equal to 0.1, 0.2, and 0.5 mmHg. Such
noise levels are typically observed in experimentally measured arterial blood pressure signals.
Similar to the noise-free case, For each of the three noise levels, Fig. 4.22 then shows the
values of time constant as estimated from our proposed method (τˆprop, blue crosshairs) and
from Mukkamala et al. [7] (τˆmuk, red stars) and compares them with their true value (τtrue,
black line). Accordingly, Fig. 4.23 displays the optimal piecewise quadratic function (Qprop,
red dashed line in right plot) found by the proposed method.
It is evident from Fig. 4.22 that, as per our earlier analysis, the algorithm by Mukkamala
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et al. [7] is quite robust to noise when the zero diastolic flow assumption is met, like in the
present simulation data. Intuitively thinking, exponential fitting on the pressure diastolic
decay via a least squares method is optimal when pressure is corrupted by zero-mean white
gaussian noise, as done herein. Since the algorithm by Mukkamala et al. [7] is considered
an improved exponential pressure fitting technique that uses a least squares method to
estimate an nth-order ARX model, it is thus expected to have such a good accuracy of the
time constant estimates even when used on noisy data.
On the other hand, our proposed algorithm is slightly more susceptible to estimation
errors when measurement noise corrupts the pressure signal. This issue is exemplified in
the case of 0.5 mmHg noise standard deviation and especially when pulse pressure attains
its lowest value, equal to about 22 mmHg (see, for example, in Fig. 4.22c around 1000 and
4000 s, and before 7000 s time marks). Such a pulse pressure value is, however, abnormally
low since a resting pulse pressure in healthy adults is about 30–40 mmHg, with a value below
25 mmHg indicating congestive heart failure. In addition, we notice that for the same low
pulse pressure value, a high mean pressure yields worse estimation results. For instance, the
proposed estimation algorithm returns abnormally high time constant values (truncated in
Fig. 4.22c) for the simulated data around the 4000 s time mark that show a very high mean
pressure (about 220 mmHg) with the lowest pulse pressure value. Even the estimates from
the method by Mukkamala et al. [7] illustrate a lower accuracy as compared with those in the
rest of the dataset. However, it is worth mentioning that even severe hypertensive patients
do not reach such high values of arterial pressures [147]. Based on these two observations, we
can hence conjecture that the algorithmic performance may degrade in extreme pathological
conditions—although the cases shown here can be reasonably conveyed as unrealistic.
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(a) Results on simulated data with 0.1 mmHg noise standard deviation.
(b) Results on simulated data with 0.2 mmHg noise standard deviation.
(c) Results on simulated data with 0.5 mmHg noise standard deviation.
Fig. 4.22. Comparison of the estimated time constant values from simulated pressure data
corrupted by different levels of gaussian distributed white noise. Missing entries have ab-
normally high values. See Fig. 4.20 legend for explanation of symbols.
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(a) Results on simulated data with 0.1 mmHg noise standard deviation.
(b) Results on simulated data with 0.2 mmHg noise standard deviation.
(c) Results on simulated data with 0.5 mmHg noise standard deviation.
Fig. 4.23. A sample segment of three cardiac cycles showing the optimal piecewise quadratic
function (Qprop, right plot) found by the proposed estimation algorithm on simulated pressure
data corrupted by different levels of gaussian distributed white noise. See Fig. 4.21 legend
for explanation of symbols.
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4.6.2 Simulation studies on a distributed systemic arterial model
As explained thoroughly at the beginning of the current section, simulation studies on data
generated by a distributed model is of particular importance for algorithmic evaluation due
to the realistic dynamics that such data can portray. To this end, we will use the distributed
model that we developed based on the work by Stergiopulos et al. [6] and introduced in
Section 4.3.2. In contrast, though, to the simulation studies on a Windkessel model (Sec-
tion 4.6.1), we will herein only focus on changes in peripheral resistance. As contemplated
by multiple investigators [7, 133, 134, 148, 149, 150], the arterial compliance can be approx-
imated as constant over a wide pressure range and it is hence expected to exhibit minimal
changes during a patient’s hospitalization period.
It is important to note that a distributed-parameter model, like the one by Stergiopulos
et al. [6], requires a set of boundary conditions to be cast, both at the first and terminal
nodes of the model (i.e., proximal and distal ends of the arterial tree, respectively). Anatom-
ically, the first node of the model is part of the aortic root segment, while the terminal nodes
represent the systemic circulation’s peripheral vessels. It thus reasonable to prescribe the
aortic blood flow (as dictated by the heart’s pumping action) as the proximal boundary
condition, whereas the impedance at the distal end of each terminal arterial segment ought
to characterize the dynamics of the peripheral vessels and microcirculation. As such, Ster-
giopulos et al. [6] proposed the use of three-element Windkessel models (see Fig. 4.7a) as
the terminal impedance of the distributed model’s terminal segments, thereby representing
both resistive and compliant effects of the vessels beyond the termination points (i.e., mi-
crocirculation). Consequently, in the present study, we will simulate changes in peripheral
resistance by increasing or decreasing the respective resistance, Rt, of all terminal three-
element Windkessel models. In particular, we induce changes in Rt with steps of 25% of
their nominal values, first by increasing them to 125%, 150%, and 175%, and finally low-
ering them to 125% of their initial values (each step change in Rt was maintained over a
duration of 10 minutes). That is, if Rt,nom represents a nominal peripheral resistance value
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at the beginning of the study, the actual Rt value over the course of this case simulation
study will be: Rt = [1.25, 1.5, 1.75, 1.25] · Rt,nom. For example, Fig. 4.24 shows how such
changes in Rt affect the ascending aortic pressure waveform (Pasc), in terms of mean (P¯ )
and pulse (PP ) pressure values. Even though we only considered changes in the resistive
properties of the terminal impedances—changes in P¯ are thus expected—, we notice that
pulse pressure of Pasc is also influenced. This is a consequence of the varying levels of wave
reflections, whose magnitude is known to be affected by the terminal boundary conditions
(i.e., peripheral vessels in the arterial tree). Notice that ascending aortic blood flow (Qac)
is unaffected because it is the model’s forcing function (proximal boundary condition) and
thus imposed by us—we herein assume a constant cardiac activity.
Fig. 4.24. Ascending aortic flow (Qasc, upper plot) and pressure (Pasc, middle plot) waveforms
simulated from the distributed-parameter model by Stergiopulos et al. [6]. P¯ and PP (lower




We will first evaluate the proposed algorithm on synthetic data from the ascending aortic
model segment (see Fig. 4.24). As detailed in Fig. 4.15, the ascending aortic flow is approxi-
mately zero during diastole and thus Pasc decays exponentially. Such a physiological behavior
resembles the dynamics of Windkessel-type models52, like the two-element Windkessel model
used for the simulation studies in Section 4.6.1, thus making the estimation of the system’s
time constant readily available by fitting the pressure exponential decay during diastole.
Having this observation in mind, we will then consider as the system’s “true” time constant
the value estimated from the exponential diastolic decay of the ascending aortic pressure
waveform. For example, Fig. 4.25 shows the exponential fitting function Pf on the diastolic
part of Pasc during the segment of the simulated data in Fig. 4.24, where parameters are at
their nominal levels. The time constant of such a decay is, hence: τ = 1/1.288 = 0.78 s.
Fig. 4.26 compares the estimation results from our proposed estimation algorithm (τˆprop,
left column) and the algorithm by Mukkamala et al. [7] (τˆmuk, right column). As in Sec-
tion 4.6.1, we evaluated the algorithmic performance under different levels—in terms of the
noise standard deviation (σ)—of additive zero-mean gaussian white noise corrupting the
pressure waveform; namely, σ = 0 for noise-free conditions (deterministic case, first row in
Fig. 4.26) and σ = 0.1, 0.2, and 0.5 mmHg for the stochastic case (second, third, and fourth
rows in Fig. 4.26 respectively). It is important to point out that, as mention earlier, such type
of noise is treated as measurement noise and is not related to disturbances from unmodeled
phenomena. However, in the simulation studies analyzed herein, the discrepancy between
the model for data generation (i.e., distributed-parameter model) and the model considered
in the estimation routine (i.e., lumped-parameter ARX model) gives rise to unmodeled dy-
namics (i.e., dynamics that cannot be explained by the estimated model). Undoubtedly, such
a phenomenon is present when estimation algorithms are applied on experimental data, thus
52Recall that Windkessel-type models were developed precisely for detailing the load of the arterial tree
on the heart as portrayed in the pressure and flow waveforms at the aortic root level.
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Fig. 4.25. Exponential fitting on the diastolic part of the ascending aortic pressure (Pasc)
simulated from the distributed-parameter model by Stergiopulos et al. [6]. Pf , exponential
fitting function; P0, initial value of exponential function (not meaningful in this case).
making the simulation studies on distributed model-generated data an essential component
if one wants to complete a thorough evaluation of any potential estimation algorithm, prior
to using experimental data.
A quick examination of the data in Fig. 4.26 reveals that the estimates from the algo-
rithm by Mukkamala et al. [7] attain values closer to the system’s “true” time constants
(black dots in all plots of Fig. 4.26) as computed by fitting an exponential function on the
diastolic pressure decay for every beat in the dataset. In addition, Mukkamala et al. [7]
algorithm maintains its robustness to additive white noise, consistent with our conclusion
from the simulation studies on lumped-parameter data (see Fig. 4.22). On the other hand,
our proposed technique seems to be prone to some errors when additive noise is corrupting
the pressure waveform, particularly when the 6-minute segment under investigation contains
data generated from different model parameters, i.e., different time constants, and noise has
a standard deviation of σ = 0.5 mmHg (see dashed encircled estimates in bottom left plot
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of Fig. 4.26). Further, our algorithm’s estimates (τˆprop) obtain lower values as compared
with the system’s “true” time constants. Notice, however, that despite such an estimation
error in absolute terms, the percent change in τˆprop for each step change in the model’s
peripheral resistances is relatively consistent with the change in τtrue. Particularly, in the
σ = 0.1 mmHg noisy case (second row in Fig. 4.26), τˆprop progressively increases from 0.37 s
to 0.43, 0.53, and 0.62 s and finally decreases to 0.43 s. In relative terms, with reference to
the initial τˆprop of 0.37 s, the percent change in τˆprop is: 16%, 43%, 68%, and finally 16%
(compare that with the change in τtrue of 25%, 50%, 75%, and back to 25%). In contrast,
τˆmuk values respectively change from 0.87 s to 1.3, 1.8, 2.3 s and then back to 1.3 s, which
correspond to a relative percent change of 49%, 108%, 164%, and finally 49%. Such an out-
come is of particular significance since the final output of algorithms that aim to estimate
the circulatory system’s time constant is a relative cardiac output value. As mentioned in
Section 4.4.2, such algorithms rely on an accurate time constant estimation in order to infer
cardiac output within a proportionality constant equal to the inverse of the total arterial
compliance (4.16). It is hence apparent that even though τˆprop is erroneous in absolute terms
with respect to the model’s “true” time constant, our proposed estimation scheme seems to
be advantageous as compared to the one by Mukkamala et al. [7] because the change in τˆprop
is relatively consistent with the change in τtrue.
Finally, Fig. 4.27 shows the optimal piecewise quadratic function (Qprop, red dashed
line in right plot) found by the proposed method for the three noise-corrupted cases, i.e.,
σ = 0.1, 0.2, and 0.5 mmHg (from top to bottom). As anticipated from the estimation results
on lumped-parameter data, increasing the noise level leads to slightly skewed optimal flow
profiles. This outcome is attributed to the fact that the onset, peak, and return indices of the
piecewise quadratic function depend on the pressure onset, which is affected by the additive
noise. Nevertheless, one can appreciate the relatively good performance of the algorithm to
approximate the system’s true blood flow Q.
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Fig. 4.26. Comparison of the estimated time constant values from ascending aortic synthetic
data with different levels of additive white noise. τtrue (blank dots), true time constant
value; τˆprop (crosshairs in left column), estimated time constant from the proposed algorithm;
τˆmuk (stars in right column), estimated time constant from the algorithm by Mukkamala
et al. [7]; σ, standard deviation (in mmHg) of additive gaussian zero-mean white noise.
Dashed encircled estimates indicate segments containing data generated from different model
parameters, i.e., different time constants.
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(a) Results on simulated data with 0.1 mmHg noise standard deviation.
(b) Results on simulated data with 0.2 mmHg noise standard deviation.
(c) Results on simulated data with 0.5 mmHg noise standard deviation.
Fig. 4.27. A sample segment of three cardiac cycles showing the optimal piecewise quadratic
function (Qprop, right plot) found by the proposed estimation algorithm on synthetic ascend-
ing aortic pressure data corrupted by different levels of gaussian distributed white noise.





In this section, we investigate the performance of the proposed algorithm on data from
the deep femoral model segment. As opposed to the waveforms from the ascending aortic
segment, analyzed in the previous section, deep femoral pressure and flow waveforms are
affected by wave reflections, similar to those observed in the femoral artery (see, for ex-
ample, Fig. 4.15). The reason, though, that we focused on data simulated from the deep
femoral segment of the distributed model, instead of using the femoral artery waveforms,
is twofold: 1) Anatomically, the deep femoral artery originates from the same location as
the femoral artery; that is, from the iliac artery. Hence, experimental flow and pressure
waveforms from these two arteries are expected to have relatively similar dynamic character-
istics. 2) Stergiopulos et al. [6] modeled the deep femoral artery as a terminal segment of the
distributed model via a lumped-parameter Windkessel model (distal boundary condition).
As a consequence, we know precisely the values of the terminal resistance and compliance
that contribute to the time constant to be estimated. It is important to reiterate, however,
that even though the deep femoral arterial segment has been modeled via a three-element
Windkessel model, its pressure waveform does not exhibit an exponential decay during dias-
tole, as evidently shown in Fig. 4.28 for a segment of the dataset considered in the present
study. Fig. 4.29 then summarizes the main features of the deep femoral pressure waveform
(i.e., mean and pulse pressures in upper plot of Fig. 4.29) along with the true time constant
(lower plot of Fig. 4.29) over the entire dataset. Even though we only induced changes in
terminal resistance, it is noticeable that pulse pressure was also affected, a clear indication
of the wave reflection phenomena influencing the deep femoral waveforms53.
Similar to how we analyzed the results on the ascending aortic waveforms, Fig. 4.30 shows
the estimated time constant values from our proposed algorithm (τˆprop) and from the algo-
rithm by Mukkamala et al. [7] (τˆmuk) and compares them with the true value (τtrue). Then,
53Compare such an observation with Fig. 4.19, which depicts the dataset used for the simulated studies
on Windkessel model-generated data, and notice that a change in Rt of the Windkessel model did not affect
the ensuing pulse pressure (see, for instance, around the 2800 s time mark when Rt is increased).
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Fig. 4.28. Sample deep femoral flow (Qdeep,fem, top plot) and pressure (Pdeep,fem, bottom
plot) waveforms generated from the distributed model by Stergiopulos et al. [6].
Fig. 4.31 depicts the optimal piecewise quadratic function (Qprop) found by the proposed
estimation scheme. Clearly, our method is able to get more accurate estimation results for
all levels of additive white noise, except for some instances, like the two unreasonably high
estimates in the noise-free case, that require further investigation. Remarkable is also the
fact that despite the marked difference in the underlying model dynamics, the time con-
stant estimates by Mukkamala et al. [7] exhibit a minor change in value as compared with
those from the ascending aortic case (e.g., the estimated values on the first data segment are
around 1 s for both ascending aortic and deep femoral cases). On the contrary, though, to
the observations from Fig. 4.26, the estimates from both algorithms show a relative change
with respect to their initial values similar to the change observed in τtrue after each step
change in terminal resistance (i.e., 25%, 50%, 75%, and back to 25%). For example, in the
σ = 0.1 mmHg noisy case (second row in Fig. 4.30), we get the following results: τˆprop = 0.14,
0.18, 0.22, 0.25, and 0.18 s (that is, 28%, 57%, 78%, and 28% increase of the initial value)
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Fig. 4.29. Pressure features (P¯ and PP , beat-by-beat mean and pulse pressures, respec-
tively) and time constant (τ = RtCt, lower plot) of the terminal three-element Windkessel
model at the terminal node of the deep femoral arterial segment of the distributed model by
Stergiopulos et al. [6].
and τˆmuk = 0.91, 1.08, 1.31, 1.52, and 1.08 s (that is, 19%, 44%, 67%, and 19% increase of
the initial value)
4.7 Conclusion and future work
In this chapter, we first introduced the concepts of system identification and parameter esti-
mation and briefly described how such algorithms can be applied on assessing the structure
and parameters of a dynamic system of interest. We then explained the function of the car-
diovascular system by considering the heart as a source and the systemic circulation as a dy-
namic system. Accordingly, we discussed the efforts of the research community to model the
complex dynamics of the arterial tree either via lumped-parameter or distributed-parameter
modeling techniques. Before delineated our proposed model-based algorithm to estimate the
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arterial tree’s time constant from arterial blood pressure measurements, we deemed neces-
sary to summarize the current clinical methods and the existing model-based techniques for
cardiac output assessment and highlight their limitations. Finally, we evaluated the per-
formance of the proposed estimation scheme via simulation studies on data generated from
either a lumped or a distributed model of the systemic arterial tree. The validation showed
the potential of such an algorithm but also revealed some of its limitations. Particularly,
the estimation results from the proposed method seemed to be less robust during abrupt
changes in the underlying model parameters (e.g., a change in peripheral resistance). Nev-
ertheless, we believe that such sudden changes in the mechanical properties of the arterial
tree are unrealistic and we, instead, expect them to happen gradually over a period of time.
It is hence desirable to extend our validation process on datasets with gradual changes in
the model parameters and evaluate the algorithm’s estimation results under such a more
physiological hemodynamic response. In addition, it is also necessary to assess the effect of
the duration of the data segment under consideration on the algorithm’s performance. We
herein assumed a duration of 6 minutes for the data segment that the algorithm will process
to infer an estimated time constant. Besides any clinical considerations on the necessity of
having shorter segments, it is also worth analyzing the effect of the segment’s duration when
noise levels are increasing. In terms of noise, precise evaluation of its impact on estimation
results needs to be conducted via Monte-Carlo simulations. Finally, adoption of any newly
proposed algorithm requires its validation on experimental data collected from human or
animal studies. This is undoubtedly the ultimate and most crucial step for assessing the
algorithm’s clinical applicability and potential impact. It is worth pointing out that the
nonlinear nature of the cardiopulmonary system and the occurrence of unforeseeable events
may lead to suboptimal experimental conditions, compromising the quality of the collected
data. Nevertheless, the necessity of experimental validation is indisputable and it is of high
priority in our future work.
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Fig. 4.30. Comparison of the estimated time constant values from deep femoral synthetic
data with different levels of additive white noise. τtrue (blank dots), true time constant value;
τˆprop (crosshairs in left column), estimated time constant from the proposed algorithm; τˆmuk
(stars in right column), estimated time constant from the algorithm by Mukkamala et al. [7];
σ, standard deviation (in mmHg) of additive gaussian zero-mean white noise.
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(a) Results on simulated data with 0.1 mmHg noise standard deviation.
(b) Results on simulated data with 0.2 mmHg noise standard deviation.
(c) Results on simulated data with 0.5 mmHg noise standard deviation.
Fig. 4.31. A sample segment of three cardiac cycles showing the optimal piecewise quadratic
function (Qprop, right plot) found by the proposed estimation algorithm on synthetic deep
femoral pressure data corrupted by different levels of gaussian distributed white noise. P =




Summary and future research
In this thesis, we introduced a set of tools that could become the foundation of future devel-
opments in patient-tailored critical care medicine. They could also lead to major improve-
ments in the design phase of medical devices such as mechanical ventilators—the specific
case presented herein. To this end, we leveraged the power of mathematical models in or-
der to describe and analyze physiological heart-lung interaction phenomena and to propose
a model-based parameter estimation technique to infer the function and properties of the
cardiovascular system.
In particular, in Chapter 2, we proposed a series of improvements on a previously de-
veloped cardiopulmonary model to better replicate the heart-lung interaction mechanisms
typically observed in mechanical ventilation conditions. As such, we appended the peri-
cardial membrane and interventricular septum and we modified the pulmonary circulation
model to account for the compression of the pulmonary peripheral vessels from lung infla-
tion; hence, the modified cardiopulmonary model (CP Model). We compared this newly
proposed modified model with the original model in normoxic, hypercapnic, and hypoxic
conditions and we validated its response against literature data collected under mechanical
ventilation conditions. Finally, we used simulations from the modified model to: 1) analyze
heart-lung interaction phenomena during two common clinical interventions, i.e., mechanical
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ventilation and fluid resuscitation, and 2) provide physiological explanations to a few con-
tradicting experimental results regarding the effects of PEEP on right ventricular function
and on the position of the interventricular septum. All these simulation studies provided
further credence to the capability of the model in describing the underlying mechanisms of
cardiorespiratory interactions.
We then presented the patient emulator system (Chapter 3), a novel device that is based
on the proposed modified cardiopulmonary model. The novelty of this system is the fact
that it includes a piston-cylinder configuration which allows the software-implemented vir-
tual patient (i.e., the modified model of Chapter 1) to interface with a physical ventilator.
Hence, the patient emulator is capable to reliably and correctly reproduce the physiological
cardiorespiratory interaction mechanisms that are of profound importance in mechanically
ventilated patients. It is then possible for one to use the proposed patient emulator to:
1) quantitatively test and compare mechanical ventilation therapies in a well-controlled ex-
perimental environment, and 2) assess therapeutic outcomes for different cardiorespiratory
pathologies based on to the virtual patient’s health progression—a clear advancement from
the current state-of-art devices, such as the mechanical (e.g., bellows-type) systems and the
simple model-based breathing simulators. In that regard, we demonstrated a test case sce-
nario where we simulated a realistic pressure support ventilation step protocol and showed
good agreement between the emulator-simulated response and averaged experimental data
from human subjects.
Lastly, in Chapter 4, we first summarized and described the most commonly used devices
to assess cardiac output in a clinical setting. We then detailed existing model-based algo-
rithms for cardiac output estimation along with their limitations. Accordingly, we proposed
a novel model-based technique to estimate two clinically important attributes of the cardio-
vascular system, namely the cardiac output and the arterial tree’s time constant. Although
an absolute cardiac output estimate is practically not feasible, we described the clinical
importance of providing relative cardiac output values. Such values are expected to be pro-
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portional to the true cardiac output and hence follow any changes in the true value. This
is particularly important for hemodynamic unstable patients whose cardiovascular function
needs to be monitored when external interventions (e.g., fluid resuscitation) are considered
and unforeseen cardiac complications need to be avoided. Finally, we evaluated the per-
formance of the proposed estimation scheme on realistic synthetic data generated from a
distributed-parameter model of the systemic circulation.
5.1 Future research
The solutions proposed and developed in this thesis constitute a small step toward im-
proving the current standard of medical care and enhancing the clinical decision-making
process. Although we primarily focused on mechanical ventilation therapy, the mathemati-
cal frameworks, on which the proposed solutions are based, can be applicable to other areas
of therapeutic care, such as fluid management, anesthesia, and drug infusion.
In particular, we envision the combination of forward modeling approaches and of estima-
tion techniques (inverse modeling) into a single platform that would allow the development
of patient-tailored therapies across the continuum of care (operating room, ICU, general
ward, home). The solutions for critical care management, including decision support tools
for clinical interventions (e.g., fluid management and PEEP titration) and optimal closed-
loop strategies for bedside medical devices (e.g., mechanical ventilators), are of paramount
importance in improving medical practice. As such, potential future research can be sum-
marized via the block diagram presented in Fig. 5.1 and previously introduced in Chapter 1
as part of our vision. Fig. 5.1 schematically shows how the current standard of care (blue
and orange boxes) can be enhanced by the solutions presented in this thesis (green boxes).
In a typical clinical setting, attending physicians interact with medical devices, such as a
mechanical ventilator and an infusion pump, in a purely empirical and heuristic way. That
is, before considering any intervention or therapeutic path, medical personnel assess the
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health status of each patient by primarily relying on their knowledge and personal clinical
experience for the interpretation of the physiological data from the bedside clinical instru-
mentation. However, such an empirical assessment provides an insufficient image of the
patient’s true condition, primarily due to the following two factors: 1) the low specificity of
the data that are typically monitored in the ICU, and 2) the data overload problem. Most
of the bedside physiological data offer limited information about the patient’s underlying
condition, unless some highly invasive interventions (e.g., pulmonary artery catheterization)
are considered. For example, hypotension can be easily determined via the ubiquitous blood
pressure monitoring. However, as illustrated in Section 2.5, hypotension is a clinical mani-
festation of more than a single pathology. It can be linked to either a cardiac complication
(e.g., low cardiac output), a vascular disease (e.g., sepsis), or blood loss (hypovolemia). Cru-
cially, though, each of these pathological conditions requires a different treatment; volume
expansion, for instance, is only beneficial to those patients who are truly in hypovolemic
state. It is then evident that by relying only on pressure monitoring, the hypotensive pa-
tient’s true pathology cannot be effectively determined unless additional, highly invasive,
techniques are employed, such as the pulmonary artery catheterization for the measurement
of cardiac output. In addition to this difficulty in measuring quantities that are essential for
inferring the patient’s true condition, physicians have to deal with the problem of data over-
load, particularly when it comes to multi-bed care units. Every day, attending physicians
have to oversee a large number of critical care patients. Furthermore, for each patient, there
is a plethora of signals and vital signs being displayed at the bedside monitoring devices. As
a result, these two factors add further burden on the clinicians’ daily load and may hamper
the correct interpretation of the available physiological data during the short time window
of the decision-making process. It is also important to note that attaining a more accurate
health status assessment is not necessarily correlated with the number of clinical data be-
ing collected; it is rather the relevance between the measured variables and the patient’s
pathology that matters the most. For example, in the hypotension case presented above,
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collecting additional pressure waveforms (e.g., arterial and venous pressures) will not provide
additional information about the cardiovascular status of the patient. On the contrary, it
is the monitoring of specific variables, such as the cardiac output, that would ultimately




















Fig. 5.1. A high-level schematic representation of potential future research based on the
work presented in this thesis (green boxes). System ID, system identification; CDS, clinical
decision support.
One way to mitigate the aforementioned two problems is by enhancing the clinical
decision-making process via the development of clinical decision support (CDS) tools. In
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that regard and as illustrated in Fig. 5.1 (green boxes), forward modeling techniques offer
significant benefits. Physiology-based mathematical models, such as the cardiopulmonary
model introduced in Chapter 2, can provide a holistic understanding of the function of the
human body, including the effects of the neural feedback mechanisms and of the mechani-
cal heart-lung interactions. As a result, model-based computer simulations can provide an
efficient quantitative tool to analyze cardiopulmonary dynamics. Using such simulations,
medical personnel can conduct virtual physiological experiments, investigate different clini-
cal scenarios, and assess the outcomes of specific treatments based on the virtual patient’s
health progression.
Despite these advantages in performing in-silico physiological experiments, there are
certain limitations with our modified CP Model. In particular, such a model is purely de-
terministic in nature since model parameters are deterministic quantities. In other words,
the user (e.g., a clinician) can only select a specific set of parameter values that would, in
turn, result in a specific trajectory in the model-simulated variables, such as the pressures
and flows in the model’s cardiovascular component. Typically, such a set of model param-
eters would be selected so that it represents average values for a particular patient class of
interest, such an ARDS patient. Consequently, the model’s dynamic response, as described
via the model outputs, would replicate features that are typical to the average patient class
data. It is then apparent that a probabilistic framework to simulating the model outputs
can offer substantial benefits and improvements to clinical decision support. Describing the
model parameters via probability density functions over the parameter space would allow the
physicians to utilize the fact that certain values of a parameter are more (or less) likely than
others, based on previous studies or knowledge. The model outputs can then be represented
as stochastic processes rather than deterministic time-dependent variables. The inherent
capability of stochastic processes to be associated with probability density functions will
render the possibility to simulate the health progression of the entire patient class instead
of just of a single subject. This will practically allow the physicians to promptly examine
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the effects of a specific treatment for the entire class of interest (even for marginal patient
cases within each class) without having to rerun the simulations with different parameter
sets from the same class.
Aside from the probabilistic simulation framework, the modified CP Model can be fur-
ther expanded, with respect to the version presented in Chapter 2, by adding the following
components: 1) long-term humoral regulation (e.g., renin-angiotensin-aldosterone system),
2) fluid filtration in the lungs, and 3) a renal component for describing the acid-base and
fluid balance in the human body. All these additional model subsystems are expected to
improve the model’s overall response under certain disease states and clinical interventions.
For example, in ARDS patients, the increased permeability of the pulmonary vascular wall
allows fluid to seep into the alveolar compartments, thereby affecting lung fluid filtration.
On the other hand, regulation of body fluids by the kidneys can be of paramount importance
during fluid resuscitation scenarios, when fluids are administered to the patient in an effort
to improve their cardiovascular status.
The patient emulator system of Chapter 3 is as another useful tool for enhancing clinical
decision making. Not only does it provide a physical device on which clinicians can examine
the effects of different device settings and therapeutic paths, but it can also be used by medi-
cal device companies for verification and validation of their new products, such as mechanical
ventilators. Thus, upgrading the patient emulator system in terms of hardware components
can address certain limitations of the current implementation and enhance its value in testing
and developing new medical devices. We envision the following improvements:
1. Gas mixing inside the emulator’s piston-cylinder arrangement, according to the model-
predicted oxygen and carbon dioxide fractions in expired air, would be a highly de-
sirable upgrade. Currently, the ventilator’s gas fraction settings and sensors are not
interfaced with the model’s parameters and variables; for example, a change in the
ventilator’s F IO2 setting is not sensed by the model, unless a corresponding change in
the respective model parameter is made. In addition, gas mixing will also allow test-
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ing of respiratory devices that monitor end-tidal CO2, another critical and universally
used vital sign for ventilated patients.
2. A more sophisticated hardware interface between model and ventilator, i.e., improving
or replacing the piston-cylinder arrangement, can also be considered. This is expected
to enhance the system’s closed-loop response, which currently relies on the piston-
cylinder’s default hardware controller.
Lastly, the concepts and theoretical frameworks of parameter estimation, or system iden-
tification, are at the core of the development of personalized clinical decision support tools
and optimal closed-loop strategies, as per Fig. 5.1. The importance of such techniques lies in
the fact that they can turn a generalized model into a patient-specific one, which is then able
to accurately replicate the dynamic behavior of the patient at hand. For example, continual
cardiovascular system identification could enable monitoring of the effects of a specific ven-
tilation or fluid therapy (e.g., change of ventilator settings or administration of fluids) on the
particular patient under treatment. As analyzed in Chapter 4, our efforts focused on classic
(or Fisherian) estimation approaches, in which the parameters to be estimated are assumed
deterministic and the only information available to the algorithm is the measurement data
from the bedside monitoring devices. Future work can then be extended into probabilis-
tic (or Bayesian) approaches. These assume that a priori information about the unknown
parameters is available in the form of probability density functions. Such information is
typically generated from population studies and, if appropriately selected, can practically
constrain the feasible parameter space and appreciably enhance the estimation accuracy.
Moreover, parameter estimation algorithms can also be applied for different body organs,
such as the respiratory (see earlier work by our group [32, 151, 152, 153]) and renal systems.
Combining the estimation results from different physiological subsystems (e.g., cardiovas-
cular and respiratory) would allow us to develop feedback control strategies that optimally
alter ventilator settings, or fluid administration rates, while taking into consideration the
specific patient’s particular clinical condition. The optimality of such control strategies is
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greatly associated with the fact that the selected therapeutic path may have opposite effects
on different organs. As shown, for instance, in the simulation studies in Chapter 2, PEEP
application may improve ventilation and gas exchange, but it may also induce detrimental
effects on cardiac performance. We can, hence, envision the use of optimal control strategies
that regulate the level of PEEP while monitoring its influence on the particular patient’s
cardiac function.
Complementary to the aforementioned model-based estimation approaches (whether clas-
sic or Bayesian), data mining (or machine learning) methods can also be incorporated into
the health status assessment component (see Fig. 5.1). Although not mentioned in this
thesis, machine learning offers significant advantages over model-based methods, particu-
larly with respect to disease detection and patient class classification. For example, we can
consider running classification algorithms to specify the class of the patient at hand before
applying Bayesian estimation which would then utilize the a priori information of the classi-
fied patient class. Furthermore, data mining techniques can be developed to take advantage
of non-physiologic data, such as the information stored in the patient’s electronic medical
records (EMR), drug types, and administration rates, as well as different waveform features
that can be associated to the patient’s health condition.
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Appendix
The equations describing the pulmonary circulation model of Section 2.3.3 are obtained
by applying the conservation of mass (continuity equation) and momentum (compatibility
equation) laws on the electrical analog in Fig. 2.3.
Cpa · d(Ppa − Ppl)
dt
= Qrv,o −Qpa (A1)
Vpa = Cpa · (Ppa − Ppl) + Vu,pa (A2)
Lpa · dQpa
dt
= Ppa − Ppal −Rsa ·Qpa (A3)
Cpal · d(Ppal − Ppl)
dt
= Qpa − (Qpal +Qps) (A4)







Vpal = Cpal · (Ppal − Ppl) + Vu,pal (A7)
Cpc · d(Ppc − PA)
dt





Vpc = Cpc · (Ppc − PA) + Vu,pc (A10)
Cpv · d(Ppv − Ppl)
dt
= Qps +Qpc −Qpv (A11)
Qps =
sh





Vpv = Cpv · (Ppv − Ppl) + Vu,pv (A14)
Derivation of (2.10) from (2.9) is based on the following two assumptions:
1. Rpp,tot is the total resistance of the pulmonary peripheral circulation, i.e., the equivalent
resistance of the electrical circuit between Ppal and Ppv in Fig. 2.3, at steady-state
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conditions and at a nominal functional residual capacity, FRCnom,
Rpp,tot =
Rps · (Rpc + Ppal(VA = FRCnom))
Rps +Rpc + Ppal(VA = FRCnom)
. (A15)
2. Similar to the model by Lu et al. [30], the resistance Rpc does not change with respect
to VA. Its value is considered equal to Rpal when alveolar volume is equal to FRCnom,
Rpc = Rpal(VA = FRCnom). (A16)






⇒ Rps = 1− sh
sh
· (Rpal(VA = FRCnom) +Rpc)
=




Rpp,tot = 2 · (1− sh) ·Rpal(VA = FRCnom). (A18)





















2 · (1− sh) . (A21)
Notice that the shunt resistance Rps does not need to be explicitly specified because the flow
over the pulmonary shunts, Qps, is replaced by Qpal according to (A12).
200
